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Abstract
Transdermal drug delivery offers many advantages over traditional drug administration
methods such as injections and oral delivery, including increased patient compliance, and
avoiding first-pass effects. However, due to the low skin permeability, transdermal drug
delivery is currently limited to only a handful of drugs that are hydrophobic and of low
molecular weight. The pharmaceutical relevance of many molecules that are excluded
from this category, such as proteins, peptides, and DNA, has stimulated the investigation
of various skin permeation enhancement methods, among which ultrasound represents a
promising skin permeation enhancer. Previous work by our group has shown that
ultrasound at a frequency of 20 kHz significantly enhances transdermal transport of
drugs, a phenomenon referred to as Low-Frequency Sonophoresis (LFS). The objective
of this thesis was to develop a fundamental understanding of the mechanisms of low-
frequency sonophoresis (LFS) with an emphasis on the transdermal transport of
hydrophilic permeants. An important goal was to utilize this mechanistic understanding
to develop guidelines for the rational design of clinical LFS systems.
With this in mind, a transport theory was developed to characterize the skin porous
pathway of hydrophilic permeants, and to account for the effects of convection during
LFS. Through a combined theoretical and experimental investigation of transdermal
transport of hydrophilic permeants in both the presence and in the absence of ultrasound,
I demonstrated that skin transport of hydrophilic permeants can be described adequately
with a skin porous-pathway model. The theory developed can be used not only to predict
the rate of drug penetration across the skin, but also to characterize the effect of various
ultrasound conditions on the skin microscopic transport properties (the effective pore
radius and the ratio of porosity to tortuosity of the skin porous pathway), thus enabling
the optimization of the ultrasound conditions for the rational design of LFS drug delivery
systems. In addition, the theory can potentially be utilized to characterize the effects of
other skin permeation enhancers, such as chemical enhancers (for example, water) and
iontophoresis, on the skin porous pathway.
Based on two-photon microscopy imaging of the 3D-distribution of hydrophilic
probes in the skin, the relevance of the intercellular and the intracellular domains for the
transport of hydrophilic permeants was inferred. Results suggest that LFS causes the
formation of localized transport regions on the skin, and that within each localized
transport region, the distribution of the skin pathway of hydrophilic permeants is a
function of the skin depth. Specifically, in the superficial region of the skin, the pathway
is both intercellular and intracellular, while in the deeper regions of the skin, the pathway
is primarily intercellular. This inhomogeneous 3D-distribution of the hydrophilic probe in
the skin during LFS suggests heterogeneity in the nature of the skin permeabilization
mechanisms by LFS, which could possibly be attributed to the cavitation mechanism.
The role of the ultrasound-induced cavitation during LFS was assessed utilizing a
custom-designed high-pressure LFS cell which can generate high ambient pressures to
suppress cavitation during LFS, while not affecting the non-cavitational effects induced
by ultrasound. Results from the high-pressure LFS cell studies showed that cavitation
indeed plays the key role during LFS. An acoustic method was then utilized to
characterize the importance of two types of cavitation activities, transient and stable
cavitation, during LFS, and a good correlation was found between skin permeabilization
and the activity of transient cavitation. Subsequently, the roles of the various mechanisms
via which transient cavitation affects the skin barrier (including shock waves, high-
velocity jets, or free-radical production) were investigated utilizing chemical and
mechanical dosimetry techniques. Results indicated that LFS-induced skin
permeabilization results mainly from the direct impact of cavitation bubbles collapsing
on the skin surface (microjets and shock waves), and future investigations directed at
optimizing LFS conditions should aim at localizing transient cavitation activity in the
vicinity of the skin membrane (for example, by using focused ultrasound).
To address the in vivo/in vitro correlation of LFS, a comparative study of in vivo/in
vitro skin was conducted using pig as the animal model and mannitol as the model
hydrophilic permeant. Three types of commonly utilized in vitro skin models for passive
skin permeation studies were investigated, including heat-stripped skin, split-thickness
skin, and full-thickness skin. Results show that in vivo and in vitro skin respond to LFS at
different rates, and upon exposure to the same ultrasound energy dose, no good
correlation is observed between the in vivo skin and the three in vitro skin models
examined. When using the skin electrical resistance as a quick indicator of the skin
permeabilization state during LFS, the difference between the in vivo and the in vitro
skin can be diminished. Specifically, under a constant skin electrical resistance protocol,
a good correlation was observed between the LFS permeability of mannitol measured
using the three in vitro skin models examined and that of the in vivo pig skin.
Histological studies conducted with the in vivo pig skin revealed that the LFS protocol
that was shown to be efficacious in enhancing the skin penetration rate of mannitol across
the in vivo pig skin (28-fold), and was also utilized for the in vivo/in vitro skin
comparative studies, is safe for the living skin.
The usefulness of a two-parameter Fickian diffusion model (with constant parameter
values) for predicting the skin steady-state permeability based on measurements of
transient diffusion was evaluated using both hydrophilic and hydrophobic permeants. The
modeling results provide useful insight into the skin permeation mechanisms of these two
classes of permeants. In addition, the effects of skin hydration (water being viewed as a
skin permeation enhancer) on the microscopic properties of the skin porous pathway were
characterized using the Fickian diffusion model and a skin porous-pathway theory
developed earlier in this thesis. The results showed that during a 48 h in vitro diffusion
cell study with excised pig skin as the skin model, hydration-induced skin permeation
enhancement of hydrophilic permeants occurs through a mechanism of new pore
induction and/or reduction of the tortuosity of the skin porous pathway within the pig
skin.
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Chapter 1
Introduction
1.1 Transdermal Drug Delivery
Transdermal drug delivery offers many advantages over traditional drug administration
methods such as injections and oral delivery, including increased patient compliance,
avoiding first-pass effects, and the ability to deliver drugs at a nearly constant rate over
long time periods. However, in spite of the many advantages associated with transdermal
drug delivery, systemic as well as topical delivery of drugs via the transdermal route is
limited by the low skin permeability which is attributed to the stratum comeum (SC), the
outermost layer of the skin. 1 The SC consists of disk-like dead cells (keratinocytes)
containing keratin fibers and water, surrounded by densely-packed lipid bilayers. The
highly-ordered structure of the lipid bilayers confers a highly impermeable character to
the SC. A variety of approaches have been suggested to enhance transdermal drug
transport. These include: i) use of chemicals to either modify the skin structure or to
increase the drug concentration in the transdermal patch,2 , 3 ii) applications of electric
fields to create transient transport pathways [electroporation] 4, 5 or to increase the
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mobility of charged drugs through the skin [iontophoresis], 6 and iii) application of
ultrasound [sonophoresis]. 7 , 8
Sonophoresis was shown to enhance transdermal drug transport about half a
century ago by Fellinger et al. 9 who showed that application of ultrasound increases
transport of hydrocortisone across the skin. Following this study, attempts were made to
enhance transdermal transport of more than 15 drugs including steroidal anti-
inflammatory drugs such as hydrocortisone, dexamethasone; non-steroidal anti-
inflammatory drugs such as salicylates and ibuprofen; anesthetic agents such as
lidocaine; and proteins such as insulin. Three ranges of ultrasound frequencies have been
investigated to enhance drug transport rates, including: therapeutic frequency (1-3 MHz),
imaging frequency (10-16 MHz), and low frequency (20-150 kHz). A complete literature
review of sonophoresis in these three frequency ranges can be found in a recent
review. 10 Transdermal transport enhancement induced by low-frequency ultrasound has
been found 8, 10 to be much more significant than those induced by therapeutic
ultrasound and by imaging-frequency ultrasound. Hence, an investigation of low-
frequency sonophoresis has been identified as the focal point of this thesis. Below, I
present a review of various aspects of ultrasound that are pertinent to this thesis (see
Section 1.2), including a discussion of the progress made in the field of low-frequency
sonophoresis in recent years (see Section 1.3).
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1.2 Overview of Ultrasound
1.2.1 Generation of Ultrasound and Ultrasound Parameters
Ultrasound is a sound wave possessing frequencies above 20 KHz, 1 1 , 12 and is generated
using a device referred to as a sonicator. This device consists of an electrical signal
generator which generates an electrical AC signal at the desired frequency and amplitude.
This signal is then applied across a piezo-electric crystal (transducer) to generate
ultrasound. The thickness of the piezo-electric crystal is selected so that it resonates at the
operating frequency. Sonicators operating at various frequencies in the range of 20 KHz
to 3 MHz are available commercially and can be used for sonophoresis.
If a sonicator operating at the desired frequency is not available commercially, it
is possible to assemble one using commercially available signal generators, amplifiers,
and transducers. Such sonicators operating at frequencies of 10 MIHz and 16 MHz have
been assembled by Bommannan et al. 13 In addition, recently, Professor Mitragotri's lab
at UCSB has constructed a series of custom-built transducers with operating frequencies
in the range of 19.6-93.4 kHz to study the dependence of sonophoresis on ultrasound
frequency in the low-frequency range (personal communication with Professor
Mitragotri).
Ultrasound waves are characterized by two main parameters: frequency and
amplitude. The amplitude of an ultrasound wave can be represented in terms of peak
wave pressure (P, in units of Pascals) or in terms of intensity (I, in units of W/cm 2). P and
I are related by the equation I=P2/(2pc), where p is the density of the ultrasound coupling
medium, and c is the sound velocity in the medium (c in water or soft tissue is 1500 m/s).
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Ultrasound can be applied either continuously or in a pulsed manner. In the latter case, an
additional parameter, duty cycle, is required to characterize the ultrasound application.
Duty cycle is the fraction of time that ultrasound is ON. Ultrasound exposure time (or
ON-time), which is an important parameter for determining the extent of the biological
effects of ultrasound, equals the product of the total ultrasound application time and the
duty cycle. Another important ultrasound parameter for sonophoresis is the distance of
the ultrasound probe from the skin tissue. When an unfocused ultrasound source is
utilized to sonicate the skin during sonophoresis, the intensity of ultrasound at the skin
surface is a function of the distance from the ultrasound probe. 14 Accordingly,
ultrasound application for sonophoresis can be controlled by five main parameters:
frequency, intensity, duty cycle, exposure time, and skin distance from the ultrasound
probe.
1.2.2 Transmission of Ultrasound from the Transducer to the Skin
1.2.2.1 Transmission through the Medium
Ultrasound requires a coupling medium for transmission from the transducer to the
desired tissue. The coupling medium should result in proper transmission of ultrasound
from the transducer to the skin. The transmittive properties of a medium are controlled by
its acoustic impedance (Z). A coupling medium is appropriate for sonophoresis if its
acoustic impedance (Z) is comparable to that of the skin (1 .6x 106 kg/m2s). Z-values for
various materials can be found in Refs. 1 1, 12. For example, water has a Z-value of 1x10 6
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kg/m2s, and is a reasonable coupling agent. Z-values of several biological media are
listed in Table 1 below.
1.2.2.2 Absorption of Ultrasound
Every medium absorbs ultrasound to a certain extent. The ability of a medium to absorb
ultrasound is indicated by the absorption coefficient (a). The extent of absorption is
given by the following equation:
f(r)=1- exp(-ar)
where f(r) is the fraction of ultrasound intensity absorbed as the ultrasound beam
propagates in a medium characterized by an absorption coefficient (a) and a thickness
(T). An estimation of a-values for various materials at various ultrasound frequencies
may be found in Refs. 11, 12. In the case of water, the a value is 0.0006 at an ultrasound
frequency of 1 MHz, suggesting that a 1 cm thick column of water absorbs less than 0.1%
of ultrasound intensity at 1 MHz, that is, that water is a reasonable coupling medium.
Absorption coefficients for several biological media are also listed in Table 1 below.
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Table 1.1: Acoustic Impedances and Absorption Coefficients of Several Biological
Media.
Acoustic Impedance (Z) Absorption Coefficient (a)
Biological Medium (kg/m2s) at 1 MHz (cm')
Water 1.5x10 6  0.0006
Skin 1.6x10 6  0.62
Blood 1.6x10 6  0.028
Bone 6.3x10 6  3.22
Fatty Tissue 1.54x10 6  0.14
Muscle 1.6x106 0.76
Air 4.0x10 2 2.76
1.2.2.3 Ultrasound Reflection
Ultrasound is reflected at the boundary of two media possessing different acoustic
impedances. It is known that 99.99% of ultrasound is reflected at the air-water boundary
when an ultrasound beam is incident upon it from either side.15 The reflection coefficient
for various interfaces may be estimated from the acoustic impedances of two media
adjacent to the interface using equations described in Refs. 1 1, 12.
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1.2.3 Biological Effects of Ultrasound and Their Implications for
Sonophoresis
In order to understand the mechanisms of sonophoresis, it is important to identify various
effects of ultrasound exposure on the human tissue, since one or several of these effects
may contribute to the mechanism of sonophoresis. A brief description of the various
biological effects of ultrasound is provided below.
1.2.3.1 Thermal Effects
Absorption of ultrasound results in a temperature increase of the medium. Materials
which possess higher ultrasound absorption coefficients, such as bones, experience severe
thermal effects as compared to muscle tissues which have a lower absorption coefficient
(a). As discussed in Section 1.2.2, a values for several biological tissues can be found in
Refs.1 5 , 16 (see also Table 1). The absorption coefficient of a medium increases
proportionally with the ultrasound frequency, indicating that the thermal effects of
ultrasound are proportional to the ultrasound frequency. The increase in the temperature
of a medium upon ultrasound exposure at a given frequency varies proportionally with
the ultrasound intensity and exposure time. The thermal effects can be substantially
decreased by pulsed application of ultrasound. For a detailed discussion of the thermal
effects of ultrasound, see Ref. l5. During sonophoresis, ultrasound-induced temperature
increases in the skin tissue may lead to an increase of the drug diffusion coefficient in the
skin, as well as to skin structural alterations. Both effects can result in an enhancement of
the transdermal drug permeation rate.
24
1.2.3.2 Acoustic Streaming
Acoustic streaming is the development of large time-independent fluid velocities in a
medium under the influence of an ultrasound wave.14 The primary causes of acoustic
streaming are the reflections and other distortions of the ultrasound wave propagation.
Oscillations of cavitation bubbles may also contribute to acoustic streaming. The shear
stresses developed by streaming velocities may affect the neighboring structures (for
example, biological tissues). 17 In addition, the streaming of drug solutions on top of the
skin (convective fluxes along the direction of the wave propagation, shown in Figure 1),
can lead to mixing of the drug delivery vehicle, which may also potentially induce
convective transport across the skin and thereby enhance transdermal drug transport.
US Transducer Donor Compartment
Skin
Receiver Compartment
Figure 1-1: Schematic representation of the "quartz-wind streaming" generated by
ultrasound in the donor compartment of a Franz diffusion cell.
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1.2.3.3 Cavitation Effects
Cavitation is the formation of gaseous cavities in a medium upon ultrasound exposure.18
19 The primary cause of cavitation is the ultrasound-induced pressure variations in the
medium. The cavitational effects vary inversely with ultrasound frequency and directly
with ultrasound intensity. Cavitation involves either rapid growth and collapse of a
bubble (transient cavitation) or slow oscillatory motion of a bubble in the ultrasound field
(stable cavitation). Cavitation affects tissues in several ways. Specifically, collapse of
cavitation bubbles releases a shock wave which can cause structural alterations in the
surroundings. If bubbles collapse in a liquid medium close to a membrane, high-speed
liquid jets form in the direction of the membrane surface, which may lead to mechanical
point impact on the membrane surface, and may also lead to convective transport. 1 5, 20
Cavitation may occur both inside and outside the skin during sonophoresis. Biological
tissues contain numerous air pockets trapped in the fibrous structures which act as nuclei
for cavitation upon ultrasound exposure. Accordingly, significant cavitation activity is
known to occur inside many biological tissues upon ultrasound exposure. 15 However,
direct evidence of the presence of cavitation bubbles in the skin tissue during
sonophoresis has not been reported in the literature. Significant attention has been
devoted to exploring which of the above mentioned cavitational phenomena plays an
important role in sonophoresis.
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1.3 Literature Review of Low-Frequency Sonophoresis
(LFS)
Over the past half a century, the use of ultrasound for enhancing local as well as systemic
transdermal delivery of drugs (sonophoresis) has attracted a great deal of research
interest. However, until very recently (about ten years ago), ultrasound frequencies
utilized for sonophoresis have been restricted to a narrow range. Specifically, therapeutic
ultrasound with frequencies in the range of 1-3 M7Hz has been used exclusively to
enhance transdermal drug transport, a technique referred to as therapeutic sonophoresis.
In these studies of therapeutic sonophoresis, there have been some controversial results
regarding the efficacies of sonophoresis (the observed ultrasound enhancement of
transdermal transport varied from drug to drug).2 1 In cases where significant
enhancement of transdermal drug transport was observed, the enhancement was limited
to low-molecular weight drugs, and was typically less than 10-fold. 10
Following this period, a few research groups have conducted sonophoresis studies
using ultrasound frequencies above 3 MHzl3 22 and below 1 MHz.8 , 23-26 Based on
these studies, a new range of ultrasound frequencies (low-frequency ultrasound with
frequencies less than 1MHz) has been identified as a more efficient ultrasound condition
for enhancing transdermal drug transport rates, a technique referred to as low-frequency
sonophoresis (LFS). Below, I present an overview of the progress that has been made in
the field of low-frequency sonophoresis (LFS) prior to this thesis, with emphasis on the
efficacy and mechanistic studies of LFS, to lay the foundations for the work that will be
presented in this thesis.
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1.3.1 Effects of Low-Frequency Sonophoresis
Tachibana et al. investigated 2 3 , 24 the effects of 48 kHz/105 kHz ultrasound on the
delivery of insulin into hairless mouse and diabetic rabbits in vivo (mice were partially
immersed in an aqueous insulin solution, while rabbits were exposed to ultrasound by
using a metal cup). The ultrasound intensities used were 3000-8000 Pa and 5000 Pa,
respectively. They showed that 5 min (CW, continuous wave) and 90min (PW, pulsed
wave, 5 sec on-5 sec off) exposure were effective in delivering insulin into the hairless
mice and the rabbits, respectively. In 1993, Tachibana et al. also reported 2 5 enhanced
lidocaine absorption by hairless mice from aqueous solutions with 48 kHz ultrasound
(0.17W/cm 2 CW, 5 min).
Mitragotri et al. 8 applied 20 kHz ultrasound (125mW/cm 2, PW, 0.1 sec on-0.9
sec off) to deliver 7 different drugs across heat-stripped human skin, and found that low-
frequency ultrasound enhanced transdermal transport of drugs more effectively than
therapeutic ultrasound (the enhancement ratios ranged from 3 (for estradiol) to 5000 (for
sucrose). Furthermore, they demonstrated that low-frequency sonophoresis can induce
transdermal transport of drugs which do not permeate passively across the epidermis due
to their high hydrophilicity and large molecular size, while therapeutic sonophoresis
cannot. For example, Mitragotri et al. reported 26 the delivery of therapeutic doses of
three large molecular weight proteins(insulin, y-interferon, and erythropoeitin) across
human heat-stripped skin in vitro. In vivo studies with diabetic hairless rats further
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demonstrated that low-frequency ultrasound was effective in delivering insulin to the
living animal.2 6
1.3.2 Mechanisms of Low-Frequency Sonophoresis
Based on the above LFS studies, LFS was shown to be capable of facilitating the
transdermal delivery of protein drugs. As such, it represents a promising skin permeation
enhancement technique for the delivery of hydrophilic permeants, including proteins and
peptides (the transport of hydrophilic permeants across the skin has been of particular
interest because this group of permeants has pharmaceutical relevance, but currently
cannot be delivered passively through the transdermal route due to their extremely low
skin passive permeabilities). Many mechanistic hypotheses have been put forward to
explain this observed effect of LFS. Tachibana et al. hypohesized2 7 that application of
low-frequency ultrasound results in acoustic streaming in the hair follicles and sweat
ducts of the skin, thus leading to enhanced transdermal transport. In addition, in a recent
publication by the same group, Yamashita et al. reported a SEM study of hairless mouse
skin (in vivo) and human full-thickness skin (in vitro) after exposure to low-frequency
ultrasound (48 kHz, 0.5 W/cm 2). The authors concluded that the morphological changes
of the skin SC (removal of some of the keratinocytes around the hair follicles) may
account for the observed enhancements of transdermal drug transport during LFS.
Because the imaging technique (SEM) utilized in the above study does not involve probe
molecules, the exact route of drug transport across the skin during LFS remains
unresolved (that is, whether the LFS-mediated transdermal drug transport occurs mainly
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through the transfollicular pathway remains unclear). Moreover, the authors did not
comment on the relationship between (or the relative importance of) the two proposed
possible mechanisms of transport enhancement due to LFS, acoustic streaming (that is,
convective transport) and skin structural alterations (that is, enhancement of skin
diffusion).
Mitragotri et al. proposed 8 that low-frequency ultrasound (20 kHz) induces
cavitation both inside and outside the skin, which results in the disordering of the SC
lipids and the penetration of water into the disordered lipid bilayer region, and hence, in
the generation of aqueous channels in the skin. As a result, a transcellular pathway of
drugs, as opposed to the intercellular pathway of drugs in the case of therapeutic
sonophoresis,7 formed across the skin during LFS. This hypothesis was put forward to
explain the observed similarities between the measured values of the skin permeability of
both hydrophilic and hydrophobic permeants during LFS. 8 However, there have not been
direct experimental measurements of cavitation activity in the LFS system to support the
above proposed cavitation mechanism of LFS. In other words, two important issues
remains unresolved: (i) whether and where does cavitation take place in the LFS system
(inside or outside the skin, or both), and (ii) how important is cavitation during LFS, as
compared to the other ultrasound-induced phenomena, such as thermal effect and
acoustic streaming. Moreover, there has been no direct visualization of the skin transport
pathway during LFS to support the presence of the transcellular aqueous pathway of the
hydrophilic permeants, hypothesized by the authors. 8
In summary, review of the literature on low-frequency sonophoresis reveals that
in spite of the promising findings regarding the efficacy of LFS, there are many important
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unresolved issues regarding the mechanisms responsible for the transdermal permeability
enhancement by this technique. These include: i) the relative importance of the two
possible skin transport enhancement mechanisms of LFS (including skin structural
alteration and convective transport) remains to be evaluated, ii) the role of cavitation
during low-frequency sonophoresis is not well understood. Specifically, it is not known
where does cavitation take place in the LFS system, and how does it influence the skin
structure, iii) the transport pathway of hydrophilic permeants during LFS remains to be
characterized, that is, whether this class of permeants traverse the skin via an aqueous
pathway or via a lipoidal pathway, and what are the contributions of the skin lipids and
the cellular structures to this transport pathway (is it intercellular vs. intracellular).
The literature review also reveals that there is another important question
regarding the applications of LFS that needs to be addressed, that is, the in vivo/in vitro
correlation of LFS. Because of the simplicity associated with in vitro experiments, the
effects and mechanisms of LFS are most frequently studied by conducting an in vitro
experiment. A question then arises-whether the results obtained from the in vitro LES
experiments using excised skin as the skin model can be extrapolated to the in vivo skin
case. Due to the fact that the utilization of LFS to enhance the skin transport rate is a
relatively new area, there have been no direct in vivo/in vitro comparative studies to
address the in vivo/in vitro correlation question posed above, as well as to identify the
most suitable in vitro skin models for the LFS studies.
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1.4 Thesis Objectives
The central objective of this thesis is to develop a fundamental understanding of the
mechanisms of low-frequency sonophoresis, with an emphasis on the transdermal
transport of hydrophilic permeants. The following specific goals will be pursued: (i) to
investigate the mechanisms of transdermal transport of hydrophilic permeants in the
presence and in the absence of LFS in order to provide a theoretical framework for
predicting skin permeation rates of hydrophilic permeants in the presence and in the
absence of skin permeation enhancers, (ii) to characterize the cellular distribution of the
transport pathway of hydrophilic permeants across the SC during LFS, (iii) to investigate
the role of ultrasound-induced cavitation in skin permeabilization during LFS, (iv) to
investigate the in vivo/in vitro correlation during LFS to identify the relevant in vitro skin
models and ultrasound conditions that may be used in in vitro LFS studies to predict the
effects of LFS in vivo, (v) to evaluate the usefulness of a Fickian diffusion model for
predicting the skin steady-state permeability based on measurements of transient skin
diffusion to shorten the duration of skin permeability measurements for both hydrophilic
and hydrophobic permeants.
Attaining these five thesis goals will advance our understandings of the mechanisms
of low-frequency sonophoresis, a promising noninvasive drug delivery technique for
delivering a wide spectrum of pharmaceutically relevant agents via the transdermal route.
The mechanistic understanding gained in this thesis will also enable us to optimize the
ultrasound conditions and achieve better control and prediction of the efficacy of this
technique, which in turn will facilitate the rational design of LFS systems for future
clinical applications.
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1.5 Thesis Overview
The thesis is organized as follows. Chapter 2 presents a combined experimental and
theoretical investigation of the mechanisms of transdermal transport of hydrophilic
permeants and of the transport enhancement of this class of permeants by LFS. A theory
describing the transdermal transport of hydrophilic permeants in both the absence and in
the presence of ultrasound was developed using fundamental equations of membrane
transport, hindered-transport theory, and electrochemistry principles. With mannitol and
sucrose as the model hydrophilic permeants, the role of convection in LFS was evaluated
experimentally with two commonly used in vitro skin models-human cadaver heat-
stripped skin (HSS) and pig full-thickness skin (FTS). The theory developed (skin
porous-pathway theory) was then compared against the experimental measurements (skin
permeation rate of hydrophilic permeants and skin electrical resistance) to characterize
the nature of the skin transport pathway of hydrophilic permeants (porous vs. lipoidal), as
well as to quantify the effects of ultrasound on the microscopic transport properties of the
skin transport pathway of hydrophilic permeants. Specifically, two possible mechanisms
of skin permeabilization due to ultrasound were evaluated: (i) enlargement of the skin
effective pore radius, and (ii) creation of more pores and/or reduction of the tortuosity of
the existing pores. A long-term LFS protocol was utilized in these in vitro mechanistic
studies of LFS (10 h sonophoresis for HSS, and 20 h sonophoresis for FTS).
Chapter 3 presents an investigation using two-photon microscopy (TPM) to
examine the cellular distribution of the skin transport pathway of hydrophilic permeants
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in the presence and in the absence of LFS. Based on the TPM imaging of the 3D-
distribution of a hydrophilic probe (Sulfurhodemine B) in the skin, the relevance of the
intercellular and intracellular domains for the transport of hydrophilic permeants was
inferred. The spatial distribution patterns of the skin transport pathway of hydrophilic
permeants in the presence and in the absence of LFS were compared to shed light on the
mechanisms of skin permeation enhancement induced by LFS.
Chapter 4 presents a systematic investigation of the role of ultrasound-induced
cavitation during LFS. The role of cavitation during LFS was first tested using a custom-
made high-pressure LFS cell which can generate high ambient pressures to suppress
cavitation during LFS, while not affecting the non-cavitational effects of ultrasound.
Results from the high-pressure LFS cell studies definitively proved that cavitation is the
key mechanism of LFS. An acoustic method was then utilized to characterize the roles of
two types of cavitation activities, transient and stable cavitation, during LFS, and a good
correlation was found between skin permeabilization and the activity of transient
cavitation. Subsequently, the roles of the various mechanisms through which transient
cavitation modifies the skin barrier (including shock waves, high-velocity jets, or free-
radical production) were investigated utilizing both chemical and mechanical dosimetry
techniques.
In an attempt to identify relevant in vitro skin models and ultrasound conditions
that may be used in in vitro LFS studies to predict the effects of LFS on the transdermal
transport of hydrophilic permeants in vivo, an in vivo/in vitro correlation study of LFS
was conducted and is presented in Chapter 5. Using mannitol as the model hydrophilic
penneant, the transdermal transport properties of in vivo pig skin and of three in vitro
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skin models (including full-thickness and split-thickness pig skin, and heat-stripped
human cadaver skin) during LFS were directly compared. Various parameters that
characterize the skin responses to LFS were measured and compared between the in vivo
and the in vitro skin cases, including the enhancement of the skin permeation rate of
mannitol due to LFS, changes in the skin electrical resistance due to LFS, and the effects
of LFS on the skin concentration of mannitol. Histological studies were conducted with
the in vivo pig skin to assess the safety of the ultrasound conditions utilized. Short-term
ultrasound protocols were utilized in the in vivo/in vitro comparative studies, which
differ from the ultrasound protocols examined in Chapter 2 (long-term continuous LFS
protocols), due to the skin safety constraint and the in vivo compliance considerations.
Specifically, two types of short-term ultrasound pretreatment protocols were examined in
Chapter 5 (a constant ultrasound energy dose protocol and a constant skin electrical
resistance protocol). Results obtained with these short-term pretreatment LFS protocols
and those obtained earlier with the long-term continuous LFS protocols (Chapter 2) were
compared to provide guidelines for selecting suitable in vitro skin models and ultrasound
conditions during in vitro LFS studies.
The applicability of a two-parameter Fickian diffusion model for predicting the
skin steady-state permeability based on measurements of the transient transport of
permeants across the skin was evaluated in Chapter 6. Using five model permeants
possessing different physicochemical properties (both hydrophilic and hydrophobic) and
pig skin as the model membrane, the skin permeabilities predicted by the two-parameter
Fickian diffusion model were compared with the measured skin permeabilities. The
modeling results were then utilized to shed light on the skin permeation mechanisms of
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both classes of permeants. Lastly, the effects of skin hydration on the microscopic
properties of the skin porous pathway of hydrophilic permeants were characterized
utilizing a previously developed skin porous-pathway theory (Chapter 2), along with the
Fickian diffusion model, to gain insight into the mechanisms of hydration-induced skin
permeation enhancement of hydrophilic permeants (viewing water as a skin permeation
enhancer). Finally, a summary of the thesis as well as a discussion of possible future
research directions are presented in Chapter 7.
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Chapter 2
Theoretical and Experimental Investigation
of the Transdermal Transport Mechanisms
of Hydrophilic Permeants
2.1 Introduction
Transdermal drug delivery offers several advantages, particularly for those drugs that
when taken orally are lost due to gastrointestinal and liver metabolism (first-pass
effect).2 8 ' 29 However, due to the presence of the Stratum Corneum (SC), the outermost
layer of the skin, the skin is generally impermeable, especially to large and/or hydrophilic
molecules, such as peptides and proteins.3 0 To increase the transdermal drug delivery
rate to therapeutically significant levels, various chemical and physical approaches have
been investigated, including chemical enhancers, 3 1-34 electric fields (iontophoresis 3 5-3 8
and electroporation 3 9 ), and ultrasound waves (sonophoresis), 8, 22, 25, 26, 40 The
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enhancement mechanisms can be divided into the following four categories (or
combinations of these): (1) increased drug solubility in the donor formulation or
increased drug partitioning into the SC (chemical enhancers), 3 1-34 (2) increased
migration of charged molecules or ions under an applied electrical potential gradient
(iontophoresis and electroporation), 3 5-39 (3) induced convective flow of solvent or the
bulk solution, for example, electroosmosis in iontophoresis due to an applied electric
field,3 6 or forced convection due to ultrasound pressure waves,4 1 and (4) increased skin
intrinsic diffusion coefficient due to skin structural alteration (chemical enhancers, 31-34
iontophoresis,37, 38 electroporation, 3 9 and sonophoresis7 8 ). In particular, the last two
mechanisms (induced convection and increased skin intrinsic diffusion coefficient due to
skin structural alteration) may play a role in ultrasound-mediated transdermal drug
delivery (sonophoresis), which is the primary focus of this Chapter. Developing an
understanding of the relative roles played by these two mechanisms in sonophoresis is of
both fundamental and practical relevance. Indeed, one may be able to utilize this
understanding to improve, as well as to predict, the efficacy of sonophoresis for future
clinical applications.
In previous studies of ultrasound effects on transmembrane transport, 7, 8, 26, 41-
43 the possible role of convection was investigated. Fogler et al. 42 showed
mathematically that when an acoustic wave propagates through a porous membrane, a
time-independent secondary flow, referred to as acoustic streaming) 7 can be produced
within the medium inside the pores, which superimposes on the diffusive transport and
enhances the total rate of mass transfer through the membrane. Edwards et al. 4 1also
proposed that forced convective flow may be of importance in sonophoresis. Specifically,
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the propagation of longitudinal pressure waves through the skin may result in a rapid
oscillatory convective motion, and thereby augment the total transport rate of drugs
across the skin, a phenomenon referred to as convective dispersion. Lenart et al. 43
studied the transport of electrolytes across a cellophane membrane under 1MHz
ultrasound exposure. Their results suggested that ultrasound-induced convection plays an
important role in the total transport. However, previous studies by our group showed that
during low-frequency sonophoresis (LFS, 20 kHz), convection had little effect on the rate
of water transport across delipidized SC. The differences in the above results are
probably due to the differences in the model membranes examined and the experimental
protocols utilized, for example, differences in the ultrasound conditions. Indeed, since the
effects of convection may depend upon both the membrane structure and the ultrasound
conditions, in order to understand the role of convection in sonophoresis, direct
experimental evidence using actual skin membranes is desired. In the studies reported in
this Chapter, we have utilized two commonly used in vitro skin models-human Heat-
Stripped Skin (HSS) and pig Full-Thickness Skin (FTS)-to assess the importance of
convection in LFS.
LFS can significantly enhance the transdermal drug delivery rates, especially for
those drugs that have very low passive permeabilities due to their high hydrophilicity
and/or large molecular size. 8 , 24, 26 However, it remains unclear through which type of
pathways hydrophilic drugs traverse the skin during LFS. Previous studies by our group
showed that LFS at 20 kHz induced up to a 3000-fold transport enhancement of several
hydrophilic drugs, including insulin, across human cadaver HSS.8 , 26 It was
hypothesized that cavitation induced by LFS may result in water penetration into the SC,
accompanied by the formation of aqueous pathways across the skin lipid bilayers. 8 To
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test the porous pathway hypothesis, as well as to elucidate the role of convection in LFS,
a combined experimental and theoretical approach was adopted in this Chapter. Using
mannitol, a low molecular weight monosaccharide (MW=182 Dalton), as the model
permeant, the following two issues regarding the mechanisms of LFS were addressed
quantitatively using a theory developed in this Chapter based on principles of
electrochemistry and hindered-transport theory 44: (i) the relative contributions of forced
convection and enhanced diffusion in transport enhancement during LFS, and (ii) the
nature and properties of the skin transport pathways to hydrophilic drugs in the absence
and the presence of 20 kHz ultrasound. Subsequently, sucrose, a disaccharide (MW=342
Dalton), was utilized to test the generality of the developed transport theory, as well as to
further verify the mechanisms of LFS.
2.2 Theory
2.2.1 Contribution of Convection in Sonophoresis
We hypothesize that in both the absence and the presence of ultrasound, hydrophilic (or
polar) permeants migrate through the skin via a porous pathway, the same pathway
traversed by the current-carrying ions. Since the partition coefficients of hydrophilic
permeants between the donor solution and the liquid-filled pores within the skin equal
unity, the general equations describing the steady-state transdermal fluxes of hydrophilic
permeants during passive diffusion (control), Jdpjsve , and sonophoresis, J~fcn can
be expressed as follows:
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jpassive = -D Passive dC(1)
diffd
and
nS DusdC+(2)
diff+conv dx
where C is the permeant concentration, x is the penetration depth of the hydrophilic
permeant into the SC, Dpassive and DUS are the diffusion coefficients of the permeant
within the skin (SC) during passive control and sonophoresis, respectively, which are
functions of the intrinsic properties of the permeant and the skin structure, and v is the
effective convective velocity of the permeant. Equation 2 shows that ultrasound can
enhance the drug permeation rate through two possible mechanisms. The first involves an
increase in the skin intrinsic diffusion coefficient of the permeant (that is, Du s> Jpassive)
via skin structural alteration. The second involves inducing convective transport (that is, v
>0) by the ultrasound wave. One should note that v may differ from the superficial
solvent velocity. Specifically, for large permeants whose molecular dimensions are
comparable to the effective pore radius of the skin pathways, there is a significant
filtration effect (hindrance effect) on the convection of the permeant, in which case, the
permeant convective velocity, v, is smaller than that of the solvent. 44 On the other hand,
if the permeant is small compared to the typical effective pore radius of the skin
pathways, v is equal to the superficial solvent velocity.
To quantify the contribution of convection during sonophoresis, it is useful to write the
diffusive component of the total sonophoretic flux, Jisy, as follows:
dC
Jg =-D"'(3)
dx
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An enhancement factor due solely to convection, Eco,,, can then be defined as the ratio of
the total sonophoretic flux, Jdfff given in eq 2, and the diffusive flux, Jfgi, given
in eq 3. Integration of eqs 2 and 3, with Jgff and Jdq4con constant at their steady-
state values, and using the two boundary conditions: C=O at x = 0, and C=Cd at x = -Ax,
then yields
Ji "s,, = (4)dif+ co 1 - exp(- Pe)
and
diff (5)
where Cd is the donor concentration, Ax is the membrane thickness (that is, the thickness
of the SC, the major skin barrier), and Pe is the Peclet number, which is defined as
follows:
Pe =V -- (6)
D"'
Using eqs 4,5 and 6, the enhancement ratio due solely to convection,
E = ldf+conv us., , is given by
Pe
E . = (7)
1 - exp(-Pe)
Note that the Peclet number reflects the relative importance of convection and diffusion
in the total sonophoretic transport of the permeant. Equation 7 clearly shows that when
the Peclet number is very small, the enhancement ratio due to convection, Econ,
approaches unity, thus indicating that convection has a negligible effect during LFS.
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2.2.2 Relationship between Skin Permeability to a Hydrophilic
Permeant and Skin Specific Resistance in the Absence of
Ultrasound
In the absence of ultrasound, the transdermal flux of a permeant is due entirely to
diffusion. The general expression for the passive (diffusion-driven) permeability, Pdiff, of
a hydrophilic permeant diffusing through a porous membrane (the skin in our case) is
given by4 5
0 pore
Pdif - x(8)
where e, v, and Ax are the porosity, tortuosity, and thickness of the membrane,
respectively, and D Pore is the diffusion coefficient of the permeant in the liquid-filledP
pores within the membrane. Since E, r, and Ax are all intrinsic properties of the
membrane, they can be grouped into a single constant, C1. According to hindered-
transport theory, 44 D pore is a function of both the permeant and the membraneP
characteristics, which can be expressed as the product of the diffusion coefficient of the
permeant at infinite dilution, D', and the permeant diffusion hindrance factor, H(Ap),
where , is the ratio of the hydrodynamic radius of the permeant, r, and the effective
pore radius of the membrane, r (that is, 4A, =r, / r). After making the above substitutions
in eq 8, one obtains
Pdff = clD;H%(A,) (9)
43
C1 - 6(10)
For X , <0.4 (this is satisfied for mannitol and sucrose with the skin membranes studied in
this Chapter, see Appendix 2A), the diffusion hindrance factor, H(p), can be calculated
as follows: 44
H(Al )=(1-2,)(1-2.104X, +2.0943 -0.95A4) (i)
Based on our porous pathway hypothesis, an equation similar to eq 9 can be written for
the passive (diffusion-driven) permeability of the current-carrying ions. Specifically,
Pion = nCDgjnH(Zg 0 n) (12)
where D,, is the ion diffusion coefficient at infinite dilution, and H(Ai0 n) is the ion
diffusion hindrance factor, given in eq 11 with A replaced by Aon, where hion = rion / r,
with ri0, the radius of the ion. Taking the ratio of the two permeabilities in eqs 9 and 12
then enables us to express the passive permeability of a hydrophilic permeant as a linear
function of the ion passive permeability. Specifically,
Pdiff =C2Pion (13)
where
-D;OH(AP) (14)C2 = P4
D 0in H(Aion
The theoretical derivation of the relationship between Pdiff and Pion (eqs 13 and 14) is
related to the approach utilized by Peck et al.4 5 These authors utilized hindered-transport
theory and a dual-labeling method to model the relative permeabilities of two hydrophilic
permeants traversing through a given human epidermal membrane sample. The physical
description of the skin porous pathway utilized here is similar to that proposed by the
authors of Ref. 25, except that in our theoretical description, instead of using two
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hydrophilic permeants as the probe molecules, we have treated the current-carrying ions
as one of the two hydrophilic permeants. Furthermore, in our theoretical analysis, we will
utilize fundamental principles of electrochemistry to express the skin permeability to the
conducting ions, Pi,, as a function of an easy-to-measure variable, the skin electrical
resistivity, R, and in so doing, we will be able to correlate the skin permeability to a
hydrophilic permeant, Pdff, to the corresponding skin electrical resistivity, R. Since skin
resistivity can be measured instantaneously and simultaneously during skin permeability
measurements, modeling the relationship between skin permeability and skin resistivity
requires very little additional experimental work, and potentially involves less
experimental uncertainty when compared to modeling the relationship between two skin
permeabilities. The theoretical development of the relationship between the skin diffusive
permeability to a hydrophilic permeant, Pdiff, and the skin resistivity, R, is presented next.
The fundamental relationship between the absolute mobility of an ion, Uabs, and the ion
diffusion coefficient at infinite dilution, Drn , is given by the Einstein relation 4 6
Dijn = kTuabs (15)
where k is the Boltzmann constant, and T is the absolute temperature. For a z:z-valent
electrolyte, the specific conductivity of the electrolyte solution, as,,,, can be related to the
absolute mobility of the ions as follows: 46
Gsl=z2Feioneo (uabs)+ + (uabs )] (16)
where the plus and minus signs in Uabs denote the contributions of the cations and the
anions, respectively, z is the electrolyte valence, F is the Faraday constant, ci0n is the
electrolyte molar concentration, and eo is the electronic charge. Assuming that the
positive and negative electrolyte ions have comparable mobilities, namely, that
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(Uabs )+ (Uabs ) =Uabs (17)
and utilizing eq 15 to replace Uabs by Din in eq 16, one obtains
s uabs(2Z2 Fcineo)= D1n(2z2 FCioneO (18)Sol abs ~ion ion kT
or
D = kT Col(19)
2z2Fcione0
Equation 19 relates the specific conductivity of an electrolyte solution, asol, to the
corresponding ion transport property, Din . Similar to eqs 8 and 9, the skin specific
conductivity, a, can be expressed as a function of asol as follows:
CT=-asolH(k0)lon (20)
Utilizing eq 20 to replace as01 by a in eq 19, one obtains
kTD aC(21)ion =2z2 Fcioneo ion
Substituting D from eq 21 in eq 12, with C1 given in eq 10, the following relationship
between the passive permeability of the current-carrying ions, Pion, and the skin specific
conductivity, a, is obtained:
kT 1 (2Pion 29 -a(22)
2z2Fcione0 A
Substituting eq 22 in eq 13, we obtain the following relationship between the passive
(diffusion-driven) permeability of a hydrophilic permeant, Padff, and the skin specific
conductivity, a:
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Pdiffg =C3a -(23)Ax
where
kT D c OH (A
C3 = (24)
2z2Fcione0 Dn(ion
Substituting the skin resistivity, R=Ax/a, for the skin specific conductivity, a, in eq 23,
and rewriting the relationship in logarithmic form yields
logPdiff =logC 3 -log R (25)
Equation 25 indicates that in the context of our porous pathway hypothesis, when the
transport of a permeant occurs via pure diffusion, log Pdff vs. log R should exhibit a linear
behavior with a slope of -1. Equation 24 indicates that the y-intercept, log C3, is a
function of: (1) the absolute temperature, T, (2) the characteristics of the electrolyte
solution in which the permeant is dissolved (as reflected in the electrolyte valence, z, and
concentration, con), (3) the diffusion coefficients of the current-carrying ions and the
hydrophilic permeant at infinite dilution, Dn and D', respectively, and (4) the effective
radius of the liquid-filled pores within the skin, r, the hydrodynamic radius of the
permeant, rp, (appearing in A, = r, / r) and the hydrodynamic radius of the ions, rio,,,
assumed to be the same for the electrolyte anion and cation, (appearing in Awn = rion /r).
Equation 25 provides a general formula to theoretically describe the diffusion of a
hydrophilic permeant across the skin under any permeation conditions, including passive
control, diffusion after ultrasound treatment, and even diffusion during ultrasound
treatment. However, note that although the linear relationship between log Pdff and log R
is general, the y-intercept (the log C3 term in eq 25) may differ for the various permeation
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conditions, depending on the skin effective pore radius, r, corresponding to a particular
permeation condition (recall that C3 depends on r through H(Ap)/H(Aion) in eq 24). It is
noteworthy that among all the four skin structural parameters (skin porosity, e, tortuosity,
z, thickness, Ax, and effective pore radius, r), only the skin effective pore radius, r,
appears in C3 (see eq 24). Accordingly, a change in r can manifest itself through a change
in the intercept of the log Pdff vs. log R correlation curve, while changes in E, r, and Ax
do not affect the intercept value. In the later part of this Chapter (Section 2.4), we will
utilize this interesting behavior of the intercept value to distinguish between the two
possible modes of skin structural alteration due to LFS: (i) modification of r, and (ii)
modification of the ratio E IT.
2.2.3 Relationship between Skin Permeability to a Hydrophilic
Permeant and Skin Specific Resistance in the Presence of
Ultrasound
As discussed above, in the presence of ultrasound, convection may superimpose on
diffusion, and thereby contribute to the total transdermal flux (v >0, see eq 2). Therefore,
the enhancement mechanisms involved in sonophoresis may be two-fold: (i) enhanced
diffusion, and (ii) forced convection. Hence, the skin permeability to hydrophilic
permeants in the presence of ultrasound, Pffcncan be calculated as follows:
Pdiff+conyv cn Edf = Econy -C3 / R (26)
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where eq 23 has been utilized (with Pdff replaced by Pif, and R=Ax/a), and Eo,, is
given in eq 7. The contribution of enhanced diffusion is included in P4ff, which is
defined as the skin permeability due solely to diffusion in the presence of ultrasound, as
described by eqs 8 and 25. The contribution of convection is reflected in Eco, an
enhancement factor due solely to convection (see eq 7). Equation 26 can be rewritten in
logarithmic form as follows:
log P = log E + log C3 -log R (27)
Equations 25 and 27 represent two theoretical relations that relate the skin
permeability to a hydrophilic permeant to the skin electrical resistivity in the absence and
in the presence of ultrasound, respectively. In each case, the skin permeability is
inversely proportional to the corresponding skin resistivity, although the proportionality
factor (or the intercept term in the log-log relation) is case-specific, depending on the skin
effective pore radii in each case (through C), as well as on the role of convection
(through Econy). Specifically, equation 25 is a special case of eq 27. Indeed, when there is
no convection effect during LFS, or when the contribution of convection is negligible
(log Ec, 0), eq 27 reduces to eq 25.
In previous studies of percutaneous absorption, an inverse correlation between the
skin passive permeability to hydrophilic permeants (such as sodium ions, urea, and
mannitol) and the skin electrical resistivity was observed. 47-51 In this Chapter, a
quantitative relationship between the skin permeability to hydrophilic permeants and the
skin electrical resistivity has been developed using principles of electrochemistry and
hindered-transport theory in both the absence and the presence of the transport
enhancer-ultrasound. A slope of --1 is predicted for both cases (see eqs 25 and 27). In
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addition, a physical interpretation has been given to the intercept term of the logP vs.
logR correlation, which is a function of both one of the intrinsic properties of the skin (r
through C3, see eqs 24 and 27) and the contribution of convection to the total transport
(through Ec,, see eqs 7 and 27).
By taking the ratio of the two skin permeabilities in eqs 27 and 25 (with P
diff
replaced by Passive to stress the absence of ultrasound), the total transport enhancement
diff
ratio due to LFS, Etotai, can be expressed as follows:
Ettai=+conv E c 3 / R )USRCasivEk- =AE -(28)
ly"''' (Ce R )pa""''' " "' Cpas"'''' R"u
According to eq 20, the skin resistivity, R, is given by
Ax AxzT 1
R-=--= 
-(29)
a aySo1 E H (X 0o)
Substituting R (from eq 29) and C3 (from eq 24) in eq 28 then yields
Eo,,l = Econv- Ediff(30)
where
r
P
Edi = 
-(31)d )(f 1 passive
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Equation 30 clearly shows that the total transport enhancement during LFS results
from the combined effect of: (1) enhancement of diffusion due to skin alteration (through
Ediff in eq 31), and (2) induced convection (through Ecov in eq 7). Moreover, as reflected
in eq 31, two modes of skin alteration are possible in the presence of ultrasound: (1)
enlargement of the skin effective pore radius (rus > rpassve), and (2) increase of the
ratio of the skin porosity to tortuosity ((e /,r fr> (e /,r)Passive ; note that the skin porosity
and tortuosity are coupled as one variable, E 'r, in eqs 8, 20, 29, and 31). Of the two
possible modes of skin alteration induced by LFS, mode (1) is of particular interest for
the transdermal delivery of large biological molecules, such as peptides and proteins.
This is due to the fact that a threshold skin effective pore radius, r threshold,.is required to
allow the transdermal transport of these large biological molecules. Clearly, if this
threshold skin effective pore radius is not exceeded (r < r threshold), then even if
(e /rfr > (e / )Passive , no transdermal transport enhancement will take place. In the
Results and Discussion Section, we will implement our theoretical framework to
quantitatively evaluate the above mentioned two aspects of the LFS mechanisms (two
types of transport enhancement and two modes of skin alteration), with special emphasis
on the estimation of the skin effective pore radius in both the absence and the presence of
ultrasound.
2.2.4 Model Assumptions
The fundamental underlying assumption leading to eqs 25 and 27 is that both in the
absence and the presence of ultrasound, hydrophilic permeants migrate through the skin
via a porous pathway, which is the same pathway traversed by the current-carrying ions.
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Our other model assumptions include: (i) the permeant/ions behave as hard spheres which
have no specific interactions with the pore walls (this is an assumption of hindered-
transport theory4 4 for hard spheres in cylindrical pores), and (ii) the anions and cations in
the electrolyte solution have the same valence, z, and similar transport characteristics
(that is, have the same DZ,, and ri,, values). In this Chapter, sodium cations and chlorine
anions are the two. dominant conducting ions in the electrolyte solution, which satisfy
assumption (ii) reasonably well (see Appendix 2A). In addition, since the skin has a net
negative charge,3 0 in order to neglect the electrostatic interactions between the charged
ions and the skin pore walls, the skin effective pore radius must be much larger than the
Debye-Hiickel screening length, a characteristic length scale associated with the decay of
electrostatic interactions.4 6 The validity of this last assumption is tested and discussed in
Appendix 2B.
2.3 Experimental Section
2.3.1 Materials
[3H]mannitol and [14 C]sucrose were obtained from ARC (St. Louis, MO). In vitro
transport experiments were performed with both pig full-thickness skin (FTS) and human
cadaver heat-stripped skin (HSS5). Human cadaver skin (male or female abdominal or
back skin, frozen at -80 0C) was obtained from the National Disease Research Institute
(Philadelphia, PA). Yorkshire pig FTS (back or abdominal) was harvested within 1 hour
52
after sacrificing the animals (Yorkshire). The preparation and storage of HSS and FTS
have been described previously.7 , 52
2.3.2 Methods
2.3.2.1 In Vitro Transdermal Permeability Measurements
Vertical Franz diffusion cells (Permegear Inc., Riegelsville, PA) were utilized in the in
vitro transport studies. All experiments were performed at room temperature (23±1 C).
The temperature in the diffusion cell was recorded continuously during the ultrasound
experiments using a fine rigid wire thermocouple and a digital thermometer (VWR
Scientific); the measurement was taken in the donor solution-skin surface interfacial
region, as well as at other locations in the diffusion cell. No spatial variation of
temperature was detected in the donor and the receiver compartments at steady state.
Prior to each experiment, a skin section was mounted in the diffusion cell with the
SC facing the donor compartment. When human HSS was used in the permeability
studies, a nylon mesh (3-160/53, Sefar America, Inc., Kansas City, MO) was placed
underneath the skin to avoid any skin stretching and deformation due to the ultrasound
application and the hydrostatic pressure difference in the two compartments. For
consistency, a nylon mesh was also utilized as a membrane support for pig FTS, even
though no difference in transport was detected with and without the support. Both the
donor and the receiver compartments were filled with phosphate-buffered saline (PBS;
phosphate concentration, 0.01 M; NaCi concentration, 0.137 M; Sigma Chemical
Company, St. Louis, MO) to hydrate the skin for one hour before each experiment, and
allow the skin initial baffler property to reach a steady state. The PBS buffer in the donor
compartment was then replaced with a solution of the radio-labeled permeant in PBS (1-
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10 kCi/mL). The receiver compartment was stirred with a magnetic stirrer at a speed of
400 rpm during the duration of the experiment. Throughout the experiments, solution
samples were withdrawn from both the receiver and the donor compartments at the
predetermined time points, and the concentration of the permeant in the two
compartments (Cr and Cd, respectively) were measured using a scintillation counter
(model 2000 CA, Packard). When transport achieved steady state, the skin permeability,
P, to a given permeant, in the presence or in the absence of ultrasound, was then
calculated as follows:
P dQ (32)
AAC dt
where AC is the permeant concentration difference between the donor and the receiver
compartments,' A (=1.77 cm2) is the permeation area, and Q is the cumulative amount of
permeant transported into the receiver compartment at time point t.
2.3.2.2 Electrical Resistance Measurements
During each skin permeation experiment, two Ag/AgCl electrodes (E242, In Vivo
Metrics, Healdsburg, CA) were placed in the donor and receiver compartments to
measure the electrical resistivity of the skin. A 100 mV AC voltage (RMS) at 10 Hz was
generated by a signal generator (model HP 4116A, Hewlett-Packard), and was applied
across the two electrodes for about 5 seconds. The electric current across the skin was
1Note that in all the cases tested in this Chapter, except for the LFS experiments across HSS, an infinite
sink and infinite dose condition is maintained in the receiver and the donor compartments, respectively,
throughout the experiment. Therefore, AC in eq 32 can be replaced by the initial donor concentration, Cdo .
In the case of the LFS experiments across HSS, where the skin membrane exhibits the largest permeability,
fresh donor solution was added to the donor compartment every hour to replenish the permeant in the donor
compartment to keep the donor concentration approximately constant (that is, to satisfy the infinite dose
condition). Since during the LFS experiments across HSS, the infinite sink condition does not hold in the
receiver compartment, AC in eq 32 is calculated as Cd -C,. (note that even in this high skin permeability
case, the maximal permeant concentration in the receiver compartment is less than 15% of that in the donor
compartment).
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measured using an ammeter (Micronta, Tandy Corporation). The electrical resistance of
the skin was then calculated from Ohm's law. The resistance of PBS (background) was
measured separately using the same assembly but without mounting the skin. Since the
measured skin resistance is the sum of the actual skin resistance and the background PBS
resistance, the latter was subtracted from the measured skin resistance to obtain the actual
skin resistance. The skin resistivity was then obtained by multiplying the actual skin
electrical resistance by the skin area (1.77 cm2). Skin resistivity measurements were taken
before and during the permeation experiments at each predetermined sampling point.
Only skin with an initial resistivity higher than 35 kQ-cm 2 was utilized in the permeation
studies (a well-accepted criterion for selecting suitable in vitro skin samples4 8). For each
skin sample, an average skin resistivity was determined over the same time period for
which the steady-state skin permeability was calculated. This average skin resistivity,
referred to hereafter as the steady-state skin resistivity, was then analyzed along with the
corresponding skin permeability using the theoretical framework developed in this
Chapter.
2.3.2.3 Ultrasound Application
Ultrasound was applied using an ultrasonic transducer (VCX 400, Sonics and Materials,
Inc., Newtown, CT) operating at 20 kHz. Before each experiment, the ultrasound
transducers were tuned, and the ultrasound intensity was measured using a calorimetric
method as described previously.3 1 The same ultrasound protocol was utilized to assess
both the role of convection and the effect of LFS on the skin pathways of hydrophilic
permeants. Specifically, during sonication, the ultrasound transducer was immersed in the
donor compartment filled with a 2.5 ml PBS solution of radio-labeled permeant at a
55
distance of 0.8 cm from the skin surface. Ultrasound at 1.6 W/cm2 was applied in a
pulsed mode (100 millisecond pulses applied every second) to minimize thermal effects.
Ultrasound was applied for a period of 20 hours on FTS (human cadaver or pig), and for
a period of 9 hours on HSS (human cadaver). Note that the ultrasound application time
for HSS was shorter than that for FTS. This is because the thickness of HSS is very small
(only about 100-~ 150 nm5 3 ), and therefore, the transport across HSS achieved its
steady-state faster than in the case of FTS. During ultrasound application, the temperature
of the receiver compartment was constant (23±1 C), while the temperature of the donor
solution and the skin surface reached a steady-state value of 28±1'C after about 10
minutes of sonication (5*C above room temperature); the impact of this temperature
increase will be discussed in Sections 2.4.2.1 and 2.4.3.1. Transport measurements
continued for an additional 28 or 15 hours after ultrasound was turned off, for FTS and
HSS, respectively (referred to hereafter as a post-sonophoresis phase). The steady-state
permeability of a given permeant and the steady-state skin resistivity were measured
simultaneously during both the sonophoresis phase and the post-sonophoresis phase. At
the end of each ultrasound experiment, the HSS and FTS samples were removed from the
diffusion cell and examined under a light microscope to check the macroscopic integrity
of the skin samples (that is, to verify the absence of small holes or tears).
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2.4 Results and Discussion
2.4.1 Passive Pathways of Hydrophilic Drugs: The Base Case
We first performed passive skin permeation studies to verify the validity of our
theoretical framework, and to estimate the passive skin effective pore radius. These
studies will serve as the base case for assessing the effects of sonophoresis on the
effective pore radius and porosity/tortuosity of the trandermal transport pathways.
Passive permeation studies of mannitol (MW = 182 Dalton, log Ko/, = -3.1)54
were carried out with human cadaver HSS and with pig FTS, two widely used in vitro
skin models in transdermal transport research. The measured steady-state skin passive
permeability to mannitol, P (or Passve), is plotted in Figure 2-1 versus the measured
steady-state skin resistivity, R, for the two types of skin examined (@ for HSS, N=8, and
o for FTS, N=9). Each data point in Figure 2-1 represents the P and R values
corresponding to one skin sample. Note that the data measured under the same passive
permeation condition span a range of log P and log R values. This spreading of the data
in terms of both permeability and resistivity is due to skin variability. Figure 2-1 shows
that the data from the two types of skin follow a similar linear trend in the log P vs. log R
plot. Linear regressions and a subsequent t-test of the data reveal that there is no
statistically-significant difference (p<0.05) between the two trends exhibited by the two
groups of data. This indicates that the two types of in vitro skin provide similar transport
pathways for hydrophilic permeants (such as mannitol) under passive diffusion
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Figure 2-1: Experimental correlation between the mannitol passive permeability, P
(cm/hr), and the skin electrical resistivity, R (kQ-cm 2).
Key: (0) human HSS (N=8), (0) pig FTS (N=9). The slope of the best-fit curve resulting
from linear regression is -0.88 with r 2=0.80. The trend line shown in the graph has an
ideal slope value of -1. Each data point represents the passive permeability of one skin
sample at steady-state and the corresponding average skin electrical resistivity over the
same time period.
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conditions. In fact, it is known that pig skin in vitro represents a good model for human
skin in vitro during percutaneous absorption studies. 55 Therefore, below, we combine
the passive permeation data of pig FTS and human HSS, and analyze these together in the
context of the theoretical framework developed earlier. Linear regression of the HSS and
FTS data in Figure 2-1 yields a slope of -0.88 ±0.26. This slope is not different from -1
(p<0.05; note that a trend line with a slope value of -1 is plotted in Figure 2-1 for the data
shown), which is in excellent agreement with our theoretical prediction (see eq 25).
Therefore, our theory, including its underlying porous pathway hypothesis, is verified by
the passive diffusion results of mannitol. To obtain an average intercept value for the
passive data shown in Figure 2-1, we extrapolated each data point to the y-axis (at log
R=0) using a theoretical slope value of -1, and averaged all the extrapolated intercept
values. Based on this average intercept value (-2.94) and eqs 24 and 25, the skin effective
pore radius during passive diffusion was estimated to be around 26 A (for details, see
Appendix 2A). This value is comparable to previously reported value of skin passive pore
radius (15-25 A) within a human epidermal membrane (or HSS), estimated based on a
different theoretical framework using hindered-transport theory.4 5
It is noteworthy that a similar linear correlation between log P and log R has been
reported previously by other researchers for the passive diffusion of mannitol and urea
across human epidermal membrane (HSS). 4 7 , 49, 50 The r2 value of our data (r2 =0.80)
shown in Figure 2-1 is comparable to the previously reported r2 values (ranging from 0.77
to 0.96).
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2.4.2 Low-Frequency Sonophoresis (LFS) across Full-Thickness
Skin (FTS)
2.4.2.1 Experimental Evaluation of the Role of Convection during LFS of
FTS
Since LFS-enhanced transdermal transport involves two mechanisms-enhancing
diffusion through skin alteration and/or inducing convection, to simplify the modeling of
LFS, we first adopt a purely experimental approach to assess the role of convection
during LFS. Specifically, if convection is negligible (log Econ,=0), then eq 27 reduces to
eq 25. On the other hand, if convection turns out to play an important role during LFS,
then the log Econ, term in eq 27 has a finite value.
During LFS, the enhancement of diffusion results from ultrasound-induced skin
alteration, with a recovery rate that depends on the ultrasound conditions utilized. As
ultrasound intensity and exposure time increase, the skin structure is altered to a larger
extent. Consequently, the structural recovery of the skin samples takes a longer time, and
becomes less complete as observed in in vitro experiments. Eventually, the structural
alteration of the skin may become irreversible, which can be inferred from the skin
resistivity measurement, a very sensitive, instantaneous indicator of the skin structure. 5 6
In contrast to skin alteration which may persist after ultrasound is turned off, convection
ceases after ultrasound treatment stops (the time constant of convection is on the order of
a few seconds, see Appendix 2C). With this in mind, we first subjected the skin
membrane to a long-term ultrasound protocol to ensure that any structural changes can
reach steady state, such that the skin structure and associated diffusion rates of permeants
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remain constant before and after ultrasound is turned off. Since convection ceases after
ultrasound is turned off, by comparing the transdermal fluxes before and after ultrasound
has been turned off, with the diffusion rate of the permeant kept constant, one can
quantify the effect of convection. Specifically, if there is a significant drop in the total
transdermal flux of a permeant after ultrasound is turned off, while the skin resistivity
remains constant, one can then conclude that convection contributes significantly to the
total transdermal transport during LFS. If, on the other hand, there is no change of the
transdermal flux of a permeant after ultrasound is turned off, then the opposite conclusion
can be reached, that is, that convection does not play an important role during
sonophoresis under the ultrasound conditions examined.
With mannitol as the model permeant, ultrasound at 20kHz (1.6 W/cm 2, 100 msec
pulses applied every second) was applied on FTS for 20 hours to achieve steady-state
transdermal transport during sonophoresis. The transdermal transport of mannitol was
measured for a total period of 48 hours (in other words, after the 20-hour sonophoresis
phase, the transport measurements continued for 28 additional hours, referred to as the
post-sonophoresis phase). The results of a typical LFS experiment with three parallel FTS
samples are shown in Figure 2-2(a) (N=3). The x-axis in Figure 2-2(a) denotes time (in
hours). The y-axis on the left in Figure 2-2(a) represents the measured normalized
resistivity of FTS during sonophoresis (the first 20 hours) and after sonophoresis (the
remaining 28 hours), shown as 0. The y-axis on the right in Figure 2-2(a) represents the
corresponding cumulative amount of mannitol transported into the receiver (*). The skin
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Figure 2-2 (a): Time variation of the normalized skin (FTS) electrical resistivity and the
normalized cumulative amount of mannitol transported across the skin during LFS.
Key: (0) normalized skin (FTS) electrical resistivity, (0) normalized cumulative amount
of mannitol transported across FTS during LFS and after ultrasound was turned off (post-
sonophoresis phase). The amount of mannitol transported is normalized by AC and A
(1.77 cm2). Each number indicates the mean ± SD (error bars) of three skin samples.
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Figure 2-2 (b): Comparison of skin (FTS) perm eabilities to mannitol during passive
control and LFS, as well as during post-LFS phase.
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resistivity was normalized using the initial resistivity value of each skin sample, and the
cumulative amount of mannitol was normalized by AC, the permeant concentration
difference between the donor and the receiver compartments, and A, the permeation area.
Figure 2-2(a) shows that the skin resistivity drops to about 7% of its initial value
within the first 6 hours of ultrasound treatment and gradually reaches a steady-state
(about 6 % of its initial value after 16 hours of ultrasound treatment). After ultrasound is
turned off at the end of 20 hours, the skin resistivity remains constant, indicating that the
diffusion rate of mannitol, before and after the ultrasound is turned off, remains constant.
Moreover, the corresponding transport profile of mannitol atross the same FTS (shown
as * in Figure 2-2(a)) exhibits an approximately constant slope before and after the
ultrasound is turned off (note that the slopes of the linear portions of the transport profile
reflect the steady-state permeability of mannitol). To examine the permeability values
more closely, the steady-state permeabilities of mannitol during and after sonophoresis
are plotted in Figure 2-2(b). The passive control permeability of mannitol across pig FTS
was also measured and plotted in the same graph for comparison purposes (N=9). A
student t-test revealed that there is no statistically-significant difference between the two
mannitol permeabilities in both the sonophoresis and the post-sonophoresis phases
(p<0.05),2 indicating that no significant convection takes place during LFS of FTS.
Consequently, log E,,0,=0 in eq 27 under the LFS protocol examined. The observed
enhancement of mannitol transport across FTS is due solely to the enhancement of
diffusion resulting from ultrasound-induced skin alteration.
2 The slight decrease in mannitol permeability (not statistically significant) after ultrasound is turned off
can be attributed to the thermal effect of ultrasound. The temperature of the skin decreases by 5 0C after
ultrasound is turned off. In a different set of passive diffusion experiments, we found that a temperature
decrease of 5"C leads to about a 1.3-fold drop in the mannitol permeability, which is within the typical error
of a permeability measurement.
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2.4.2.2 Theoretical Analysis of LFS across FTS
In this section, we utilize the theory presented in Section 2.2 to characterize the transport
pathways of hydrophilic permeants (such as mannitol) within FTS during LFS, and
thereby, to unravel the modes of skin alteration induced by LFS. As already pointed out,
our interest was to find out whether certain LFS conditions can enlarge the effective pore
radius of the skin pathways within FTS. Since our experimental results have shown that
convection has a negligible effect (log Econ, =0) on the total transdermal transport of
mannitol during LFS of FTS, eq 25 applies to both the passive control and the LFS cases.
In other words, the intercept terms of the log P vs. log R correlation curves in both cases
have the same functional form-logC 3. For a given permeant (mannitol in this case) and
under a fixed electrolyte solution condition, C3 is only a function of the skin effective
pore radius, r (see eq 24, with r appearing in both Ip and ti). Therefore, any shift in the
intercept value (logC3) from the passive control case to the LFS case can be attributed to
a r-modification effect due to LFS. For example, an increase in logC 3 indicates an
enlargement of r because of the increased value of H(2p)/H(i 0 n) (see eq 24).
LFS studies were carried out with multiple pig FTS samples following the same
protocol described in the previous section (N=16). The FTS steady-state permeabilities to
mannitol during LFS, P, were measured and plotted in Figure 2-3 against the measured
steady-state skin resistivities, R. Each data point (0) in Figure 2-3 represents the P and R
values corresponding to one skin sample. The passive data from Figure 2-1 is also shown
in Figure 2-3 to provide a baseline for comparison (note that the passive data of both pig
FTS and human HSS have been plotted in Figure 2-3 using the same symbol, 0). Similar
to the passive controls, the LFS data measured under a single LFS protocol also span a
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Figure 2-3: Comparison of the experimental log P-log R correlation during LFS of FTS
(20 kHz, 1.6 W/cm 2) with that during passive diffusion.
Key: (0) during LFS, (0) in the absence of ultrasound (passive controls). Each data point
represents the permeability of one skin sample at steady-state and the corresponding
average skin electrical resistivity over the same time period. The slope of the best-fit
curve of the LFS data is -0.87 with r 2= 0.75. The trend line shown in the graph has an
ideal slope value of -1.
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range of logP and logR values. This data spreading is due both to the variability of the
skin samples and the variations in the performance of the ultrasound probes. The LFS
data (@) shown in Figure 2-3 are located towards the top left corner in the logP vs. logR
plot, compared to the corresponding passive controls (0), indicating that during LFS, P of
a skin sample is generally increased, while its R is generally reduced.
Similar to the passive control baseline, the LFS data shown in Figure 2-3 exhibit a
linear trend with a slope not statistically different from -1 (p<0.05; note that a trend line
with an ideal slope value of -l is plotted in Figure 2-3 for the data shown). This again is
consistent with our theoretical prediction (see eq 25). The porous pathway hypothesis,
therefore, is also valid for transdermal transport of mannitol in the presence of
ultrasound. Moreover, in Figure 2-3, the LFS data fall on the same trend line as that of
the passive control data. In other words, the intercept value corresponding to the LFS
case (-2.98±0.27) is not statistically different from that corresponding to the passive
control case (-2.94±0.28), indicating that under the LFS protocol examined, the skin
effective pore radius, r, within FTS is not enlarged by the ultrasound treatment. 3 Based
on the data shown in Figures 2-3 and 2-1, the average P values of mannitol across FTS
during LFS (N=16, @ in Figure 2-3) and passive control (N=9, 0 in Figure 2-1) are 5.79
x10-4 cm/hr and 2.23 x10-5 cm/hr, respectively. Therefore, the total enhancement of
mannitol permeability by LFS, Etot =Ediff - Econ= Ediff (since Econv =1), is about 26-fold.
3 Because of the slightly smaller mean value of the intercept position in the LFS case
relative to that in the passive control case, r during LFS was even slightly decreased due
to the influence of ultrasound. However, this decrease in r is not statistically significant.
Interestingly, our finding regarding the effects of LFS on r is somewhat similar to the
results obtained by other researchers who studied the effects of other types of transdermal
enhancers, includindg ethanol4 5 and iontophoresisso, on r. These previous reports have
shown that the r values in the presence of these enhancers were slightly decreased
compared to the passive values, although the difference was not statistically significant.
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According to eq 31, this 26-fold diffusion-driven enhancement results from two possible
modes of skin alteration: (1) enlargement of r, and/or (2) increase of &',. Because r
within FTS remains unchanged during LFS, the observed enhancement of skin
permeability to mannitol must be solely attributed to the second mode of skin alteration.
In other words, (e/t)" =26 (tj)Passve for FTS (see eq 31).
Our theoretical framework offers an alternative way of quantifying the changes in
the value of e/t during LFS, based on the measurements of the reduction in the skin
resistivity. From the data shown in Figures 2-3 and 2-1, the average FTS resistivities
during LFS (N=16, 0 in Figure 2-3) and passive control (N=9, O in Figure 2-1) are 6.9
kD-cm2 and 188 kJ-cm2, respectively. Therefore, the average resistivity of FTS was
reduced by about 27-fold due to LFS. According to eq 29, this decrease in R also
originates from two possible skin alteration effects. Specifically,
(33)
Because r within FTS remains unchanged during LFS, it follows that H(rion / r P'"")
H(ri,0 / r "") in eq 33, and therefore, the total observed reduction in the skin resistivity
implies that (et)""= 27 (&/t)Passw* for FTS. This result is in excellent agreement with the
result obtained above using the permeability-based approach (26-fold). Moreover, the
average absolute values of dt for the FTS samples examined can also be determined
using our theoretical framework in the absence and the presence of ultrasound, based on
the measured skin resistivities. Specifically, given a,,l of the PBS solution, 1.2 x10-2
(f.cm)-1,21 we first estimated the average Ut value for FTS during passive diffusion.
The average steady-state resistivity of FTS during passive diffusion is R=188 kt-cm2
(N=9, 0 in Figure 2-1). According to eq 29, with Ax=15gm, rio0 = 2.2 A, and r passive= 26
A, we find that (E/t)passive =(Ax/GsoI R)/H(Xon = rion / r passive) = 9.6 xlO-7. During LFS, the
average value of E/t within FTS is increased to be around (E/T)us =27 (E/)passive =2.6x10-5
2.4.3 Low-Frequency Sonophoresis (LFS) across Heat-Stripped
Skin (HSS)
In the previous section, we showed that, during LFS of FTS, convection does not play an
important role, and the examined LFS protocol does not lead to an enlargement of the
skin effective pore radius within FTS. Similar questions can be posed in the case of
another commonly used in vitro skin model-HSS. Specifically, (1) what is the role of
convection during LFS with HSS as the model membrane, and (2) can the LFS protocol
examined above lead to an enlargement of the skin effective pore radius within HSS.
2.4.3.1 Experimental Evaluation of the Role of Convection during LFS of
HSS
As in the FTS case, we began our investigation with a purely experimental assessment of
the role of convection during LFS of HSS. LFS experiments were performed with human
cadaver HSS using the same ultrasound protocol utilized in the studies of pig FTS. Figure
2-4(a) shows the results of a typical LFS experiment (N=3). The normalized resistivity of
HSS during sonophoresis (the first 9 hours) and after sonophoresis (the remaining 15
hours), shown as 0, along with the corresponding transport profile of mannitol (@), both
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Figure 2-4 (a): Time variation of the normalized skin (HSS) electrical resistivity and the
normalized cumulative amount of mannitol transported across the skin during LFS.
Key: (0) normalized skin (HSS) electrical resistivity, (0) normalized cumulative
amount of mannitol transported across FTS during LFS and after ultrasound was turned
off (post-sonophoresis phase). The amount of mannitol transported is normalized by AC
and A (1.77 cm 2). Each number indicates the mean ± SD (error bars) of three skin
samples.
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Figure 2-4 (b): Comparison of skin (HSS) permeabilities to mannitol during passive
diffusion and LFS, as well as during post-LFS phase.
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as a function of time, are shown in Figure 2-4(a). The cumulative amount of mannitol
was again normalized by AC, the permeant concentration difference between the donor
and the receiver compartments, and A, the permeation area, and therefore, the slopes of
the transport profile represent the permeabilities of mannitol. Figure 2-4(a) shows that the
skin resistivity drops to about 0.06 % of its initial value within the first 7 hours of
ultrasound treatment, and reaches a plateau before ultrasound is turned off at the end of 9
hours. Thereafter, the skin resistivity remains approximately constant, indicating that the
diffusion rate of mannitol across HSS is constant during the steady states of the
sonophoresis and the post-sonophoresis phases. In contrast, the transport profile in Figure
2-4(a) exhibits an abrupt decrease in its slope after ultrasound is turned off. A comparison
of the deduced skin permeabilities to mannitol during and after sonophoresis (based on
the slopes of the transport profile in Figure 2-4(a)), shown in Figure 2-4(b), reveals that
there is an about 20-fold drop (the sonophoresis bar divided by the post-sonophoresis bar)
in the mannitol permeability after ultrasound is turned off.4 Therefore, convection plays
an important role during LFS of HSS. Recall that in the previous section, we have shown
that convection plays a negligible role during LFS of FTS. The contrasting results
revealed that under the same ultrasound protocol, convection plays different roles
depending upon the type of skin membrane utilized. In the next section (Section 2.4.3.2),
the observed different roles of convection during LFS across HSS and FTS will be
explained using the estimated effective pore radii of the two types of skin membranes
during LFS. In the current Chapter, we present the following possible mechanisms for the
4 Note that thermal effects may also contribute to the observed drop in the transdermal penneability when
ultrasound is turned off. The temperature of the skin decreases by 5 'C after ultrasound is turned off.
However, a 5 0C drop in temperature can cause only a 1.3-fold decrease in mannitol permeability.
Therefore, thermal effects alone cannot account for the total 20-fold drop observed in the transdermal
permeability of mannitol when ultrasound was turned off.
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ultrasound-induced convection during LFS: (1) radiation pressure 13 exerted on the skin
membrane by an ultrasound wave may lead to a net volume flow, (2) pulsating flow
(having a time-average velocity of zero) triggered by the ultrasound wave may lead to
transport enhancement of the solute via a convective dispersion mechanism in the
absence of net volume flow, 3 9 , 55 and (3) upon ultrasound exposure with intensities
above the cavitation threshold, microstreaming associated with stable cavitation 15, 40
and liquid jets formed by asymmetric collapse of cavitation bubbles on the membrane
surface 50, 56 may lead to convective dispersion and a net volume flow, respectively,
thereby enhancing transport. All the above convection mechanisms can lead to transport
enhancement that differs from that resulting from the enhancement of molecular diffusion
due to the skin structural alteration.
A comparison of Figures 2-4(b) and 2-2(b) reveals that although the passive
permeabilities of mannitol across human HSS and pig FTS are comparable (3.42 ± 2.06
x10-5 cm/hr vs. 2.23 ± 1.41 xl0-5 cm/hr), the sonophoretic permeability of mannitol
across HSS (3.97 ±2.05 x10-1 cm/hr in Figure 2-4(b)) is three orders of magnitude higher
than that across FTS (5.63 ± 1.35 x10-4 cm/hr in Figure 2-2(b)). These results clearly
indicate the need to validate the in vitro skin models for LFS studies, and to determine
which in vitro skin model is predictive of the in vivo case. Studies along these lines are in
progress and will be reported elsewhere.
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2.4.3.2 Theoretical Analysis of LFS across HSS
LFS studies were carried out with multiple HSS samples following the same protocol as
described in the previous section. The measured steady-state sonophoretic permeabilities
of HSS (N=7), P, are plotted versus the corresponding measured steady-state skin
resistivities, R, in Figure 2-5 (@), along with the passive control baseline (0). Figure 2-5
reveals that the HSS sonophoretic log P vs. log R curve follows a linear behavior
(r2=0.80) with a slope value close to -1, but that it also exhibits a significantly higher
intercept value (-1.19, corresponding to the log R=0 value of the top line in Figure 2-5)
than that of the passive control baseline (-2.94, corresponding to the log R=0 value of the
bottom line in Figure 2-5). Based on eqs 25 and 27, as well as on our experimental
findings regarding the role of convection during LFS of HSS, we know that the observed
shift in the intercept value results from a combined effect of ultrasound-induced
convection and skin effective pore-radius modification: (intercept)"-(intercept)passive = log
Ecov+ log ((C3)"1 / (C3fpassive), with Econy and C3 given in eqs 7 and 24, respectively (Note
that siT does not affect the intercept value). Below, we discuss how to apply the theory
developed in Section 2.2 to quantitatively study the above two mechanisms during LFS
of HSS, followed by an assessment of the change of /t within HSS due to LFS.
First, to estimate the skin effective pore radius within HSS during LFS, we took
advantage of the data collected in the post-sonophoresis phase to decouple the convection
effect and the skin effective pore-size modification effect. As shown in Figure 2-4(a),
after LFS, the HSS resistivity over the post-sonophoresis phase (t 9 hours) is
approximately the same as that during the steady state of the sonophoresis phase (t: from
8 to 9 hours), suggesting that the skin structure remains the same during both phases (that
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Figure 2-5: Comparison of the experimental logP-logR correlation during LFS of HSS
(20 kHz, 1.6 W/cm2) with that during passive diffusion.
Key: (0) LFS of HSS, (0) in the absence of ultrasound (passive controls). Each data
point represents the permeability of one skin sample at steady-state and the corresponding
average skin electrical resistivity over the same time period. The slope of the best-fit
curve of the HSS sonophoresis data is -0.77 with r 2 = 0.80. A trend line with an ideal
slope value of -1 is shown for each case.
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is, the effective pore radius, r, of HSS is identical in both phases). Therefore, by
characterizing r in the post-sonophoresis phase, we can deduce its value in the
sonophoresis phase. The measured steady-state permeabilities of mannitol across HSS
during the post-sonophoresis phase are plotted versus the corresponding measured skin
steady-state resistivities in Figure 2-6 (A), along with the same data shown in Figure 2-5
(@, corresponding to the sonophoresis phase, and 0, corresponding to the passive
controls). Note that the post-sonophoresis data corresponds to a lower curve in the logP
vs. logR plot, compared to that of the sonophoresis phase, because of the absence of
convection.
Based on the intercept value of the post-sonophoresis curve (-2.50, corresponding
to the log R=0 value of the intermediate line in Figure 2-6), the effective pore radius of
HSS during the post-sonophoresis phase (as well as during the steady state of the
sonophoresis phase) was estimated by our theory to be greater than 92 A (or "infinitely"
large relative to the size of the permeant).5 In other words, during sonophoresis of HSS,
aqueous pathways having an effective pore radius much greater than that of the permeant
were formed within HSS. Therefore, this result confirmed the previous pathway
hypothesis made by our group during an investigation of the mechanisms of LFS with
HSS as the model membrane. 8 Comparing the structural responses of HSS and FTS
under the same sonophoresis protocol, it is clear that the ultrasound conditions examined
affected the structures of HSS and FTS to different extents. Specifically, LFS greatly
increased the effective pore radius within HSS5 (r >92 A), while it did not significantly
5 Following the methodology described in Appendix A, we obtained H(k)/H(io) ~'1 from the intercept
value corresponding to the post-sonophoresis phase (-2.50). This value indicates that the effective pore
radius within HSS is "infinitely" large relative to the radius of the permeant. With mannitol as the model
permeant, given a typical ±10% uncertainty in the determination of the intercept value for the logP vs. logR
correlation, our hindered-transport based theory does not distinguish between a pore radius of 92 A and
"infinity".
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Figure 2-6: Experimental correlation between the mannitol permeability, P (cm/hr), and
the skin electrical resistivity, R (kQ-cm 2), of HSS during and after LFS.
Key: (0) LFS phase of HSS, (A) post-LFS phase of HSS, (0) passive controls. The
slope of the best-fit curve of the post-LFS phase is -0.95 with r 2 1= 0.82. A trend line with
an ideal slope value of -1 is shown for each case.
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change the effective pore radius within FTS. This theoretically-derived skin structural
information substantiates our experimental findings regarding the different roles played
by convection during LFS of HSS and FTS. Indeed, according to the hydrodynamic
theories of diffusion and convection, transport through small pores is dominated by
diffusion, while transport through large pores is dominated by convection.
Secondly, our theory can be used to quantify the contribution of convection
during LFS of HSS, as well as to calculate the effective convective velocity of the
permeant under the sonophoresis conditions examined. By subtracting the skin alteration
effect from the total shift of the intercept value corresponding to the sonophoresis data,
we can deduce the contribution made by convection during sonophoresis of HSS. Figure
2-6 graphically shows the decoupling of the two mechanisms of skin permeability
enhancement. As stressed above, the difference in the intercept values at logR=0
corresponding to the sonophoresis phase (0) and the post-sonophoresis phase (A)
reflects solely the enhancement contribution due to convection. Specifically, log Ec,,= -
1.19- (-2.50)= 1.31, or Eco,,,= 20. Using this result in eq 7, with Pe given in eq 6, the
effective convective velocity of mannitol across HSS under the LFS conditions examined
was determined to be v = 0.28 cm/hr (see Appendix 2C).
After estimating the skin effective pore radius for HSS during LFS, we also
assessed the changes in the value of E/T during LFS of HSS. The same methodology
adopted in Section 2.4.2.2 (corresponding to LFS of FTS) was utilized. The average
steady-state permeabilities of mannitol across HSS during LFS (N=7, S in Figure 2-5)
and passive control (N=8, S in Figure 2-1) are 2.66x10-' cm/hr and 3.42x10-5 cm/br,
respectively. Therefore, the total enhancement of mannitol permeability across HSS,
Etota= 4 gg - coy is about 7,800-fold. Since Ecn 20, it follows that Edif= 390-fold.
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According to eq 31, this 390-fold diffusion-driven enhancement results from two possible
modes of skin alteration: (1) enlargement of r, and/or (2) increase of E/t. We first
calculated the enhancement of mannitol permeability due to the first mode of skin
alteration: with rp=4.44 A for mannitol, H(y= r, / r", at r'> 92 A)/ H(Xp=r, / ?assive, at
passe = 26 A)~ 1/H(0. 1708) ~2.2-fold. Subsequently, the contribution of the second
mode of skin alteration-the increase in e/r-can be quantified using eq 31. Specifically,
the ratio, E/1, within HSS is increased by (E /r)"Sl(E /r)passive = 390 / 2.2 = 180-fold, due to
LFS. Since the skin resistivity of HSS and FTS measured during passive diffusion are
comparable (see Figure 2-1), the average value of E/ within HSS during passive
diffusion approximately equals that within FTS, that is, (E/T)Psive of HSS ~~ (E/)passive of
FTS = 9.6x10-7 (see Section 2.4.2.2). Therefore, during LFS, the average value of (E /T)"
within HSS is increased to (9.6x10-7 ) (180) =1.7 x10-4 .
2.5 Model Consistency and Error Analysis
2.5.1 Validation of Model Consistency Using Two Extreme Cases
We considered two extreme cases of transport, and compared our theoretical predictions
with the experimental measurements to validate the consistency of the theoretical
framework. The first case corresponds to the passive diffusion of mannitol across dermis.
In the case of dermis, the SC layer of the skin is completely removed, which is equivalent
to an effective skin layer where the effective pore radius within the "SC" of that skin
membrane is "infinitely" large as compared to the radius of the permeant (the remaining
dermal layer has a macroscopic porous structure). Given the above description of the skin
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membrane structure, we used our theory to predict the log P vs. log R correlation curve
corresponding to this limiting case. Since the passive diffusion of mannitol across the
skin (in this case, the effective skin layer) is described by eqs 24 and 25, we substituted
H(k=r/r) / H(Xon=rion/r)~H(O)/H(O)=l (corresponding to the case where r is "infinitely"
large), along with the values of the other constants given in Appendix 2A, into eq 24, to
determine an intercept value. Subsequently, this calculated intercept value (logC 3 = -2.75)
was used along with a slope value of -1 to generate the theoretical logP vs. logR
correlation curve shown by the dashed line in Figure 2-7. We carried out passive
diffusion studies of mannitol across pig dermis, and compared the measured P and R
values with our theoretical prediction. The dermis data point is shown in Figure 2-7 as an
open circle (the error bars in both directions represent the standard deviation of five
dermis samples). Figure 2-7 reveals that the measured P and R values for the dermis
indeed fall on the dashed line corresponding to our model prediction. Therefore, given
the structural characteristics of the dermis, our theory successfully interprets the passive
diffusion results of mannitol across the dermis. The second extreme case that we
considered corresponds to a "pseudo-skin" layer consisting of a pure PBS solution.
Assuming that this PBS layer has the same thickness as that of the SC (Ax =15p m 1),
since the diffusivity of mannitol at 25 CC in this layer is D'=0.65 x10-5 cm2/s,5 7 the
"permeability" of mannitol across this "pseudo-skin" layer is determined to be P= D' /Ax
= 15.6 cm/hr. Since the specific conductivity of the PBS solution is =1 .2 x10-2(Q-cm),
41 the resistivity of this "pseudo-skin" layer is R=Ax /a=1 .25 x10 4^ kQ-cm2. Plotting the
permeability of this "pseudo-skin" layer against its resistivity value in Figure 2-7 (@), we
find that the resulting data point also lies on the log P vs. log R correlation curve
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Figure 2-7: Comparison of the theoretically predicted logP-logR correlation curve
(dashed line) for the limiting case (H(Xp)/H(ko0 )=1), and the measured values for two
extreme cases (dermis and PBS solution).
Key: passive diffusion of mannitol across dermis (0), and across a PBS solution (0).
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generated by our theory (with H(%)/H(Xi,)~1), corresponding to an extreme case of a
porous membrane with "infinitely" large pores.
The two extreme cases considered above indicate that the transport theory
developed in this Chapter is self-consistent. Indeed, this theory provides a useful tool for:
(i) quantifying the mechanisms of LFS (that is, induced convection vs. enhancement of
diffusion due to skin structural alteration), and (ii) characterizing the porous pathways of
hydrophilic permeants (through the corresponding r and E/t values) for various skin
membranes under different permeation conditions.
2.5.2 Model Validation Utilizing an Additional Hydrophilic
Permeant
In the previous sections, we utilized mannitol as the model permeant to assess the role of
convection during LFS. In addition, we characterized the barrier properties (through r and
Es) of both FTS and HSS in the presence and the absence of ultrasound. Theoretically,
these properties are only functions of the skin membrane characteristics and the
ultrasound conditions utilized, and should be independent of the type of hydrophilic
permeant used to probe them. To test the generality of our theoretical framework, an
additional hydrophilic permeant- sucrose- was studied.
2.5.2.1 Assessment of the Role of Convection during LFS with Sucrose as
the Model Permeant
Using sucrose as the model permeant, we followed the same experimental design
presented in 2.4.2.1 and 2.4.3.1 to decouple the effects of skin structural alteration and
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ultrasound-induced convection during LFS to assess the role of convection. The same
ultrasound protocol and two types of skin membranes-FTS and HSS-were examined.
With sucrose as the model permeant, we arrived at the same conclusions regarding the
role of convection during LFS as we did with mannitol. Specifically, convection plays an
important role during LFS of HSS (an about 20-fold drop in the total transport rate of
sucrose across HSS was observed when ultrasound was turned off), while convection is
negligible when FTS is utilized (no change in the total transport rate of sucrose across
FTS was observed when ultrasound was turned off).
2.5.2.2 Estimation of the Skin Effective Pore Radius with Sucrose as the
Model Permeant
Similarly, we carried out a theoretical analysis of the transport of sucrose across both
FTS and HSS to estimate the skin effective pore radii and the ratios of skin porosity and
tortuosity in the presence and the absence of ultrasound. The estimated r and /t values
were then compared to those obtained with mannitol to test the generality of our theory.
First, LFS studies with pig FTS as the model membrane were carried out. The
measured steady-state sonophoretic permeabilities, P, of sucrose are plotted versus the
corresponding measured steady-state skin resistivities, R, in Figure 2-8. The closed
circles represent the sonophoresis case, while the open circles represent the passive
controls. Figure 8 reveals that, like in the mannitol case (Figure 2-3), with sucrose as the
permeant, the log P vs. log R plots in both the absence and the presence of ultrasound
exhibit linear trends with slope values close to --l (p<0.05). Therefore, one can conclude
that the linear nature of the log P vs. log R correlation is general for different hydrophilic
permeants, although the correlation intercept values vary from permeant to permeant,
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Figure 2-8: Experimental correlation between sucrose permeability, P (cm/hr), and skin
electrical resistivity, R (kQ-cm2), of FTS.
Key: (0) passive diffusion, (0) LFS. Each data point represents the permeability of one
skin sample at steady-state and the corresponding average skin electrical resistivity over
the same time period. The slope of the best-fit curve of the passive diffusion data is -1.01
with r 2= 0.76. The slope of the best-fit curve of the sonophoresis data is -1.05 with r 2
0.76. The trend line shown in the graph has an ideal slope value of -1.
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depending on the physicochemical properties of the permeants (see eqs 24, 25, and 27).
The intercept values measured from Figure 2-8 are listed in Table 2.1, along with the
corresponding r values estimated using our theory (for details, see Appendix 2A). Based
on the sucrose data shown in Figure 2-8, E/t values for FTS, during both passive
diffusion and LFS, were also estimated following the same methodology presented in
Section 2.4.2.2, and are summarized in Table 2.1. The mannitol results are also listed in
Table 2.1 for comparison purposes. The physicochemical parameters, r, and D', of
mannitol and sucrose utilized in the estimations of the pore radii are listed in Table 2.2.
Table 2.1: Intercept values of the log P vs. log R correlation (at log R=0) measured for
the transport of mannitol (Figure 2-3) and sucrose (Figure 2-8) across FTS under various
conditions (including passive diffusion and LFS), and the deduced r and e/r values.
Permeant Intercept Value r (A) E/T
Passive LFS Passive LFS Passive LFS
Mannitol -2.94±0.28 -2.98±0.27 26±20 22±20 a 9.6 x 10-7 2.6 x 10-5
Sucrose -3.13±0.24 -3.21±0.24 28±15 23±10 a 2.5 x 10-6 2.5 x 10~5
a r within FTS during LFS was not significantly different from that during passive diffusion.
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Table 2.2: Hydrodynamic radii, rp, and free diffusion coefficients, D7, of the permeants
examined.
Permeant r, (A) D (cm 2 /s) at 25 *C D7 (cm2/s) at 37 *C
Mannitola 4.44 6.72 x 10-6  9.03 x 10-6
Sucroseb 5.55 5.20 x 10-6 6.98 x 10-6
a The 37 0C data of mannitol is taken from Peck et al. 4 5 The diffusion coefficient of mannitol was
corrected for temperature and viscosity from 37 'C to 25 0C based on the Stokes-Einstein equation (the
viscosity value was approximated using that of pure water58).
b The 37 0C data of sucrose is taken from Peck et al. 26 and Deen et al.5 9 The diffusion coefficient of
sucrose was corrected for temperature and viscosity from 37 'C to 25 'C based on the Stokes-Einstein
equation (the viscosity value was approximated using that of pure water5 8 ).
Table 2.1 shows that, for both mannitol and sucrose, the intercept values of the
experimental logP vs. logR correlation curves during LFS are comparable to the
corresponding passive diffusion intercept values. This common trend exhibited by both
the mannitol and the sucrose data indicates that the LFS condition examined did not
significantly alter r within FTS. Moreover, the estimated r and E/T values for FTS based
on the two different permeants agree very well (see Table 2.1).
Similarly, using human cadaver HSS as the model membrane, the effect of LFS
on the transport pathways of hydrophilic permeants within HSS was also quantified with
sucrose as the model permeant. Figure 2-9 shows the log P vs. log R correlation curves
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Figure 2-9: Experimental correlation between the sucrose permeability, P (cm/hr), and
the skin electrical resistivity, R (kQ-cm 2), of HSS during and after LFS.
Key: (0) LFS phase of HSS, (A) post-LFS phase of HSS, (0) passive controls. The
slope of the best-fit curve of the passive diffusion data is -1.01 with r 2= 0.76. The slope
of the best-fit curve of the sonophoresis data is -0.90 with r 2= 0.83. The slope of the
best-fit curve of the post-LFS phase is -0.88 with r 2 = 0.76. A trend line with an ideal
slope value of -1 is shown for each case.
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measured for sucrose transport across HSS in the presence (*, LFS phase) and the
absence of ultrasound (0, passive controls), as well as following the ultrasound treatment
(A, post-LFS phase). All three cases in Figure 2-9 exhibit linear trends which are similar
to those shown in Figure 2-6 in the case of mannitol. The intercept values of the log P vs.
log R correlation curves measured with sucrose as the model permeant are summarized in
Table 2.3, along with the skin effective pore radii estimations (for details, see Appendix
2A). The estimated /t values for HSS during both passive diffusion and LFS obtained
with sucrose as the model permeant are also summarized in Table 2.3. The corresponding
mannitol results are also listed in Table 2.3 for comparison purposes.
Table 2.3 (or a comparison of Figures 2-6 and 2-9) shows that: (1) for both
mannitol and sucrose, the intercept values measured during LFS across HSS are
significantly higher (less negative) than the corresponding passive control intercept
values, and (2) the intercept values corresponding to the post-sonophoresis curves,
measured with both mannitol and sucrose, fall between the intercept values
corresponding to the passive and sonophoresis curves. These common trends exhibited by
both the mannitol and sucrose data suggest that the LFS condition examined in this
Chapter induces significant convective flow across HSS (as reflected by the difference
between the sonophoresis and post-sonophoresis intercept values), as well as significantly
enlarges the skin effective pore radius within HSS (as reflected by the difference between
the post-sonophoresis and passive control intercept values). The absolute values of r
within HSS during both passive diffusion and LFS deduced based on these two
permeants agree very well quantitatively (see Table 2.3). Specifically, with sucrose and
mannitol as the model permeants, our theory estimates the passive r values within HSS to
be 28±15 A and 26 ±19 k, respectively, while during LFS, our theory estimates the lower
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bound on the r values within HSS to be 125 A and 92 A, respectively. In addition, the
values of E/t estimated for HSS during LFS and passive diffusion using the two
permeants also show excellent agreement (see Table 2.3).
Table 2.3: Intercept values of the log P vs. log R correlation (at log R=0) measured for
the transport of mannitol (Figure 2-6) and sucrose (Figure 2-9) across HSS under various
conditions (including passive diffusion, LFS, and post-LFS), and the deduced r and E/t
values.
Permeant Intercept Value R (A) E/t
Passive LFS Post-LFS Passive LFS Passive LFS
Mannitol -2.94±0.28 -1.19±0.21 -2.50±0.21 26±19 >92 9.6 x 1.7 x
10-7  10-4
Sucrose -3.13±0.24 -1.27±0.18 -2.61±0.22 28±15 >125 a 2.5 x 2.3 x
10-6 10-4
a With sucrose as the model permeant, following the methodology described in Appendix 2A, we obtained
H(Xp)/H(k 0 )~~1 from the intercept value of the post-LFS phase (-2.61). This value indicates that the
effective pore radius within the skin is "infinitely" large relative to the radius of the permeant. With sucrose
as the model permeant, given a typical ±10% uncertainty in the determination of the intercept value of the
logP vs. logR correlation, our theory does not distinguish between a pore radius of 125 A and "infinity".
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2.5.3 Sensitivity of the Skin Effective Pore Radii Estimations
To quantitatively assess the uncertainties associated with the skin effective pore radius
estimation, in Figure 2-10, we plotted the maximum percent error allowed in the
measurement of the intercept value to induce a within 30% error in the estimation of the
skin effective pore radius, r, as a function of r, for both mannitol (r, = 4.44 A, dashed
line) and sucrose (rp = 5.55 A, solid line). Figure 2-10 shows that, for a given r value, the
larger the value of rp, the more experimental uncertainty is allowed in the determination
of the intercept value (or the less sensitive is the estimation of r to errors in the
determination of the intercept value). Therefore, sucrose constitutes a better probe
permeant compared to mannitol. With sucrose as the probe, the skin effective pore radii
deduced in the present study are in a range where the experimental errors in the intercept
value determination do not lead to significant errors in the estimation of r. Specifically,
with sucrose as the probe permeant, the skin passive r value was estimated to be 28±15 A
(for both HSS and FTS). During LFS, r within FTS remained unchanged, while r within
HSS was enlarged to a value greater than 125 A (see Table 2.3).
90
S- C 0.15
0.1
>%cr) 0.05
0*0 20304 0 0 70 8
S :
r (A)
Figure 2-10: Sensitivity of the model estimation of the skin effective pore radius, r, to the
uncertainty in the measurement of the intercept value.
The percent uncertainty allowed in the intercept value measurement for a less than 30%
error in the estimated r value is plotted against r (A). Key: dashed line (mannitol), solid
line (sucrose).
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Having determined that sucrose is a reliable model permeant for estimating the
skin effective pore radius, below, we utilize this permeant to examine the sensitivity of
our skin effective pore radius estimation to the uncertainties in the permeant
physicochemical parameters, as reflected in D' and rp. Because the permeant diffusivity
at infinite dilution, D', is related to the permeant hydrodynamic radius, rp, through the
Stokes-Einstein equation, there is only one independent variable in this case. With this in
mind, in Figure 2-11, we plotted the maximum percent error allowed in the measurement
of Dj to induce a within 30% error in the estimation of r as a function of r for both
passive diffusion (dashed line) and LFS (solid line) conditions. Figure 2-11 shows that
for smaller r values, the estimation of r is less sensitive to the uncertainties in D'. With
sucrose as the probe permeant, the skin effective pore radii in the present study are in a
range where the experimental error in the D' determination (~5.9 %) 57 does not lead to
significant errors in the r estimation.
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Figure 2-11: Sensitivity of the model estimation of the skin effective pore radius, r, to the
errors in the value of the free diffusion coefficient of sucrose at infinite dilution, DO.
The percent uncertainty allowed in the value of D' (25 *C) for a less than 30% error in
the estimated r value is plotted against r (A). Key: dashed line (passive diffusion, when
the measured intercept value equals -3.13), solid line (LFS, when the measured intercept
value equals -3.21).
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2.6 Conclusions
The enhancement of transdermal drug transport by low-frequency sonophoresis (LFS,
20kHz) may result from enhanced diffusion due to ultrasound-induced skin alteration
and/or from forced convection. To understand the relative roles played by these two
mechanisms in LFS, a combined theoretical and experimental investigation was
conducted in this Chapter. A theory describing the transdermal transport of hydrophilic
permeants in both the absence and the presence of ultrasound was developed using
fundamental equations of membrane transport, hindered-transport theory, and
electrochemistry principles. With mannitol as the model permeant, the role of convection
in LFS was evaluated experimentally with two commonly used in vitro skin models-
human cadaver heat-stripped skin (HSS) and pig full-thickness skin (FTS). My results
suggest that, under a long-term LFSprotocol (9-20h), convection plays an important role
during LFS of HSS, while its effect is negligible when FTS is utilized. The theory
developed was utilized to characterize the transport pathways of hydrophilic permeants
during both passive diffusion and LFS with mannitol and sucrose as two probe
molecules. Results show that the porous pathway theory can adequately describe the
transdermal transport of hydrophilic permeants in both the presence and the absence of
ultrasound. Ultrasound alters the skin porous pathways by two mechanisms: (1) enlarging
the skin effective pore radii, or (2) creating more pores and/or making the pores less
tortuous. During passive diffusion, both HSS and FTS exhibit the same skin effective
pore radii (r = 28±13 A). In contrast, during LFS, r within HSS is greatly enlarged (r >
125 A), while r within FTS does not change significantly (23±10 A). The observed
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different roles of convection during LFS across HSS and FTS can be attributed to the
different degrees of structural alteration that these two types of skin undergo during the
long-term LFS protocols utilized (9-20 h).
In this Chapter, I demonstrated that the theory developed not only can be utilized
to characterize the effects of LFS (a physical skin penetration enhancer) on the skin
microscopic transport properties (r, skin effective pore radius, and E/T, the ratio of skin
porosity to tortuosity) of hydrophilic permeants, but can also be used to predict the skin
permeation rates of these compounds in the presence of LFS. Therefore, the theory
provides a valuable tool for optimizing ultrasound conditions for future clinical
application of LFS. The effects of a short-term ultrasound pretreatment protocol (~5
min) on the skin effective pore radius will be examined in Chapter 5. In addition, the
theoretical framework developed in this Chapter can potentially be utilized to study the
transport enhancement mechanisms of other skin penetration enhancers, such as chemical
enhancers (for example, water, see Chapter 6) and iontophoresis. Indeed, in Chapter 6 of
this thesis, I will utilize the theoretical framework developed in this Chapter to gain
insight into the effects of long-term hydration on the skin porous pathway of hydrophilic
permeants.
In the next Chapter (Chapter 3), I will present an investigation of the spatial
distribution of the skin porous transport pathway of hydrophilic permeants inside the skin
in the presence and in the absence of LFS using two-photon microscopy (TPM). The goal
was to establish the structural basis of the skin porous pathway of hydrophilic permeants,
as well as of the transdermal transport enhancement of hydrophilic permeants observed
during LFS.
95
Appendix 2A-Determination of the- Effective Pore
Radius of the Skin Porous Pathways during Passive
Diffusion
We first extrapolated each data point (open and filled circles) in Figure 2-1ito the y-axis
(at log R=0) using the ideal slope value of -1 to obtain one intercept value, and then
averaged all these values (N=17) to obtain the average intercept value corresponding to
the passive control case. Using this procedure, the intercept value of the passive diffusion
data of mannitol was determined to be -2.94. Therefore, using eq 25, it follows that:
log C3 = -2.94 (Al)
and C3 =10-2.94 =1.148xI-3 I-cm3[ hr
Using eq 24, C3 can be expressed as follows:
kT DPH(A) (A3)
2z2Fcione0 D nH(Aion)
The free diffusion coefficient of mannitol, D', is 0.672 x10 5 cm2 /s at 25 0C (see Table
2.2). Since the molar concentration of NaCl in the PBS solution is 0. 137M, more than 10-
fold higher than that of phosphate, we assume that sodium chloride is the dominant
electrolyte in PBS. In that case, the sodium ions can be used to model all the current-
carrying ions present in the solution. The free diffusion coefficient of a sodium ion, Drn
is 1.33 x10-s cm2/s at 25 C.4 6 Given the above diffusion coefficient values, eq A3 can
be used to calculate C3 using the following parameter values: k=l1.38066x10-2 J/K
(Boltzmann constant), T=298 K, F=9.6485x1i0 4 C/mol (Faraday constant), z=1 (in the
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PBS solution, NaCl is the dominant electrolyte), cie0 =0.137M=0.137x1i0 3 mole/m 3, and
eo=1.6xl0-19 C. Specifically,
C3 = 0.4914 x10~9 HX1=1.769 x[10~Hcm 1 (A4)H(Aion )j s JH(Aion) hr
Combining eqs A2 and A4, the ratio of the diffusion hindrance factors, H(Xp=rp/r)/
H(Xjo=rio11 /r), is given by:
H(A, = r, / r) 1.148 x10- 3 = 0.6489 (A)
H(ion = rion /r) 1.769 x10-3
Given the hydrodynamic radius of mannitol (r, = 4.44 A) and the hydrodynamic radius of
the ions (rion = 2.2 A), eq 11 can be used in eq A4 to calculate r (corresponding to passive
diffusion). Specifically, one obtains:
r=26 A
We can then validate the constraint on X=4 or Xo,, underlying the use of eq 11 (X<0.4).
Specifically, X,=rp/r = 4.44 A/26 A= 0.17< 0.4, and Xion=rion/r = 2.2 A/26 A = 0.085< 0.4.
Therefore, eq 11 is indeed applicable in this case. Following the same methodology, with
mannitol as the model permeant, r within HSS during LFS was estimated to be >92 A
(see Section 2.4.3.2). In a similar manner, with sucrose as the model permeant, r within
FTS and HSS during both passive diffusion and LFS can be estimated (see Section
2.5.2.2). The results are summarized in Tables 2.1 and 2.3.
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Appendix 2B-Range of Validity and Applicability of
the Theoretical Framework
Our theory relies on a number of assumptions. Equations from hindered-transport theory
utilized in our theoretical framework are valid when the permeant, as well as the current-
carrying ions, are inert hard spheres having uniform radii. Deviation from this ideal
assumption may lead to errors in the modeling. In addition, in order to satisfy the
assumption that no electrostatic interactions operate between the ions and the negatively-
charged skin pore walls, the estimated r value has to be much larger than the Debye-
ickel screening length, the length scale associated with the screening of electrostatic
interactions. For the 0.137 M PBS buffer utilized in the present studies, the Debye-
Hickel screening length is estimated to be 7 A.4 6 This value is indeed much smaller than
all the r values estimated in this Chapter (see Tables 2.1 and 2.3). Therefore, this
approximation is valid for the conditions examined in this Chapter. Note that if this
approximation was not valid, and there were significant repulsive or attractive
interactions, other than steric hindrance, operating between the negatively-charged skin
pore walls and the permeant, then our theory would tend to either overestimate or
underestimate the value of r, depending on the relative effects of these types of
interactions on the permeant partition coefficient and its diffusion coefficient inside the
skin. For example, attractive interactions would favor the partitioning of the permeant
into the skin pores, while at the same time, retarding the movement of the permeant
inside the skin pores. The relative magnitudes of these two effects would then determine
the direction of the bias associated with the r estimation.
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Appendix 2C-Estimation of the Effective Convective
Velocity during Low-Frequency Sonophoresis of HSS
According to our theoretical framework and experimental findings, the shift in the
intercept value of the HSS sonophoresis data from the passive control baseline, as shown
in Figure 2-5, reflects a combined effect of forced convection and skin effective pore
radius enlargement. By subtracting the skin alteration effect from the total shift in the
intercept value, we can deduce the contribution made by convection during LFS of HSS.
Figure 2-6 graphically shows the decoupling of the two mechanisms of skin permeability
enhancement during LFS of HSS. The difference in the intercept values between the LFS
phase (@) and the post-LFS phase (A) reflects the contribution of convection during
LFS. Specifically, by subtracting the post-LFS intercept (-2.50) from the LFS intercept (-
1.19), one obtains
logEc -=-l1.19-(-2.50)=1.31 (C1)
or
Ec = 20 (C2)
From eq 7, the value of the Peclet number can be determined from Econy, and is given by
Pe = 20 (C3)
From eq 6, the convective velocity of mannitol, v, under the examined HSS sonophoresis
condition can then be obtained as follows:
Dus
v = (Pe) = (Pe)Pu = (Pe)P( post - sonophoresis) (C4)
The post-sonophoresis permeability of mannitol across HSS, P(post-sonophoresis), can
be determined by averaging the permeability values for all the HSS samples (A, N=7) in
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Figure 2-6. The resulting value is P(post-sonophoresis)= 1.41x10-2 cm/hr. Therefore, it
follows that
v = 0.28cm / hr (C5)
Consequently, the time constant associated with convection across the SC during
sonophoresis of HSS (20 kHz, 1.6 W/cm 2, 100 msec pulses applied every second) is
given by
Ax 0.0015cmI=-= 0. cm = 0.0054hr=19 sec (C6)
V 0.28cm / hr
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Chapter 3
Visualization of LFS-Mediated Transdermal
Permeation of Hydrophilic Permeants Using
Two-Photon Microscopy
3.1 Introduction
Two-Photon Microscopy (TPM) is a technique that permits the 3-dimensional
visualization of the cellular distribution of fluorescent probes in unfixed tissue samples.
TPM has been utilized recently for the noninvasive imaging of skin samples. 61 , 62 In
contrast to confocal microscopy, a technique commonly used in 3-dimensional imaging
of tissue, two-photon microscopy involves a three-body collision in which two photons,
each having twice the wavelength of the excitation, interact with one fluorescent
molecule to create an excitation event. Because a three-body collision occurs with a
much lower probability than the excitation of a fluorescent molecule by a single photon,
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fluorescence imaging is confined to the focal volume of interest. The quadratic
dependence of the fluorescence intensity on photon flux results in enhanced depth
discrimination compared to other imaging techniques, because the photon flux drops off
rapidly away from the focal plane. 63 -65 The geometry of the two-photon microscopy
system allows the scattered photons to be collected by a large area detector, which leads
to a high photon collection efficiency. Accordingly, photons that would typically be
blocked off by the confocal pinhole aperture in a confocal microscope system, can be
detected using TPM in a highly scattering medium, such as the skin.66 In addition,
compared with confocal microscopy, TPM also possesses the following attributes: (i) the
use of infrared excitation in TPM allows deeper light penetration, and therefore, enables
the imaging of deeper regions in the tissue samples (the absorbance in the infrared
spectral range is an order of magnitude smaller than that in the UV or blue-green range),
(ii) photobleaching and photodamage are reduced by limiting the excitation events to the
focal volume, and (iii) the difference between the excitation and the emission
wavelengths allows the fluorescence photons to be filtered out as signal.61 , 67 Access to
the two-photon laser scanning microscope was obtained through a collaboration with
Professor Peter T.C. So at MIT.
Based on the above description of TPM, the advantages of employing this
technique to image the skin are quite appealing. Three-dimensional constructs of the
fluorescent-probe distribution across the skin can be utilized to gain a deeper
understanding of the mechanisms responsible for transdermal drug transport both in the
presence and in the absence of skin penetration enhancers, such as ultrasound.
Specifically, in Chapter 2, I showed that transdermal transport of hydrophilic permeants
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in both the presence and the absence of LFS can be described adequately using a skin
porous (aqueous)-pathway model. An important question then arises: What is the
structural basis of this "porous" pathway for hydrophilic permeates. Or, more
specifically, (i) do these permeants traverse the SC (Stratum Corneum) primarily through
the intercellular region or through the intracellular region, and (ii) what are the relative
contributions of the skin cells and the lipids to the transport of hydrophilic permeants in
the presence of LFS, a physical skin permeation enhancer? To address questions (i) and
(ii) regarding the skin transport pathway of hydrophilic permeants, I conducted TPM
imaging studies as part of my thesis work, and the results of these studies are presented
below.
3.2 Objectives and Methods
3.2.1 Objectives
Preliminary TPM studies were conducted to identify the permeation pathway of
hydrophilic permeants across the skin during LFS (intercellular pathway vs. intracellular
pathway, see Figure 3-1). Specifically, by visualizing the spatial distribution of a
hydrophilic model permeant (Sulforhodamine B, or SRB, MW559) in the skin in the
presence and in the absence of LFS, the relative importance of the two skin structural
regions-the corneocytes and the intercelluar lipid lamellae region-to the transdermal
transport of hydrophilic permeants could be established. In addition, by comparing the
spatial distributions of SRB in the skin in the presence and in the absence of LFS, the
effects of low-frequency ultrasound on the conformation of the various forms of skin
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lipids (lipid lamellae and the lipid-cell envelope), which are responsible for maintaining
the barrier function of the skin,6 8 -7 0 could be elucidated.
(a) Intercellular(bInrclua
Figure 3-1: Possible skin permeation pathways of hydrophilic probes.
Another potential application of TPM involves investigating the mechanisms
responsible for the enhancement of transdermal drug transport due to ultrasound,
including an evaluation of the changes in the drug vehicle-to-skin partition coefficient
and the drug diffusion coefficient induced by ultrasound, and will be discussed as part of
the Future Work Section at the end of this thesis (see Section 7.2).
3.2.2 Materials and Methods
3.2.2.1 Preparation of Probe Solutions and Skin Samples
The fluorescent probe, sulforhodamine B (SRB), was purchased from Molecular Probes
(Eugene, OR), and was dissolved in PBS to obtain an aqueous solution with a probe
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concentration of 0.4 mg/ml. Full-thickness human cadaver skin from the abdominal area
(National Disease Research Institute, Philadelphia, PA) was kept frozen at -80 *C until
use. Upon use, the skin was thawed at room temperature (23 *C), and the fat from the
dermal side was removed using a razor blade. Skin samples were then mounted on
vertical diffusion cells having a transport area of 1.77 cm2 . The initial skin quality was
checked by measuring the skin electrical resistance (see Chapter 2 for a detailed
description of the method). Only skin samples with an electrical resistance larger than 50
k cm2 were utilized in the studies. Skin samples were hydrated with PBS, present in
both the donor and the receiver compartments of the diffusion cell, for I h before every
expenment.
In the passive control experiments, the donor compartment was filled with a SRB
solution, and the skin was left in contact with the probe solution for 24 h before the
images were taken. In the ultrasound experiments, 20 kHz ultrasound was applied on the
skin through the SRB solution for 20 h (1.6 W/cm 2 ultrasound was applied in a pulsed
mode, 100 millisecond pulses applied every second, with a distance of 0.8 cm between
the ultrasound probe and the skin surface). Ultrasound was applied in a pulsed mode to
minimize thermal effects. After 20 h of sonophoresis, ultrasound was turned off, and the
skin samples were mounted onto microscope slides for imaging.
3.2.2.2 Data Collection and Analysis
Both the control and the LFS experiments were conducted in duplicates. For the control
case, a total of five skin sites were scanned, while for the LFS case, a total of ten skin
sites were scanned (five skin sites correspond to the local transport region, LTR, while
the remaining five correspond to the region outside the LTR, see Section 3.3.1). Each
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scanned area had a dimension of 112 gmx112 jm. The TPM images that will be shown
in this chapter correspond to a representative skin site obtained for each skin permeation
condition. The laser power utilized in the studies was adjusted to below the detection
saturation threshold, resulting in a linear correlation between the fluorescence counts
detected and the probe concentration in the sample. Therefore, the average concentration
of the probe at a certain skin depth is reported in units of photon counts.
3.3 Spatial Distribution of the Transport Pathway of
SRB in the Skin: Intercellular vs. Intracellular
In the past decade, various imaging techniques have been utilized to visualize the routes
of transdermal permeation of tracer compounds, and to find out to what extent the
intercellular and the intracellular regions of the SC contribute to the transdermal transport
of model permeants. 2 2 , 71-74 Previous skin imaging studies have demonstrated that,
passively, both hydrophilic and hydrophobic molecules traverse the skin via an
intercellular pathway.7 1 , 74-76 Menon and Elias demonstrated 74 that discontinuous
microdomains, or lacunar dilatations, arising at sites of desmosomal dissolution within
the intercellular lamellae provide7 7 the structural basis for this intercellular pathway
under passive skin permeation conditions.
Using colloidal lanthanum hydroxide as a model hydrophilic tracer, Bonmmannan
et al. have shown2 2 that, under the influence of high-frequency ultrasound (10 or 16
MHz), the hydrophilic tracer penetrates through the SC via a seemingly intercellular
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route, similar to the passive case. In a more recent study, similar results have been
obtained.7 4 Specifically, using lanthanum nitrate and FITC-dextrans as the two
hydrophilic tracers, Menon and Elias showed7 4 that the hydrophilic tracers were
localized within the lacunar domains of the intercellular space in the SC during both
passive diffusion and high-frequency sonophoresis (16 MHz), thus suggesting that, with
or without the application of high-frequency ultrasound, the hydrophilic compounds
traverse the skin via an intercellular pathway. These results indicated that ultrasound,
under high-frequency conditions, enhances the skin permeability of hydrophilic
compounds through a mechanism of permeabilizing/disordering the intercellular lipid
bilayers, while the corneocytes remain "inactive" with respect to transdermal transport.
Five years ago, our group reported that low-frequency ultrasound (LFS, 20kHz)
provides a much more effective condition for enhancing transdermal drug transport than
therapeutic ultrasound (1-3MHz) as well as high-frequency ultrasound (>3MHz). LFS
was shown 8 to induce transdermal drug transport enhancements of up to 1000 times
higher than those induced by therapeutic ultrasound (1-3 MHz) (note that the transdermal
drug transport enhancements induced by high-frequency ultrasound (10-16 MHz) 7, 8, 13
are comparable to those induced by therapeutic ultrasound, which are usually less than
10-fold). For drugs that do not permeate across the skin passively due to their high
hydrophilicity, LFS represents a very effective skin penetration enhancer. Because the
transport enhancement attained by low-frequency ultrasound and those attained by
therapeutic or high-frequency ultrasound (1-3 or 10-16 MHz) are so different (differ by
orders of magnitude), it is reasonable to speculate that the skin structural basis
responsible for the transport enhancements for the two ranges of ultrasound conditions
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(kilo Hertz vs. Mega Hertz ultrasound) may also be different. Previously, Mitragotri et al.
hypothesized 8 that there exists an ultrasound-induced intracellular aqueous pathway for
drug transport across the skin during LFS. This hypothesis was then utilized to explain
the observed high skin permeabilities to hydrophilic permeants during LFS. However, to
date, no skin imaging studies have been conducted to test this hypothesis. In other words,
it is still unclear whether such an intracellular pathway exists for the transdermal
transport of hydrophilic permeants during LFS.
With this in mind, the primary goal of the studies reported in this Chapter was to
visualize the spatial distribution of the skin permeation route of hydrophilic permeants in
the presence and in the absence of low-frequency ultrasound, including establishing
whether the application of ultrasound at the low-frequency conditions leads to changes in
the location of the skin permeation pathway. In addition, the visualization of the
hydrophilic probe distribution in the skin, with and without ultrasound, may enable
assessing the ultrasound effects on the barrier functions of the different skin structural
regions (including the intercellular lipids and the lipid-cell envelope of the corneocytes).
Because hydrophilic permeants represent a class of compounds that attracts significant
research interest in the transdermal drug delivery area due to their pharmaceutical
relevance, a hydrophilic model compound (SRB) was chosen for the preliminary skin
imaging studies reported in this Chapter.
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3.3.1 Spatial Distribution of the Skin Permeation Route of SRB
(Intercellular vs. Intracellular)
Figure 3-2 illustrates the 3-dimensional constructs of the spatial distribution of SRB in
the skin during both passive diffusion and LFS. During passive diffusion, according to
the TPM micrograph (see Figure 3-2 (a)), the SRB molecules are localized in the
intercellular lipid region of the SC, and the hexagonally-shaped corneocytes are clearly
visible due to the contrast in the probe concentrations in the lipid vs. the corneocyte
regions. This TPM result confirmed the previously reported 74 observation that,
passively, hydrophilic permeants traverse the skin via an intercellular pathway.
During LFS, one of the most important experimental findings is that, under the 20
kHz-LFS condition examined, a single Localized Transport Region (LTR) was observed
on the skin area treated with ultrasound. The LTR was more intensely stained compared
with the surrounding area (referred to hereafter as the Inactive Transport Region, or JTR).
Since the fluorescent probe utilized, SRB, is a red dye, the LTR appeared as a red spot,
having a diameter of around 0.3-0.5 mm, to the naked eye. Because of the presence of the
two distinct transport regions (reflecting the heterogeneity in the probe distribution) in the
skin treated with LFS, the probe spatial distributions in those two regions (LTR and ITR)
were examined separately (see Figures 3-2 (b) and 3-2 (c), respectively). A comparison
of Figure 3-2 (b) and Figure 3-2 (a) reveals that, inside the LTR, enhanced probe
penetration into the skin due to LFS is evident (that is, more probe has penetrated into the
deeper regions of the skin inside the LTR). On the other hand, inside the JTR (see Figure
3-2 (c)), the SRB distribution pattern appears similar to that observed in the passive
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control case (see Figure 3-2 (a)), suggesting that the skin structure in the ITR region
remains comparable to that of the control skin.
To confurm this observation quantitatively, the average level of photon counts at
each skin depth was calculated for the three skin images shown in Figure 3-2, and the
results are plotted in Figures 3-3 and 3-4. Figure 3-3 compares the concentration profile
of SRB in the LTR of the ultrasound-treated skin (Figure 3-2(b)) with that of the control
skin (Figure 3-2(a)), while Figure 3-4 compares the concentration profile of SRB in the
ITR of the treated skin (Figure 3-2(c)) with that of the control skin (Figure 3-2(a)).
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Figure 3-2: TPM images of the 3-dimensional distribution of SRB in the skin. (a) Skin during passive diffusion; (b) Localized
Transport Region (LTR) in the skin during LFS; and (c) Inactive Transport Region (ITR) in the skin during LFS.
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Figure 3-3: SRB concentration in the skin as a function of the skin depth (comparison of
the control skin and the LTR in the ultrasound-treated skin).
Key: (P) skin during passive diffusion, (M) LTR (Localized Transport Region) in the
skin during LFS. Note that the photon counts (or concentrations of SRB) represent an
average value for the entire image (112 pmx 112 pm), including both the cellular and the
intercellular regions.
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Figure 3-4: SRB concentration in the skin as a function of the skin depth (comparison of
the control skin and the ITR in the ultrasound-treated skin).
Key: (E) skin during passive diffusion, (M) ITR (Inactive Transport Region) in the skin
during LFS. Note that the photon counts (or concentrations of SRB) represent an average
value for the entire image (112 pmx112 gm), including both the cellular and the
intercellular regions.
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Figure 3-3 reveals that inside the LTR in the ultrasound-treated skin, SRB
penetrates much deeper into the SC, compared to the passive control case (that is, the
SRB concentration in the LTR in the ultrasound-treated skin is significantly higher than
that in the control skin). In contrast, Figure 3-4 reveals that, within error bars, the
concentration profiles of SRB in the ITR in the ultrasound-treated skin and in the control
skin are not statistically different. In other words, the ITR is not significantly more
permeable than the control skin. Therefore, based on the concentration profiles shown in
Figures 3-3 and 3-4, as well as based on the TPM images shown in Figure 3-2, one can
conclude that the transport enhancement due to LFS should be attributed mainly to the
presence of the LTR in the skin (the rest of the treated skin area, ITR, is almost as
"inactive" as the control skin). The implications of this heterogeneity of probe
distribution in the ultrasound-treated skin sample (that is, the formation of the LTR
during LFS) on the mechanisms of LFS will be discussed in Section 3.3.2.
After finding that, during LFS, the LTR is the region that is responsible/relevant
for the observed SRB transport enhancement, a closer examination of the 3-dimensional
SRB distribution inside the LTR in the ultrasound-treated skin was carried out (see
Figure 3-5). The goal was to assess the relative importance of the two skin structural
regions-the corneocytes and the intercelluar lipid lamellae region-to the transdermal
transport of hydrophilic permeants such as SRB during LFS. In other words, the specific
goal was to test the hypothesis put forward in Ref 8 about the existence of an
intracellular pathway across the skin during LFS.
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Figure 3-5: 3-Dimensional spatial distribution of SRB inside the LTR in the skin during LFS.
Figure 3-5 shows the lateral distribution of the SRB molecules inside the LTR in
the ultrasound-treated skin at various skin depths. Figure 3-5 indicates that, inside the
localized transport region (LTR), the distribution of the skin pathway of SRB is a
function of the skin depth. Specifically, in the superficial region of the skin (x=Om), the
pathway is both intercellular and intracellular, while in the deeper regions of the skin
barrier (Stratum Corneum, SC), the pathway is primarily intercellular (as indicated by the
color bar in Figure 3-4, where green represents high concentrations of SRB, while purple
represents low concentrations of SRB). Note that all the images shown in Figure 3-4 were
obtained from the same skin site (112 pmx112 jm). The series of TPM micrographs
shown in Figure 3-4 reveals that the distribution of the skin transport pathway of
hydrophilic permeants in the presence of LFS (a physical skin permeation enhancer)
exhibits heterogeneity in both the vertical and the lateral directions. Therefore, one may
conclude that the skin transport pathway of hydrophilic permeants in the presence of LFS
cannot be simply classified into one of the two categories, intercellular or intracellular,
because the distribution of hydrophilic probe inside the skin does not exhibit a uniform
nature throughout the skin barrier thickness. In summary, both intercellular and
intracellular pathways are important for the transdermal transport of the hydrophilic
probe (SRB) in the presence of LFS. Specifically, (1) inside the LTR, both intercellular
and intracellular pathways are observed at the superficial level of the SC, while in the
deeper regions of the SC, the transport appears to occur primarily through the
intercellular pathway, and the corneocytes remain "inactive" with respect to transport (the
lipid envelopes of the corneocytes located in the deeper regions of the SC remain intact
and impermeable), and (2) inside the ITR, the probe localizes in the intercellular lipid
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region, indicating that intercellular transport is dominating, like in the passive diffusion
case.
3.3.2 Implications of the Formation of the LTR on the
Mechanisms of LFS
A plausible explanation for the formation of the LTR during LFS (20kHz) is as follows.
The heterogeneity in the lateral distribution of the model hydrophilic probe (SRB) in the
skin (that is, the observed formation of the LTR) may be attributed to the heterogeneity in
the cavitation zone in the coupling medium on top of the skin during LFS. It is known
that when a cavitation bubble collapses in a liquid, additional cavitation events may take
place in its vicinity during the subsequent acoustic cycles, because the small bubbles
originating from this collapsing bubble can act as additional cavitation nuclii. 19 It is also
known that unevenness on a solid surface acts as an ideal nucleation site for cavitation.19
Therefore, we hypothesize that initial cavitation events that take place on the skin surface
due to exposure to 20 kHz ultrasound lead to the formation of a localized cavitation zone
on top of that particular skin site during the subsequent acoustic cycles (that is, the
irregularities/unevenness of the skin surface caused by the initial cavitation events leads
to nucleation of more cavitation bubbles on that same site on top of the skin membrane
during the subsequent acoustic cycles). Because the cavitation zone is "locked" on top of
one specific skin area, the cumulative effect of cavitation-induced mechanical stresses
leads to the formation of a single LTR during LFS (20kHz). On the other hand, the rest of
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the skin area is not exposed effectively to significant amounts of cavitation energy, and
therefore, remains similar to the control skin.
To gain further insight into the relationship between ultrasound-induced
cavitation activity and the skin permeabilization effect due to LFS, I conducted a
systematic investigation of the cavitation activity during LFS. The results of this
investigation are presented in Chapter 4.
3.4 Conclusions
The main conclusions of this chapter can be summarized as follows:
1. From the 3-dimensional images of the probe (SRB) spatial distributions in the
skin, I demonstrated that: (1) the hydrophilic probe traverses the skin passively
via an intercellular pathway, and (2) in the presence LFS, both intercellular and
intracellular pathways contribute to the transdermal transport of the hydrophilic
probe.
2. 20 kHz ultrasound induces heterogeneity in the SRB distribution in the skin-a
localized transport region (LTR) is created per skin sample during LFS. Possibly,
this heterogeneity in the skin permeabilization due to LFS may be attributed to the
cavitation mechanism (see Chapter 4).
3. Low-frequency ultrasound is capable of not only disordering the intercellular
lipids, but also of permeabilizing the cell envelope of some of the superficial
corneocytes present in the SC. These ultrasound effects on the structure of the
different skin regions (corneocytes vs. intercellular lipids) are depth-dependent.
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In the next chapter (Chapter 4), a systematic investigation of the role of cavitation
during LFS will be presented to elucidate the relationship between cavitation activity and
the skin permeabilization effect induced by LFS.
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Chapter 4
An Investigation of the Role of Cavitation In
LFS-Mediated Transdermal Drug Transport
4.1 Introduction
Because of the widespread application of ultrasound in medical practice, the effects of
ultrasound on biological tissues have been studied extensively over the years. Ultrasound
can interact with biological tissues (such as the skin) through various mechanisms. In
general, the biophysical modes of ultrasonic action on biological tissues can be classified
into two categories:7 7 (i) thermal mechanisms, and (ii) nonthermal mechanisms. Of the
variety of nonthermal effects of ultrasound in biological tissues that have been reported,
acoustic cavitation is believed to be the most important one.7 8 Acoustic cavitation is
defined as the acoustically-induced activity of gas-filled cavities (involving nucleation,
oscillation, and collapse). There are two types of cavitation activities. The first is
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noninertial (or stable) cavitation, where the radius of the bubbles oscillates about an
equilibrium value without collapsing over a considerable number of acoustic cycles. The
second is inertial (or transient) cavitation, where bubbles grow rapidly within one or two
acoustic cycles before collapsing violently during a single compression half cycle.1 9 , 79
In previous studies of sonophoresis, acoustic cavitation has most often been
suggested to be the key mechanism responsible for the observed skin permeability
enhancement due to ultrasound. However, this hypothesis that cavitation is the key
mechanism responsible for sonophoresis was based on indirect experimental
observations, such as the appearance of "holes", or of irregularities, in the skin tissue, 22,
24, 80, 81 or the inverse dependence of the sonophoretic enhancement on the ultrasound
frequency (that is, the observed dependence of the biological effects of ultrasound on
ultrasound frequency was consistent with a cavitational mechanism 8).
The main objective of this Chapter was to conduct a systematic investigation of
the role of cavitation during low-frequency sonophoresis (LFS), a technique that has been
shown to be capable of facilitating the delivery of large protein drugs via the transdermal
route.2 6 Specifically, the objectives of this Chapter are two-fold: (1) obtain direct
experimental evidence to test the role of cavitation during LFS, and (2) investigate the
detailed mechanisms via which ultrasound-induced cavitation permeabilizes the skin
membrane during LFS (that is, to identify the critical type(s) and site(s) of cavitation that
are responsible for the observed skin permeability enhancement during LFS).
To collect experimental evidence to confirm the hypothesized key role of
cavitation during LFS, we constructed a high-pressure cell to manipulate the ambient
pressure of the LFS system, and utilized an acoustic method to detect the presence of
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cavitation bubbles in the high-pressure cell LFS system. Because the cavitation threshold
(that is, the minimum ultrasound intensity required to induce cavitation) is a sensitive
function of ambient pressure, 18 , 19 by applying high ambient pressure, one can
completely suppress the cavitation activity in the LFS system, while not affecting the
other ultrasound-induced phenomena, including thermal effects and acoustic streaming
and its associated radiation forces.7 7 By manipulating the ambient pressure, we
compared the measured magnitudes of the skin permeabilization effect during LFS in the
presence (under normal atmospheric pressure) and in the absence (under elevated
ambient pressure) of cavitation, and this comparison enabled us to unambiguously test
the role of cavitation during LFS. In subsequent studies, we sought to identify the critical
type(s) and site(s) of cavitation responsible for the observed skin permeabilization during
LFS. Specifically, three questions were addressed: (i) does cavitation occur inside the
skin membrane during LFS, (ii) which type of cavitation activities-transient or stable-
plays the key role in enhancing the skin permeability during LFS, and (iii) what are the
key mechanisms via which cavitation bubbles modify the skin structure.
4.2 Experimental Section
4.2.1 Materials
Yorkshire pig full-thickness skin (FTS) was harvested within half an hour after
sacrificing the animal. The subcutaneous fat was trimmed off with a surgery scalpel, and
the pig FTS was cut into small pieces and stored in a -80 *C freezer for up to 2 months.
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Both LFS and control experiments were conducted using Franz diffusion cells
(Permegear Inc., Riegelsville, PA). Before each experiment, the donor and the receiver
compartments of the diffusion cells were filled with PBS to equilibrate the skin for an
hour, and the skin electrical resistance was measured to check the skin quality following
the previously published method.5 2 , 82 Skin samples having a specific electrical
resistance of less than 35 kQ cm2 48 were considered damaged, and were not used in
subsequent skin permeation studies.
4.2.2 Method of Quantifying the Effect of LFS
4.2.2.1 Measurement of Skin Permeabilization during LFS
The skin electrical conductance (the reciprocal of the skin electrical resistance) is a
sensitive indicator of the skin barrier function. 5 6 Because the skin electrical
conductance/resistance can be measured nearly instantaneously and with less effort than
the skin permeability, in this Chapter, we utilized the skin electrical conductance as an
indicator to quantify the skin permeabilization effect induced by ultrasound.5 2 , 83 The
electrical conductance of in vitro pig skin was measured using methods described in Refs.
52, 82. The enhancement of the skin electrical conductance due to LFS was calculated by
taking the ratio of the skin electrical conductance measured before and after the
ultrasound exposure.
4.2.2.2 Ultrasound Application
20 kHz ultrasound was generated by an ultrasonic transducer (VCX 400, Sonics and
Materials, Inc., Newtown, CT), and was applied in a pulsed mode (0.1 sec ON, 0.9 sec
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OFF) to minimize thermal effects. The ultrasound probe was positioned 0.8 cm above the
skin inside the donor compartment of the diffusion cells during ultrasound application.
The ultrasound intensities applied were between 1.6 and 33.5 W/cm 2, depending on the
experiment (ultrasound intensities were measured using methods described in Ref. 52).
The typical ultrasound application time for the skin conductance enhancement
experiments was 2 h. The temperature in the diffusion cells during the 2-h ultrasound
treatment was recorded continuously using a fine rigid wire thermocouple and a digital
thermometer (Digithermo, VWR Scientific). During ultrasound treatment, the
temperature of the receiver compartment of the diffusion cells was constant (23±1 *C).
On the other hand, the temperature of the PBS solution in the donor compartment
increased as a function of the ultrasound treatment time. When the ultrasound intensities
utilized were greater than 14.4 W/cm 2, the temperature in the donor compartment was
found to exceed 37 0C after about 10 minutes of ultrasound treatment. As a result, during
the skin conductance measurement experiments, we replaced the coupling PBS solution
in the donor compartment with fresh PBS at room temperature as needed to maintain the
skin surface temperature ;40 'C (recall that skin lipids undergo a phase transition at
temperatures of about 40'C 84 ). Accordingly, we maintained the skin temperature during
sonication below 40 'C to minimize thermal effects).
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4.2.3 Cavitation Detection Using an Acoustic Pressure Spectrum
Analysis
The acoustic method of cavitation detection involves the detection of cavitation bubble
activity by measuring the pressure spectrum (acoustic emissions) of an acoustic field
using a pressure transducer (hydrophone). 7 7 When cavitation occurs, features associated
with the bubble response appear in the measured pressure spectrum, while such features
do not appear in the absence of cavitation.8 5 , 86 For example, if the driving acoustic field
is a continuous wave of frequencyf, the acoustic pressure field scattered by the cavitation
bubbles contains special components of harmonic frequencies (2f, 3f, etc.), subharmonic
frequencies (fl2, fl3, etc.), and ultraharmonic frequencies (3fl2, 2fl3, etc.). As a result, the
onset of subharmonic signal (f/2) has been commonly utilized as an indicator of the onset
of cavitation bubbles in a biological system, 7 7 85 and its amplitude used to characterize
the magnitude of stable (noninerital) cavitation activity.8 7 In addition, at higher
ultrasound intensities (above the threshold of transient cavitation 19 ), bubbles grow
rapidly and collapse during a single compression half cycle (a phenomenon referred to as
transient cavitation). The occurrence of transient cavitation results in the emissions of
white noise (or broadband noise), which raises both the peak acoustic signals and the
acoustic emission between the peaks. Consequently, the amplitude of the broadband
noise can be measured to characterize the magnitude of transient (inertial) cavitation
activity. 7 7 , 85 In summary, there are certain types of acoustic signals within the pressure
spectrum that are known to be associated with cavitation activities. One can use the
acoustic method to directly detect the onset of cavitation, as well as to quantitatively
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measure the magnitudes of the two types of cavitation activities (transient vs. stable) in
the regions exposed to ultrasound.
In this study, we measured the amplitudes of both the subharmonic (f/2) signal
and of the broadband noise emission in the LFS system under various ultrasound
application conditions to characterize stable and transient cavitation activities in the LFS
system. The acoustic measurements were carried out using a hydrophone (a home-made
transducer device donated to us as a gift by Prof. Ron Roy in the Department of
Aerospace and Mechanical Engineering at Boston University), which was epoxied to the
bottom of the diffusion cell. A schematic diagram of the apparatus used to measure the
real-time acoustic spectrum is shown in Figure 4-1. The output of the hydrophone was
analyzed utilizing a digital oscilloscope (Hewlett Packard, Model Infinium 54810A),
which carries out a Fast Fourier Transform (FFT) and displays the frequency spectra of
the measured acoustic field. The frequency spectra data was then fed into a PC through a
GPIB board (National Instruments) to obtain the amplitudes of the f/2 and broadband
noise signals. Both signals were measured in units of voltage (the output of the
hydrophone), and were subsequently utilized to represent the magnitudes of stable and
transient cavitation activities in the LFS system (see Result and Discussion Section).
Note that the voltage data measured by the hydrophone can be converted into pressure
amplitudes by utilizing a calibrated hydrophone. In this Chapter, for simplicity, we report
the results in units of voltage.
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The acoustic signal detection
system coupled with the
sonophoresis setup. The
hydrophone, which is epoxied to
the bottom of the diffusion cell,
allows real-time monitoring of
the activities of cavitation
bubbles during ultrasound
application.
The oscilloscope performs a Fast
Fourier Transform, which
converts the acquired electrical
signals from the time domain to
the frequency domain.
A custom designed LabView
program synchronizes the
computer with the oscilloscope,
and downloads the acoustic
spectra at an acquisition rate of
one frame per second.
Figure 4-1: Schematic diagram of the apparatus used to measure the real-time acoustic spectra.
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4.2.4 High-Pressure LFS Cell Studies
A novel, high-pressure LFS cell was constructed and utilized to assess the role of
cavitation during LFS. The rationale behind this experimental approach is discussed
below. To induce cavitation in a liquid medium, the medium must experience sufficient
tension (negative pressure). 18 This tension can be induced by the passage of an acoustic
wave, such as ultrasound. Specifically, to induce cavitation in an ultrasound field, the
pressure amplitude (intensity) of the ultrasound field must be sufficiently high, so that
during the negative pressure cycle of the acoustic wave, the submicroscopic gas nuclei
present in the liquid can grow to appreciable sizes, and as a result, cavitation activity can
take place. This minimum ultrasound intensity (pressure amplitude) that is required to
induce cavitation in a liquid is referred to as the cavitation threshold. The value of the
cavitation threshold in a liquid medium is directly proportional to the ambient hydrostatic
pressure. 1 8, 19 This is because under high ambient pressures, higher ultrasound
intensities (pressure amplitudes) are required to offset the applied high ambient pressure
to induce sufficient tension in the liquid medium in order for cavitation to occur. As a
result, by manipulating the ambient pressure and by selecting appropriate ultrasound
intensities, one can control the onset of cavitation activities in a LFS system. On the other
hand, non-cavitational effects induced by ultrasound in a LFS system, including thermal
effects, radiation forces, and macroscopic acoustic streaming, are not a function of the
ambient pressure. Therefore, by manipulating the ambient pressure during LFS, one can
decouple the ultrasound-induced cavitation phenomenon from the other ultrasound-
induced non-cavitational phenomena. The experimental approach utilized here (that is,
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controlling the onset of cavitation activity in a biological system by manipulating the
ambient pressure) provides a definitive test of the importance of cavitation in inducing
the observed biological effects of ultrasound.
Figure 4-2 shows the geometry of the high-pressure LFS cell (which was designed
to operate up to pressures of 300 psia). The pressure cell involves a cylindrical stainless
steel tube with a height of 30 cm and an inner diameter of 11.2 cm. The ultrasound source
(a flanged Sonics and Materials VCX 400 horn) is mounted on the top of the pressure cell
to sonicate the skin samples inside the pressure cell. A circular groove on the bottom of
the pressure cell is utilized to help center the diffusion cell inside the pressure cell. Two
sets of LFS experiments were conducted using the high-pressure LFS cell: Case 1
(control)-LFS under atmospheric pressure (where cavitation activity is detected in the
LFS system), and Case 2-LFS under elevated ambient pressures (where cavitation
activity is completely suppressed). Specifically, 20 kHz ultrasound at 6.5 W/cm2 was
applied to the skin samples in a pulsed mode (0.1 sec ON, 0.9 sec OFF) for 2 h under
both normal (atmospheric)(Case 1: 14.5 psia) and elevated (Case 2: 270 psia) pressures.
The ultrasound application method utilized in the high-pressure LFS cell studies was
identical to that described earlier for the normal (atmospheric) ambient pressure
experiments (see Section 4.2.2.2). The ultrasound intensity was selected such that there
would be no need to replace the PBS solution in the donor compartment of the diffusion
cell during the high-pressure-cell LFS experiments (that is, to ensure that the temperature
in the donor compartment did not exceed 40 "C during sonication). Acoustic emissions
from the LFS system inside the pressure cell were monitored using the acoustic method
129
Figure 4-2: Photograph of the high-pressure LFS cell
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described in Section 4.2.3 to detect the cavitation activities during LFS, and the
corresponding skin electrical conductance was measured simultaneously (see Section
4.2.2.1) to quantify the skin permeabilization effect due to LFS.
4.2.5 Castor Oil Studies
To test whether cavitation occurs inside the skin tissue during 20 kHz LFS (as well as to
assess the importance of cavitation inside and outside the skin), we utilized the well-
known fact that the cavitation threshold increases as the viscosity of the fluid medium
increases. 1 8, 19 We utilized a high-viscosity liquid-castor oil-to replace the PBS
solution in the donor and the receiver compartments of the diffusion cell to completely
suppress cavitation activity outside the skin, and compared the observed skin
permeabilization in the absence of external cavitation with that observed when PBS was
utilized as the coupling medium, where cavitation outside the skin can be detected. This
comparison enabled us to assess the importance of external cavitation (cavitation outside
the skin) during LFS. In addition, we applied the acoustic method described in Section
4.2.3 to monitor cavitation activities in the LFS system during both the castor-oil and the
PBS-mediated LFS experiments in an attempt to directly detect whether cavitation could
occur inside the skin tissue (internal cavitation) during LFS, which will be discussed
next.
In the castor oil studies, two sets of LFS (20 kHz, 1.6 W/cm 2, 0.1 sec ON, 0.9 sec
OFF, application time of 2 h) experiments were conducted: Case 1 (control) - LFS with
PBS as the coupling medium, and Case 2- LFS with castor oil (obtained from VWR
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Scientific) as the coupling medium. The ultrasound intensity was selected such that the
following two criteria were satisfied: (ii) when PBS is used as the coupling medium,
significant cavitation activities are detected during LFS using the acoustic method
(Section 4.2.3), and a significant LFS-induced skin permeabilization effect is observed
(therefore, it can serve as a good base case for assessing the importance of external
cavitation during LFS), and (ii) when castor oil is utilized as the coupling medium,
external cavitation is completely suppressed, as indicated by both visual inspection and
by the acoustic method (see Section 4.2.3). Specifically, to confirm that, under the
ultrasound intensities utilized, no cavitation activities take place in the coupling medium
outside the skin, we conducted an acoustic measurement experiment using a piece of
aluminum foil to replace the skin membrane in the diffusion cell during LFS (to ensure
that no internal cavitation occurs), and measured the acoustic emissions from the LFS
system to detect whether there are any cavitation signals emitted from the coupling
medium (castor oil) outside the membrane (aluminum foil). Our results (data not shown)
indicated that at ultrasound intensities greater than 1.6 W/cm 2 , external cavitation begins
to occur due to LFS with castor oil as the coupling medium. Therefore, a maximum
ultrasound intensity of 1.6 W/cm 2 was utilized for the castor oil studies (see Results and
Discussion) to assess the importance of external cavitation during LFS.
Another objective of the castor oil studies was to use the acoustic method to
directly monitor whether cavitation occurs inside the skin membrane during LFS.
Specifically, upon suppression of external cavitation (Case 2), the acoustic emissions
from the LFS system can be attributed solely to those originating from the skin
membrane. Therefore, by monitoring the acoustic spectrum of the LFS system during
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LFS using castor oil as the coupling medium, one can detect if there is any cavitation
activity inside the skin.
Because castor oil does not conduct, in order to evaluate the enhancement of the
skin electrical conductance before and after skin exposure to ultrasound during the castor
oil studies, at the end of each castor oil experiment (2 h), the skin was removed from the
diffusion cell, and the application site was subjected to three washing-blotting dry cycles
using a PBS solution and Kimwipe paper (VWR Scientific) to remove any castor oil
remaining on the skin surface. Next, the skin sample was remounted in a clean diffusion
cell with the donor and the receiver compartments both filled with a PBS solution to
allow measurement of the electrical conductance of the skin (see Section 4.2.2.1). To
determine whether there are any artifacts in the measurements of the skin electrical
conductance values during the castor oil studies due to the washing-blotting dry cycles of
the skin sample, we conducted a separate experiment in which we measured the electrical
conductance of a skin sample before and after the addition-removal of castor oil from the
skin surface according to the washing-blotting dry procedure described above. Our results
showed that there is no detectable difference in the readings of the skin electrical
conductance values before and after this procedure.
4.2.6 Cavitation Detection Using a Chemical Dosimeter
(Terephthalic Acid)
In addition to the acoustic method described in Section 4.2.3, cavitation activity can be
quantified using various chemical and physical methods.7 7 As part of our cavitation
studies, we utilized a chemical dosimetry method to quantify the cavitation activity in the
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solution outside the skin membrane. The chemical assay for cavitation detection is based
on the measurements of free radicals and chemical reaction products produced by
cavitation. Since free radical production is required for such chemical effects, this assay
specifically measures the activities of inertial (transient) cavitation in an aqueous solution
exposed to ultrasound.7 7 Specifically, when transient cavitation occurs in an aqueous
solution, the concentrated thermal and mechanical energy associated with the collapsing
cavitation bubbles induces dissociation of the water molecules into hydroxyl and
hydrogen radicals. These radicals are extremely reactive and short-lived (direct evidence
of the existence of these radicals is provided by electron spin resonance (ESR) 77), and
form the basis for the chemical assay of cavitation detection (the amount of inertial
cavitation in a solution).
In this Chapter, we utilized terephthalic acid (TA) [benzene-1, 4-dicarboxylic
acid] as a chemical dosimeter to quantify the total amount of transient cavitation
occurring outside the skin under various ultrasound intensities. TA is a highly specific
scavenger of eOH, which has been routinely utilized as a dosimeter of transient cavitation
in an aqueous solution.8 8 , 89 TA does not fluoresce, but when reacted with 9OH, it forms
a highly fluorescent compound, hydroxyterephthalic acid (HTA), whose concentration
can be determined by fluorescent spectrometry. By measuring the fluorescent counts
(expressed in arbitrary units) at an emission wavelength of 315 nm and an excitation
wavelength of 426 nm,8 8 , 89 one can detect the amount of .OH free radicals that are
generated, and consequently, quantify the amount of transient cavitation in the solution
exposed to ultrasound.
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Commercial TA was obtained from Aldrich, and was purified by extraction and
stored in a freeze drier according to the methods described in Refs. 88, 89. A 1.5mM TA
solution (pH 7.4) was prepared by dissolving 249 mg TA and 200ml NaOH solution
(0.137M) in 1L PBS (0.01M). The donor compartment of the Franz diffusion cell was
filled with the TA solution, and the receiver compartment was filled with PBS. A model
membrane, aluminum foil (Reynolds), was mounted onto the diffusion cell. Sonication
was performed for 20s in a pulsed mode (0.1s ON, 0.9s OFF), and subsequently, the
fluorescence of the liquid sample was measured using a fluorescence spectrophotometer
(Model A1010, PTI, Lawrenceville, NJ) with an excitation wavelength at 315 nm and an
emission wavelength at 426 nm. For each ultrasound condition examined (intensity
ranging from 1.6 to 33.5 W/cm 2), an average of 10 repeats were performed to minimize
experimental error.
4.2.7 Cavitation Detection Using a Physical Dosimeter
(Aluminum Foil)
Aluminum foil can be utilized as a physical dosimeter to characterize the amount of
cavitation activity in a LFS system. 5 2 Specifically, this dosimetry method measures the
amount of transient cavitation activity in the vicinity of the membrane (a mechanism
referred to as asymmetric inertial cavitation, see Section 4.3.4). Aluminum foil
(Reynolds) was mounted onto the diffusion cell in the same manner as the skin
membrane. The receiver and donor compartments were both filled with PBS. Sonication
was performed for 20-60 s in a pulsed mode (0.1 s ON, 0.9 s OFF; ultrasouand ON-time
is 2-6 s), and then the aluminum foil was removed from the diffusion cell. The number of
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indentations on a foil was counted by visual inspection. Note that the ultrasound exposure
time for these experiments was typically much shorter than that for the skin
permeabilization measurement experiments (2 h), because a longer exposure to
ultrasound results in a high number of pits, thus making the counting difficult. The
number of pits on each aluminum foil was normalized by the ultrasound ON-time, and
utilized to characterize the magnitude of asymmetric inertial cavitation outside the skin.
For each ultrasound condition examined (intensity ranging from 1.6 to 33.5 W/cm 2), an
average of 15 repeats were performed to minimize the experimental errors.
4.3 Results and Discussion
4.3.1 Assessment of the Role of Cavitation during LFS
Ultrasound induces a wide spectrum of physical phenomena, which can potentially
permeabilize the skin barrier, including thermal effects, cavitational effects, radiation
forces, and macroscopic acoustic streaming. In previous studies of sonophoresis, based
on indirect experimental observations, acoustic cavitation has been suggested to be the
key mechanism responsible for the observed skin permeability enhancement due to
ultrasound.8 , 22, 24, 80, 81 Here, in an attempt to obtain definitive experimental
evidence to test the role of cavitation during LFS, a high-pressure LFS cell was
constructed (see Section 4.2.4), and an acoustic signal measurement method utilized to
detect the onset of cavitation in the LFS system.
Figure 4-3(a) shows a typical acoustic spectrum measured in Case 1 (without
pressurizing the pressure cell). One can see that under atmospheric pressure (Case 1), the
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ultrasound protocol utilized (20 kHz, 6.5 W/cm2 , 0.1 sec ON, 0.9 sec OFF) induces
significant cavitation activity in the LFS system, as indicated by the presence of the
subharmonic f/2 emission-the spike at the frequency of f/2. Figure 4-3(b) shows a
typical acoustic spectrum measured in Case 2 (under elevated pressure, 19 atm) under the
same ultrasound protocol. The absence of the f/2 signal in the measured acoustic
spectrum in Case 2 indicates that no cavitation activity occurred in the LFS system during
Case 2.
Figure 4-4 shows the corresponding enhancement ratios of the skin electrical
conductance due to LFS measured in Cases 1 and 2, along with that of a control
experiment (Case 3: skin passively hydrated in PBS for 2 h under atmospheric pressure).
Whereas LFS induced about a 6.4-fold enhancement of the skin electrical conductance in
Case 1 (in the presence of cavitation), the same ultrasound condition induced only about
a 10% increase in the skin electrical conductance under the elevated pressure condition
(Case 2, in the absence of cavitation). Moreover, the enhancement of the skin electrical
conductance in Case 2 (~10% enhancement) is not statistically different (p>0.05) from
that in the control case (Case 3), where the skin membrane was passively hydrated in the
diffusion cell for 2 h. In other words, the ~10% increase in the skin electrical
conductance observed in Case 2 can be attributed to the effect of skin hydration and not
to the effect of ultrasound. Therefore, the results shown in Figures 4-3(a), 4-3(b), and 4-4
clearly indicate that ultrasound-induced cavitation plays the key role during LFS (the skin
permeabilization effect disappears almost completely when the cavitation activity is
suppressed).
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Figure 4-3: A typical acoustic emission spectrum measured during LFS.
(a) In the presence of cavitation (under normal ambient pressure, 1 atm), and (b) In the
absence of cavitation (under elevated ambient pressure, 19 atm).
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Figure 4-4: Enhancement ratio of skin electrical conductance during the LFS or the
passive control experiments measured during the high-pressure LFS cell studies.
Key: (Case 1) LFS under I atm; (Case 2) LFS under 19 atm; (Case 3) skin passive
hydration for 2 h under 1 atm. The error bars represent 95% confidence interval (4-8
repeats). 20 kHz ultrasound at 6.5 W/cm2 was applied to the skin in a pulsed mode (0. 1
sec ON, 0.9 see OFF) for 2 h during LFS.
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4.3.2 Assessment of the Role of External Cavitation during LFS
(Does Cavitation Occur Inside the Skin during LFS?)
During LFS, cavitation may occur both inside and outside the skin. It is well-known that
the cavitation threshold increases as the viscosity of the fluid medium increases. By
changing the viscosity of the medium in a particular region of the LFS system, one can
selectively suppress the cavitation activity in that region. With this in mind, to evaluate
the importance of internal and external cavitation during LFS, as well as to directly
monitor whether cavitation occurs inside the skin membrane, we utilized a high-viscosity
coupling medium (castor oil) to selectively suppress cavitation activity outside the skin
during LFS. Castor oil is a high viscosity fluid (6.3-8.9 poise) possessing a similar
acoustic impedance (1.431xI106 Pa.s/m) to that of water (1.483x106 Pa-s/m).6 Therefore,
replacing the water-based PBS solution with castor oil as the ultrasound coupling
medium during LFS does not affect the transmission efficiency of ultrasound energy to
the skin. In other words, castor oil selectively suppresses cavitation activity outside the
skin, while internal cavitation (if it were to occur) should not be affected during the
castor-oil-mediated LFS experiments.
Figure 4-5 shows the enhancement of the skin electrical conductance due to LFS
measured during the PBS-mediated LFS experiment (Case 1: in the presence of external
cavitation, as confirmed by the acoustic method), and during the castor-oil-mediated LFS
experiment (Case 2, in the absence of external cavitation, as confirmed by the acoustic
6 Teacoustic impedance data were obtained from URL: http://www.ultrasonic.com.
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method 7), as well as during a passive control experiment (Case 3, skin immersion in PBS
passively for 2 h). Figure 4-5 reveals that whereas LFS induces a significant skin
permeabilization effect in Case 1 (2.5-fold), when external cavitation is completely
suppressed (Case 2), no significant skin permeabilization due to ultrasound is observed
(Cases 2 and 3 are not statistically different). Therefore, one may conclude that external
cavitation plays a central role during LFS.
7 Confirmation of the onset and the disappearance of external cavitation activities in the LFS system under
the ultrasound conditions utilized (Case 1 and Case 2) was done with a diffusion cell setup with an
aluminum foil mounted in the same manner as that of the skin membrane using the acoustic method
described in Section 4.2.3.
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Figure 4-5: Enhancement ratio of skin electrical conductance during the LFS or the
passive control experiments measured during the castor-oil studies.
Key: (Case 1) LFS with PBS as the coupling medium; (Case 2) LFS with castor oil as the
coupling medium; (Case 3) skin passive hydration in PBS for 2 h. The error bars
represent the 95% confidence interval (4-8 repeats). 20 kHz ultrasound at 1.6 W/cm 2 was
applied to the skin in a pulsed mode (0.1 sec ON, 0.9 sec OFF) for 2 h during LFS.
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In an attempt to monitor whether cavitation occurs inside the skin (internal
cavitation) during LFS, we also measured the acoustic emission from the LFS system
during the castor-oil-mediated LFS experiments. Examination of the acoustic emissions
from the LFS system in Case 2 revealed that upon suppression of external cavitation,
there is no detectable cavitation signal (f/2 emission) in the measured acoustic spectrum
of the LFS system (spectra not shown). This result indicates that there is no bubble
activity inside the skin membrane (including both the SC and the skin appendages) under
the LFS protocols examined.
In the previous studies of sonophoresis, there have been many speculations about
the possible occurrence of internal cavitation inside the skin membrane (including the SC
lipid region2 2 and the corneocytes, 7 , 8 as well as the skin appendages 2 3 , 90). However,
to date, no direct experimental measurements has been conducted to support the
hypothesized presence of cavitation inside the skin. The experimental technique utilized
in this Chapter permit direct detection of cavitation in the skin membrane. Our
experimental finding (absence of cavitation bubbles inside the skin during 20kHz-LFS) is
consistent with a theoretical calculation. Specifically, under 20 kHz-LFS, the theoretical
resonant bubble radius is ~150gm in an aqueous phase, which is much larger than the
typical dimension of the skin barrier (thickness of the SC is ~10 pm) and than the
dimension of the skin appendages (the lumen of a sweat duct has a nominal diameter of
about 5 gm9 1 ).
In addition, based on a theoretical calculation of the resonance size of cavitation
bubbles, Simonin suggested 90 that under an ultrasound frequency of 1MHz, cavitation
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(radius ~ 3gm) may occur inside the skin sweat ducts, because of the matching sizes of
the cavitation bubbles with the skin sweat ducts. Since the resonant bubble size is
inversely correlated with the ultrasound frequency, the likelihood of the occurrence of
cavitation inside the skin under ultrasound frequencies higher than that considered in this
Chapter (20 kHz) awaits future investigation, with the experimental approach utilized in
this Chapter providing a valuable method for detecting cavitation activity inside the skin.
4.3.3 Identification of the Critical Types of Cavitation during LFS
Using an Acoustic Cavitation Detection Method
Based on the above experimental results, we showed that ultrasound-induced cavitation
outside the skin (in the solution on top of the skin) plays the key role during LFS.
Ultrasound-induced cavitation fields in a solution are complex. In many cases, when
inertial (transient) cavitation is produced in a liquid, non-inertial (stable) cavitation
occurs simultaneously. 7 7 The two types of cavitation activities (transient vs. stable)
interact with biological tissues (such as the skin) through different mechanisms. 7 7
Specifically, phenomena associated with inertial (transient) cavitation that can potentially
affect the skin permeation properties include direct bubble collapse stresses (high-speed
liquid jets and shock waves), and the production of free radicals and other chemically
active species. On the other hand, phenomena associated with non-inertial (stable)
cavitation that can potentially lead to skin permeabilization include microstreaming and
its related shear stress, and radiation forces exerted by the oscillating bubbles on the
neighboring structure. Understanding the relative roles played by the two types of
cavitation during LFS not only is of fundamental value, but can also provide guidelines
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for improving the efficacy of LFS, as well as for achieving better control of LFS. With
this mind, we measured the acoustic signals associated with the two types of cavitation
activities (the f/2 signal and the broadband noise) under various LFS conditions (in
particular, at different ultrasound intensities) using the acoustic method described in
Section 4.2.3, and correlated the measured acoustic signals with the observed skin
permeabilization due to LFS. The objectives were two-fold: (i) to investigate the
mechanism by which external cavitation permeabilizes the skin membrane (stable vs.
transient cavitation), and (ii) to identify acoustic signals that correlate with the effect of
LFS, and can therefore be used to provide noninvasive feedback about the efficacy of
LFS.
We conducted a series of LFS experiments under various ultrasound intensities
(1.6, 3.2, 6.5, 10.0, and 14.4 W/cm 2, 3-5 repeats were performed for each ultrasound
intensity). During these LFS experiments, skin permeabilization due to LFS, as reflected
in the enhancement of the skin electrical conductance, was measured along with the
acoustic emissions of the LFS system (which originate solely from the solution outside
the skin, since internal cavitation does not occur). We then plotted the measured
enhancement of the skin electrical conductance as a function of the measured amplitudes
of the broadband signal and of the subharmonic signal in Figures 4-6(a) and 4-6(b),
respectively. Specifically, a total of 21 experimental points are shown in each graph, with
each one corresponding to a single LFS experiment. Figure 4-6(a) shows that a
reasonably good correlation exists between the measured skin permeabilization induced
by LFS and the measured broadband noise signal (R2=0.72). On the other hand, the f/2
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signal measured does not show a good correlation with the effect of LFS, as revealed in
Figure 4-6(b) (R2=0.39).
Therefore, based on the comparison of the correlations of the two acoustic signals
with the skin permeabilization effect, one may conclude that in the LFS system
examined, transient cavitation (occurring outside the skin membrane) plays a more
important role in inducing the effects of LFS (skin permeabilization) than stable
cavitation. This mechanistic finding can be utilized to aid in the design of clinical LFS
systems to achieve better control of the efficacy of LFS. Specifically, measurements of
the broadband noise signal can be utilized to provide real-time feedback about the
performance of the ultrasound device (or to predict the degree of skin permeabilization
during LFS). The ultrasound treatment time can then be optimized to achieve the best
drug delivery results.
Similar experimental techniques have been utilized previously in the literature to
study the relationship between cavitation activities and the biological effects of
ultrasound. Liu et al. 87 studied the cell membrane permeabilization by ultrasound in a
bovine red blood cell model system. By measuring the different acoustic signals
(including subharmonic and broadband noise) in the cell suspension exposed to 24 kHz
ultrasound, the authors found that both the f/2 signal and the broadband noise signal
showed a reasonably good correlation with the effect of ultrasound. The authors,
therefore, concluded that ultrasound-induced membrane permeabilization in the cell
suspension system examined was mediated by both inertial (transient) and non-inertial
(stable) cavitation.
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Figure 4-6: Relationship between the skin electrical conductance enhancements and the
magnitudes of the acoustic signals measured during LFS.
(a) Broadband noise signal, and (b) subharmonic (f/2) signal. Key: (@) represents a
single LFS experiment (N=21). LFS experiments were conductedunder different
ultrasound intensities (1.6, 3.2, 6.5, 10.0, and 14.4 W/cm 2).
148
14
12
10
8
6
4
2
1.5 2.0 2.5 3.0 3.5 4.0 4.5
In (Amplitude of Broadband Noise)
00
G
,*0
,**p
9e
soe
a 0
S
- I I
a-
S
a--e
14
12
10
8
6
4
2
0
149
a)
a
CU
C,
c
Ea
w
4.0 5.0
In (Amplitude of f/2 Signal)
Figure 4-6(b)
2.0 3.0 6.0 7.0
-
I a I I I I
4.3.4 Possible Mechanisms for Transient Cavitation-Mediated
Skin Permeabilization
So far, we have shown that transient cavitation outside the skin plays the dominant role in
inducing skin permeabilization during LFS. Transient cavitation may occur at different
locations in the solution outside the skin, which can then enhance skin permeability via
different mechanisms. Specifically, transient cavitation may occur both near the skin
surface and in the bulk solution. Collapse of cavitation bubbles in the bulk solution
results in the formation of a spherically expanding shock wave. 19 , 92 This shock wave
may directly modify the structure of the skin barrier, or act on the nearby cavitation
bubbles in the solution, causing them to collapse, 9 3 and hence, to generate mechanical
stresses on the skin membrane. In addition, free radicals generated by shock waves in the
solution can also potentially interact with the SC. On the other hand, if a collapsing
bubble is near the skin surface, in addition to the emission of a shock wave,
nonuniformities in the surrounding pressure cause the bubble to collapse asymmetrically,
which may lead to the formation of a high-velocity liquid jet directed toward the skin
membrane surface. Theoretical calculations have predicted that the microjets formed by
bubbles collapsing near a solid wall can reach a velocity of between 50 and 180 m/s.15,
20, 94, 95 Accordingly, when these high-velocity liquid jets impinge on the skin surface,
the mechanical impact may modify the skin structure, and thus lead to an increase in skin
electrical conductance (that is, to skin permeabilization).
Because cavitation bubble collapses at the two locations in the solution (close to
the skin surface and in the bulk solution) occur in fundamentally different patterns
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(asymmetric vs. symmetric collapses, respectively), 2 0, 96 and both are capable of
modifying the skin structure, below, we investigate the relative importance of the two
locations of transient cavitation in the LFS system (surface vs. bulk, or asymmetric vs.
symmetric transient cavitation), to obtain guidelines for improving the efficacy of the
LFS technique (for example, to optimize the cavitation fields in the solution).
Specifically, we conducted the following experimental measurements. Two dosimetry
techniques of cavitation detection were utilized to characterize the transient cavitation
activities in the solution outside the skin. First, a chemical dosimeter (see Section 4.2.6)
was adopted to measure the total amount of transient cavitation occurring outside the skin
(specifically, it measures the sum of the bulk and the surface transient cavitation), and
second, a physical dosimeter (aluminum foil, see Section 4.2.7) was adopted to measure
the amount of asymmetric transient cavitation (surface transient cavitation). We
measured transient cavitation activities in the two locations of the coupling solution under
various ultrasound intensities, and then compared the dependence of the two locations of
transient cavitation activities on the ultrasound intensity with that of the observed skin
permeabilization effect during LFS on the same ultrasound parameter to elucidate the
relative importance of the two locations of transient cavitation in the LFS system
(asymmetric vs. symmetric transient cavitation). The results obtained are shown in
Figures 4-7(a), (b), and (c).
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Figure 4-7: Dependence of the transient cavitation activities in the solution and of the
skin permeabilization on ultrasound intensity.
(a) Total transient cavitation activity in the solution (both symmetric and asymmetric
transient cavitations) measured by the chemical dosimeter (N=10), (b) asymmetric
transient cavitation activity measured by the physical dosimeter (aluminum foil method)
(N=15), and (c) skin permeabilization measured by the enhancement of the skin electrical
conductance (N=8). Each point represents the mean -95% confidence interval of N
experimental repeats.
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Figures 4-7(a) and 4-7(b) reveal that the two locations of transient cavitation
activities (entire solution volume vs. surface region) measured by the two dosimetry
methods exhibit different dependences on the ultrasound intensity. Whereas the sum of
asymmetric and symmetric transient cavitation measured by the chemical assay increases
monotonically with increasing ultrasound intensity (Figure 4-7(a)), the amount of
asymmetric transient cavitation (Figure 4-7(b)) measured by the aluminum foil method
exhibits a peak value at an ultrasound intensity of about 21.9 W/cm 2. This suggests that
asymmetric and symmetric transient cavitation activities have different dependences on
the ultrasound intensity in the LFS system examined. Specifically, beyond an ultrasound
intensity of about 21.9 W/cm2, the amount of asymmetric transient cavitation begins to
decrease, while the amount of symmetric transient cavitation in the solution continues to
increase as the applied ultrasound intensity increases (a discussion of the observed
decrease in the activity of asymmetric transient cavitation beyond a certain ultrasound
intensity value will be presented below).
Skin permeabilization due to LFS, as reflected in the measured enhancement of
the skin electrical conductance, is plotted as a function of ultrasound intensity in Figure
4-7(c). Figure 4-7(c) reveals that the dependence of LFS-induced skin permeabilization
on the ultrasound intensity follows a similar trend to that observed for the asymmetric
transient cavitation activity shown in Figure 4-7(b). Skin permeabilization also exhibits a
peak at an ultrasound intensity of about 21.9 W/cm 2, beyond which this biological effect
of ultrasound starts to decrease (p<O.05). Taken together, the results shown in Figures 4-
7(a)(b)(c) indicate that surface transient cavitation (asymmetric bubble collapse) plays the
dominant role during LFS, while bulk transient cavitation (symmetric bubble collapse)
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does not appear to contribute significantly to the observed effect of ultrasound during
LFS (because beyond an ultrasound intensity of about 21.9 W/cm 2 , although the amount
of symmetric transient cavitation increases with increasing ultrasound intensity, the effect
of LFS decreases). Note that according to the notion of shock wave generation, the
activity of symmetric transient cavitation could potentially give rise to more asymmetric
transient cavitation activity through bubble-bubble interactions (bubble shattering). 9 3
Our experimental results indicate that this effect of symmetric transient cavitation is
secondary in the LFS system examined.
The relationship between asymmetric and symmetric transient cavitations (bulk
vs. surface) is complex. There are two competing mechanisms of interaction between the
two types of cavitation phenomena: (i) shock waves generated by the bulk transient
cavitation may cause the nearby cavitation bubbles to collapse, 9 3 and through that,
symmetric transient cavitation may trigger more asymmetric transient cavitation, and (ii)
because bubbles are good absorbers of ultrasound, if large amounts of bubbles form in
the bulk solution in front of the ultrasound transducer, the ultrasound becomes highly
attenuated as it passes through this bulk region. As a result, the sonication of the liquid in
the vicinity of the skin may be reduced, resulting in less surface transient cavitation
activity (less asymmetric transient cavitation). 19 This second mechanism may explain the
observed peak in the surface transient cavitation activity, shown in Figure 4-7(b). As the
amount of bulk transient cavitation increases with applied ultrasound intensity, the
surface transient cavitation activity first reaches a peak value and then it starts to fall off
at an ultrasound intensity of about 21.9 W/cm 2, because mechanism (ii) above begins to
dominate.
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Since we have shown that the skin permeabilization effect during LFS is primarily
mediated by asymmetric transient cavitation, one can speculate that in order to improve
the efficacy of LFS, localization of the transient cavitation activity in the vicinity of the
skin membrane is desirable. To diminish the likelihood of bubble formation far from the
skin membrane (that is, close to the ultrasound transducer), the pressure amplitude near
the transducer face should be kept to a minimum. However, a high pressure amplitude
must still be produced in the solution close to the skin in order to generate cavitation at
that site. Both of these requirements may be met if the ultrasound field can be focused. 19
4.4 Conclusions
In this Chapter, we reported on the detection of cavitation activities in a low-frequency
sonophoresis (LFS) system. A high-pressure LFS cell study provided definitive evidence
that cavitation plays the key role in skin permeabilization during LFS. Utilizing a direct
cavitation detection method (the acoustic signal measurement method), we demonstrated
that under an ultrasound frequency of 20 kHz, cavitation occurs solely outside the skin.
By correlating the skin permeabilization effects with the measured amplitudes of acoustic
signals (f/2 signal and broadband noise signal), which are believed to be associated with
stable and transient cavitation activities, respectively, we showed that transient cavitation
outside the skin is the key mechanism responsible for LFS-induced skin permeabilization.
Utilizing a physical dosimeter (aluminum foil) and a chemical dosimeter (a
chemical method), we also characterized the transient cavitation activities outside the
skin membrane. The importance of symmetric and asymmetric transient cavitations for
157
inducing the biological effect of ultrasound (skin permeabilization) was evaluated. Our
findings indicate that asymmetric transient cavitation is responsible for the observed skin
permeabilization during LFS, while symmetric transient cavitation does not appear to
play an important role (the dependence of the observed skin permeabilization on
ultrasound intensity deviates from that of the symmetric transient cavitation activity). The
results indicate that LFS-induced skin permeabilization results mainly from the direct
impact of bubbles collapsing on the skin surface, and future investigations on the
optimization of LFS conditions should be aimed at localizing the transient cavitation
activity in the vicinity of the skin membrane.
In the next Chapter (Chapter 5), a comparative study of the effects of LFS on the
in vivo and in vitro skin will be presented, with the goal of identifying relevant in vitro
skin models and ultrasound conditions that may be used in in vitro LFS studies to predict
the effects of LFS on the transdermal transport of hydrophilic permeants in vivo.
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Chapter 5
In Vitro and In Vivo Correlation of Low-
Frequency Sonophoresis (LFS)
5.1 Introduction
Percutaneous absorption and the effects of skin penetration enhancers on the transdermal
transport rate of various drugs are most frequently studied by conducting an in vitro
experiment. This is because in vitro experiments are simpler to implement than the in
vivo ones, and can therefore be carried out in greater numbers. 9 7 In previous studies,
using in vitro skin as the model system, we have shown that application of low-frequency
(f~20kHz) ultrasound (referred to as low-frequency sonophoresis, LFS) significantly
enhances the transdermal drug delivery rates across various types of in vitro skin,
including heat-stripped human skin and full-thickness pig skin, especially for those drugs
that have very low passive permeabilities due to their high hydrophilicity. 8 , 26 The
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transport of hydrophilic permeants across the skin has been of particular interest because
this group of permeants has pharmaceutical relevance, but currently cannot be delivered
through the transdermal route due to their extremely low skin passive permeabilities. As a
result, there is a need to develop an efficacious and safe skin penetration enhancement
method to achieve transdermal delivery of this class of permeants. With mannitol as the
model hydrophilic permeant, and full-thickness pig skin as the in vitro skin model, our
group has recently shown 51 that a threshold ultrasound energy dose (222 J/cm 2) is
required in order for LFS to significantly enhance the transdermal transport rate of
hydrophilic permeants across the excised skin membranes in vitro. More recently, we
have developed a skin porous-pathway theory to rationalize the observed quantitative
correlation between the skin steady-state permeability to hydrophilic permeants (P) and
the skin specific electrical resistance (R) during in vitro LFS studies. 8 3 At present, one
important question remains unanswered, that is, whether these previously obtained LFS
results with excised skin as the skin model can be extrapolated to the in vivo skin case. In
the past, both in vivo 13, 23, 24, 98-101 and in vitro 7, 102-106 sonophoresis studies
have been reported in the literature. However, due to the different drug detection methods
utilized (drug detection through radio-labeling in vitro vs. drug detection through the
measurement of the biological effect of drugs in vivo), as well as due to the differences in
the model permeants and in the animal species utilized, a direct comparison of the
previous in vivo and in vitro sonophoresis results has not been possible.
In the percutaneous absorption (passive skin permeation without enhancers)
literature, significant research effort has been devoted to the comparison of the in vivo
skin and the in vitro skin models. The aim was to establish guidelines for extrapolating
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the skin permeation results obtained in vitro to those obtained in vivo. Based on the
numerous in vivo/in vitro comparative studies of percutaneous absorption, a consensus
has been reached regarding the selection of proper in vitro skin models for the in vitro
percutaneous absorption studies. 10 7 Indeed, it is well-documented that in vitro
percutaneous absorption studies, when performed using suitable skin models and
appropriate procedures, can provide useful information about the transdermal penetration
potential of a compound/drug in man.9 7 Due to the fact that the utilization of low-
frequency ultrasound (a physical enhancer) to enhance the skin transport rate (referred to
as low-frequency sonophoresis, LFS) is a relatively new area, 8 there have been no direct
in vivo/in vitro comparative studies to address the in vivo/in vitro correlation question
posed above, as well as to identify the most suitable in vitro skin models for LFS studies.
In other words, it is not known whether the same in vitro skin models that have been
identified as good in vitro skin models for percutaneous absorption studies represent
suitable experimental models for the sonophoresis studies in vitro.
In this Chapter, our goal is to investigate the in vivo/in vitro correlation during
LFS. Specifically, we addressed the following three questions: (i) how do the in vitro
LFS results compare with those obtained with living skin (that is, whether, or under what
conditions, does the efficacy of LFS measured with in vitro skin correlate with that
observed in the in vivo case), (ii) which type of skin preparation in vitro represents a
suitable skin model during in vitro LFS studies for predicting the effects of LFS in vivo,
and (iii) are the low-frequency ultrasound conditions utilized in the skin transport
enhancement experiments safe for the in vivo skin.
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Ideally, to investigate the in vivo/in vitro correlation during LFS, a comparative
study should be performed with humans in vivo and in vitro human skin sections.
Because of the difficulties associated with utilizing humans as the experimental
subjects,10 8 we chose domestic pig as the animal model, and utilized the in vivo LFS
results obtained with the in vivo pig skin as the criterion to verify the relevance of the
various in vitro skin models for the LFS studies. Specifically, we utilized three in vitro
skin preparations (full-thickness pig skin, split-thickness pig skin, and heat-stripped
human cadaver skin) as the in vitro skin models (according to the percutaneous
absorption literature, these three types of in vitro skin preparations represent suitable skin
models for studying the skin passive permeation rate of hydrophilic permeants 10 7 , 109).
Because pig skin is too hairy to be heat-stripped, we utilized human epidermal membrane
in place of pig epidermal membrane. D-Mannitol, a highly polar sugar alcohol, was
utilized as the model hydrophilic permeant in the comparative studies of LFS in vivo and
in vitro. D-Mannitol was chosen because it is totally and rapidly excreted once it has
penetrated through the pig skin into the blood stream, thus permitting direct in vivo
monitoring. 10 0 In vivo pig skin is considered as a good model of human skin for
percutaneous absorption studies according to the literature. 10 8 Pig skin in vitro has also
been documented as one of the closest in vitro skin models of human skin based on its
morphological and functional characteristics. 1 10
In this Chapter, the effects of LFS on the skin permeation of mannitol across in
vivo and in vitro skin membranes were compared under two protocols. In protocol A, the
enhancements of the skin penetration rates of mannitol across in vivo and in vitro skin
due to LFS were directly compared under the same ultrasound energy dose to address the
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in vivo/in vitro correlation in terms of the efficacy of LFS. In protocol B, the in vitro skin
membranes were treated with different ultrasound energy doses until the electrical
resistance of each skin model reached approximately the same preset value as that of the
in vivo pig skin observed during the in vivo LFS studies. The skin permeation rates of
mannitol across the three in vitro skin models were then compared against that of the in
vivo pig skin to shed light on the suitability of the three in vitro skin models for LFS
studies, as well as to address the question of whether, and under what conditions, the LFS
results obtained with the skin models in vitro can be utilized to predict the effects of LFS
in vivo. During the LFS studies (protocol B), the skin concentration of mannitol were
also measured with the in vivo pig skin and the three in vitro skin models to assess the
effects of LFS on the skin partitioning of the model permeant both in vivo and in vitro. In
addition, histological studies were conducted with the in vivo pig skin to assess the safety
of the low-frequency ultrasound conditions utilized.
5.2 Experimental Section
5.2.1 Materials
D-[3H]mannitol was obtained from American Radiolabeled Chemicals (St. Louis, MO)
with a purity 99%. During the in vivo skin permeation experiments, 2 mCi/ml
[3H]mannitol in pure ethanol was diluted with phosphate-buffered saline (PBS; phosphate
concentration, 0.01 M; NaCl concentration, 0.137 M; Sigma Chemical Company, St.
Louis, MO) to obtain a lmCi/ml radio-labeled mannitol solution. For the in vitro skin
permeability measurements, the test solution of mannitol was diluted to 10 gCi/mL. In
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vitro transport experiments were performed with pig full-thickness skin (FTS), pig split-
thickness skin (STS, 700pm) and human cadaver epidermal membrane (HEM). Human
cadaver skin (male or female back or abdominal skin, frozen at -80 *C) was obtained
from the National Disease Research Institute (Philadelphia, PA). The skin was heat
stripped by keeping the full-thickness skin in PBS at 60 *C for two minutes followed by
removal of the epidermis. The HEM was then stored up to 7 days in a chamber at 4 *C
and 95% relative humidity until the experiments were performed. Yorkshire pig FTS
(back skin) was harvested within half an hour after sacrificing the animal. The
subcutaneous fat was trimmed off with a surgery scalpel, and the pig FTS was cut into
small pieces and stored in a -80 'C freezer for up to 2 months. The pig STS was prepared
from the in vitro pig FTS using a Padgett dermatome (Padgett Instruments, St. Louis,
MO) before each experiment.
5.2.2 Methods
5.2.2.1 Ultrasound Application
Ultrasound pretreatment protocols (the skin membranes were pretreated with ultrasound
prior to the application of the permeant solutions) were utilized to enhance the
transdermal transport rate of manitol both in vivo and in vitro. From a practical
viewpoint, the ultrasound pretreatment protocol is more suitable for the clinical
application of sonophoresis compared to the direct ultrasound treatment protocol, during
which the ultrasound is applied to the skin through a coupling medium that also serves as
the drug delivery vehicle. Specifically, there are three main advantages associated with
the pretreatment protocol: (i) the amount of drug delivered to the patient can be tightly
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controlled by modulating the amount of ultrasound irradiation for different patients
during the ultrasound pretreatment phase, (ii) because ultrasound is not directly applied
through the drug delivery vehicle, the possibility of drug degradation due to ultrasound
irradiation is avoided, and (iii) the type, composition, and volume of the coupling
medium and the drug vehicle can be optimized separately to achieve the best efficacy of
LFS without the limitations associated with the possible adverse interaction of the drug
molecule with the ingredients of the coupling medium, or with the limited amount of
drug vehicle that can be applied each time due to the possible high cost of the drug
molecules. Specifically, in this Chapter, two ultrasound pretreatment protocols were
utilized to compare the in vivo and the in vitro LFS results- (i) protocol A, which is
based on a fixed treatment time (that is, on a fixed energy dose), and (ii) protocol B,
which is based on fixed values of the final skin electrical resistance.
In protocol A, ultrasound energy at 20 kHz and 6.5 W/cm 2 was generated by an
ultrasonic transducer (VCX 400, Sonics and Materials, Inc., Newtown, CT), and was
applied to both the in vivo and the in vitro skin in a pulsed mode (5 sec on, 5 sec off) for
5 minutes. The transdermal transport rates of mannitol across the treated skin membranes
were subsequently measured using the methods described next. Note that pulsed
ultrasound was utilized to minimize thermal effects. 8
During the in vivo and the in vitro skin permeation experiments using protocol A,
we observed that the different skin membranes responded to the ultrasound treatment at
different rates. In other words, after the same amount of ultrasound exposure, the skin
electrical resistance (an indicator of the skin baffler function 55) of the in vitro and the in
vivo skin membranes differed significantly. In particular, the resistance of the in vivo
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skin sample decreased more than 10-fold after 5 minutes of ultrasound treatment, while
those of the in vitro skin samples remained relatively high (within 2-fold of the initial
values). This finding indicates that, for different types of skin membranes, different
ultrasound energy doses are required to permeabilize the skin barrier to a similar extent
(if one uses the skin electrical resistance as an instantaneous indicator of the skin barrier
function). To bridge the difference observed between the in vivo and the in vitro skin
cases, we utilized a second ultrasound protocol (protocol B), in which we varied the
duration of the ultrasound treatment for the various in vitro skin membranes examined to
achieve the same preset value of the skin electrical resistance at the end of the ultrasound
treatment phase (13 k- am2). This preset value of the skin electrical resistance was
selected based on the observed in vivo skin electrical resistance value at the end of the
LFS treatment under protocol A (5 min LFS). The goal was to mimic the extent of skin
permeabilization (as measured by a quick indicator, the skin electrical resistance) induced
by 5 min LFS observed in the in vivo pig skin case, during the in vitro LFS studies. By
comparing the skin permeability to mannitol of the different in vitro skin membranes to
that of the in vivo skin at about the same level of skin electrical resistance, we aimed at
gaining insight into the correlation between the in vivo skin and the various in vitro skin
models in the presence of low-frequency ultrasound.
In protocol B, ultrasound energy (20 kHz, 6.5 W/cm 2 , 5 sec on, 5 sec off) was
applied to the three types of in vitro skin models for different time periods until the skin
electrical resistance reached a value of ~13 kQ cm2. The temperature in the diffusion
cells during the in vitro ultrasound treatment was recorded continuously using a fine rigid
wire thermocouple and a digital thermometer (VWR Scientific). During ultrasound
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application in vitro, the temperature of the receiver compartment of the diffusion cells
was constant (23± 1 C). On the other hand, the temperature of the PBS solution in the
donor compartment increased as a function of time, and when the ultrasound treatment
time exceeded 5 minutes, the temperature in the donor compartment exceeded 40 'C. To
minimize this ultrasound-induced thermal effect, in this second set of in vitro
experiments where the ultrasound treatment time varied depending on the in vitro skin
membrane examined (protocol B), we replaced the coupling PBS solution in the donor
compartment with fresh PBS at room temperature as needed to maintain the skin surface
temperature s40 'C. During the ultrasound experiments in vivo, the temperature of the
skin surface was monitored using the same method as described above (the temperature
was measured in the donor solution-skin surface interfacial region), and the skin surface
temperature was maintained below 40 'C by replacing the coupling PBS solution in the
donor compartment with fresh PBS at room temperature as needed during the ultrasound
pretreatment phase.
5.2.2.2 In Vitro Skin Permeability and Drug Concentration Measurements
Franz diffusion cells (Permegear Inc., Riegelsville, PA) were utilized to determine the
transdermal permeability of mannitol across the three in vitro skin models (HSS, STS,
and FTS), as well as the skin concentration of mannitol in the presence and in the absence
of LFS. During LFS pretreatment, the ultrasound probe was immersed in PBS solution
(2.5ml), contained in the donor compartment of the diffusion cells, at a distance of 1 cm
above the skin surface. Ultrasound was then applied to the skin for different time periods
according to protocols A and B described above. Control experiments were performed by
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passively hydrating the skin sample in the diffusion cells in PBS without sonicating the
skin membrane during the ultrasound pretreatment phase. After the ultrasound
pretreatment phase, the donor compartment of the diffusion cells was emptied, and then
filled with a 2 ml radio-labeled test solution of mannitol. Samples were taken from the
receiver compartment (400 gi) periodically over 24 hours, and donor solution samples
(20 gl) were taken at the beginning and at the end of the experiments. The steady-state
skin permeability (P) was then calculated from the observed linear portion of the skin
permeation profile (20-24h) using the method described in Section 2.3.2.1. The skin
electrical resistance was measured during the in vitro skin permeability experiments
according to methods described in Section 2.3.2.2. 51, 83
At the end of each permeability measurement (after 24 hrs), the in vitro skin was
removed from the diffusion cell. The application site was subjected to three washing-
blotting dry cycles using a PBS solution and Kimwipe paper (VWR Scientific) to remove
any mannitol remaining on the skin surface. Next, tape stripping and tissue solubilization
procedures were carried out to determine the mannitol concentration in the skin tissue
(including both the stratum corneum (SC) and the viable skin tissue). When in vitro FTS
and STS were utilized, a series of tape strippings (10 times) was carried out for each skin
sample. Cellophane tape (Scotch 600, 3M, St. Paul, MIN) was pressed to the application
site. The tape was then withdrawn, leaving the stratum corneum (SC) on the adhesive.
The radioactivity in the skin tissue (SC) removed by the tape was measured after
solubilization with Soluene-350 (Packard). An 8-mm punch biopsy was then taken from
the center of the remaining skin tissue. The resulting skin specimen consisting of the
viable epidermis and the dermis was then weighed and solubilized in lml skin solubilizer
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(Soluene-350, Packard) to determine the amount of mannitol in the viable skin tissue.
The total amount of mannitol contained in the skin membrane was then calculated by
summing the amount of mannitol in the SC and that in the viable skin tissue in the cases
of FTS and STS. In the case of HSS, due to the lack of mechanical strength of the skin,
tape stripping was not conducted to separate the SC from the viable skin tissue
underneath, and the skin specimen (8-mm punch biopsy) consisting of both the SC and
the viable epidermis was weighed and solubilized in lml skin solubilizer (Soluene-350,
Packard) to determine the total amount of radioactivity in the skin.
5.2.2.3 In Vivo Pig Experiments
Female Yorkshire pigs (17-20kg) were purchased from local farms. The in vivo
experiments, including ultrasound pretreatment, drug transdermal transport
measurements, and drug tissue concentration measurements (tape stripping and punch
biopsy), were performed under general anesthesia with 5 mg/kg telazol (Fort Dodge
Animal Health, Fort Dodge, IA) or a combination of 22 mg/kg ketamine (Fort Dodge
Animal Health, Fort Dodge, IA) and 1.1 mg/kg acepromazine (Fort Dodge Animal
Health, Fort Dodge, IA). The hair in the dorsal test sites of the pigs examined was closely
clipped using an electric clipper, and a flanged glass chamber (donor compartment) with
an effective area of 1.77 cm2 (ultrasound experiments) or 19.6 cm 2 (control experiments)
was glued on the pig's back using a minimal amount of tissue glue (Nexaband,
Veterinary Products Laboratories, Phoenix, AZ). Note that because of the lower skin
permeability to mannitol in the absence of LFS, a larger diffusion area was utilized in the
in vivo control experiments, as compared to that utilized in the LFS experiments, to
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obtain accurate measurement of the amount of mannitol transported across the in vivo pig
skin (preliminary studies revealed that, utilizing a diffusion area of 19.6 cm2 , the level of
radioactivity in the urine samples collected from the control pigs was comparable to that
observed with the LFS-treated pigs, with both levels well above the detection limit). The
same diffusion area (1.77 cm 2) utilized in the in vitro LFS experiments was utilized in the
in vivo LFS experiments, to ensure that the geometry of the ultrasound treatment site was
identical in both cases. Before each in vivo experiment, the donor chamber was first filled
with a PBS solution to hydrate the skin for 1 h. After 1 h of hydration, ultrasound (6.5
W/cm 2, 5 sec pulses applied every 10 sec) was applied to the skin for 5 minutes in the
same manner as that used in the in vitro experiments. Immediately after the ultrasound
treatment, a 1 ml (ultrasound experiments) or a 3.5 ml (control experiments) radio-
labeled mannitol solution (~1000 gCi/ml) was applied to the ultrasound pretreated skin
site. The top of the application chamber was covered with a piece of Parafilm during the
experiments to prevent contamination or evaporation of the mannitol solution. During the
control experiments, pig skin was hydrated with a PBS solution without exposure to
ultrasound prior to the application of the mannitol solution. The diffusion rate of mannitol
across the in vivo pig skin was then monitored for 4.5 h (LFS) or 5 h (control) using the
method described next.
5.2.2.3.1 Measurement of the Skin Permeation Rate of Mannitol and
Skin Mannitol Concentration In Vivo
A catheter (8 French Polyvinyl chloride feeding tube, Kendall Curity Feeding Tube,
Mansfield, MA) was inserted into the bladder of the anesthetized pig to collect all the
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urine in order to obtain reliable short-term urine excretion data. Urine samples were
withdrawn every 15-30 min for 4.5 h (LFS) or 5 h (control) during the skin permeation
studies. Lactated Ringer's solution was given to the pig at a rate of 10ml/kg/h IV.
Atropine (Elkins-Sinn Inc., Cherry Hill, NJ) was injected IM to the pig at a rate of 0.04
mg/kg every hour. Urine samples were counted for radioactivity using a liquid
scintillation counter (model 2000 CA, Packard). Because D-mannitol is totally and
rapidly excreted once it has penetrated through the skin into the blood circulation, 10 0 we
measured the urine excretion rate of mannitol during the skin permeation studies as a
quantitative indicator of the skin penetration rate of mannitol. In so doing, we assumed
that: (i) skin penetration is the rate-limiting step during the transdermal absorbance and
the clearance of mannitol in the pig, and (ii) after the 4.5-5 h skin permeation studies, the
skin penetration rate of mannitol has reached nearly a steady-state (that is, that the
measured transdermal flux of mannitol toward the end of the in vivo experiments can be
utilized to calculate the steady-state skin permeability). Under these two assumptions, the
skin permeability to mannitol in vivo was calculated based on the urine excretion profile
I dQtusing Fick's First Law (P= J,, /AC= 1 d.)A AC dt
To assess the appropriateness of the above two assumptions for determining the
permeability of mannitol across the in vivo pig skin, we calculated the characteristic time
associated with the mannitol skin transport using the data that we obtained from the in
vitro skin permeation studies (which provide a direct measurement of the rate of the skin
penetration step). Specifically, in a separate set of in vitro experiments using split-
thickness pig skin as the skin model, we measured the lag time associated with the
mannitol transport across the pig skin to be between 2.5 and 3 h in the presence and in the
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absence of ultrasound pretreatment under protocol B, respectively. We then compared
this characteristic time associated with the skin penetration of mannitol with the
characteristic time associated with the clearance of mannitol (that is, with the half-life of
mannitol in the blood before it is cleared from the urine) to assess the appropriateness of
our first assumption. Specifically, a comparison of the characteristic time associated with
the skin transport of mannitol (2.5-3 h) with the literature value of the half-life (t2) of
mannitol (0.25-1.7 h) 111 indicates that our first assumption (that the skin penetration of
mannitol is the rate-limiting step compared to the distribution and excretion of mannitol)
is indeed a reasonable one. Regarding our second assumption, we again utilized the
measured characteristic time of the skin penetration of mannitol (lag time: 2.5-3h) to
estimate the error that may result from approximating the steady-state skin permeability
of mannitol using the mannitol permeation rate measured over 4.5-5 h of transport studies
(recall that due to the lag time phase associated with the transdermal transport, an error
would be incurred when we use the skin permeation rate measured in a pseudo-steady-
state to approximate the steady-state skin permeation rate). Assuming that the diffusion
of mannitol across the in vivo pig skin follows Fick's Second Law, 1 12, 113 the
transdermal flux measured over 4.5-5 h is within ~90% of the steady-state skin flux
value. This error is within the range of typical experimental errors that are encountered in
skin permeability measurements, and therefore, one may conclude that our second
assumption is reasonable also.
At the end of in vivo experiment (4.5 or 5 h), the application device was removed,
and the skin application site was subjected to the same washing procedure as that
described for the in vitro experiments. Next, the same tape stripping and biopsy (4-mm
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biopsy) procedures utilized in the in vitro case were implemented to determine the
mannitol concentration in the in vivo skin tissue.
5.2.2.3.2 Measurement of the Electrical Resistance of In Vivo Pig Skin
The electrical resistance of the in vivo pig skin was measured during the in vivo skin
permeation experiments following a similar procedure as that utilized in the in vitro
experiments (for details, see Ref 83). An AC-voltage-two-electrode system was utilized
to measure the skin electrical resistance in vivo according to Ohm's Law. Specifically,
at the beginning of each in vivo experiment, one Ag/AgC1 electrode (E242, In Vivo
Metrics, Healdsburg, CA) was implanted underneath the skin by making a subcutaneous
incision about 0.5 mm deep with a surgery scalpel (the electrode was held in a
subcutaneous "pocket" about 8-mm in diameter, and was maintained in good contact with
the viable tissue underneath). The second electrode was immersed in the PBS solution
contained in the donor compartment located on top of the skin. The lateral distance of the
two electrodes was 20 cm (the measured skin current was found to be insensitive to the
distance between the two electrodes). A 100 mV AC voltage (RMS) at 10 Hz, generated
by a signal generator (model HP 4116A, Hewlett-Packard), was applied across the two
electrodes for about 5 seconds. The electrical current across the skin was measured using
an ammeter (Micronta, Tandy Corporation). The electrical resistance of the skin was then
calculated from Ohm's law. Since the measured skin resistance is the sum of the actual
skin electrical resistance and the background resistance (including the other components
of the electric circuit, which include the connecting wires, the contact resistance of the
two electrodes, and the viable tissue between the two electrodes), we measured the
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background resistance and subtracted it from the measured skin electrical resistance to
obtain the actual skin electrical resistance (the background resistance was measured using
two subcutaneously implanted electrodes that were placed at a distance of 20 cm).
Because the skin electrical resistance is a sensitive indicator of the skin structure
55 (it is also known to be a sensitive indicator of the skin hydration level 114), during the
in vivo as well as during the in vitro skin permeation studies, we measured this skin
property as an indicator of the skin permeabilization state. It is noteworthy that various
factors, including the LFS-treatment, skin recovery, and skin hydration, can all lead to
changes in the skin electrical resistance values. Specifically, during the in vivo skin
permeation experiments, it was observed that after ultrasound was turned OFF (during
the post-exposure transport measurement phase), the skin electrical resistance of the pig
skin recovered gradually over time. Specifically, at the end of the 4.5 h of the transport
measurement phase, the electrical resistance of the in vivo pig skin increased by a factor
of about 1.3 compared to the value immediately after turning ultrasound OFF. On the
other hand, during the in vivo pig control experiments, the skin electrical resistance of the
in vivo pig skin decreased slightly over time during the transport measurement phase due
to the effects of skin hydration (the skin electrical resistance measured at the end of the
transport measurement phase was about 1.1 tol.2-fold lower than that measured at the
beginning of the transport phase). In contrast, the skin electrical resistance measured with
the three in vitro skin models showed different behaviors from that of the in vivo pig skin
during the LFS studies--no recovery was observed with the in vitro skin models in terms
of the electrical resistance values during the post-exposure transport measurement phase
(the skin electrical resistance of the in vitro skin models either stayed relatively constant,
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or showed a slight decrease over time due to the effects of skin hydration during the post-
exposure transport measurement phase in vitro). This observation indicates that the
mechanisms leading to skin structural recovery after exposure to ultrasound are not
operative in the in vitro skin models to the same extent that they are in the in vivo case,
and in addition, that skin hydration may play a more important role in vitro.
5.3 Results
5.3.1 In Vivo LFS Studies
To investigate the in vivo/in vitro correlation during the LFS studies for the case of
hydrophilic permeants, we carried out comparative studies of the effects of LFS on the
transport of mannitol across the in vivo skin and the three in vitro skin models. We first
conducted in vivo LFS studies to identify an efficacious and safe ultrasound protocol for
the living skin. This ultrasound protocol was then utilized to treat the three in vitro skin
models in the subsequent in vitro LFS experiments to assess the in vivo/in vitro
correlation of LFS (note that the in vivo studies allow one to identify the range of
ultrasound conditions that is safe for the living skin and that can be potentially utilized in
clinical applications, while the in vitro studies do not).
Utilizing a 5 min ultrasound pretreatment protocol (protocol A, as described in
Section 5.2), we measured the effects of LFS on the skin penetration rate of mannitol
across the in vivo pig skin, as well as on the skin electrical resistance of the living pig
skin. Figure 5-1 shows the variation of the amount of mannitol excreted from the urine
with time measured during the ultrasound (S, n=4) and the control (0, n-4) pig
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Figure 5-1: Variation of the cumulative amount of mannitol excreted from urine with
time during the in vivo pig experiments.
Key: (0) control (n=4), and (0) LFS (n=4).
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experiments (means±SD). Note that to directly compare the skin permeation rates of
mannitol in the LFS and the control cases, in Figure 5-1, the cumulative amount of
mannitol transported across the skin, Q,, was normalized by AC, the concentration
difference of mannitol across the skin, and by A, the permeation area (the y-axis in Figure
5-1 represents Q, /(AAC) in units of cm). The flux measured during the last hour of the
in vivo experiments (that is, the maximum flux), based on the urine excretion profiles,
was utilized to determine the skin permeability of mannitol (see Table 5.1).
Table 5.1: Mannitol permeability coefficients (P) of the in vivo pig skin measured based
on the urine mannitol excretion data.
a P of the in vivo pig skin was calculated from the urine excretion rate measured during the last hour of the
in vivo pig experiments (3.5-4.5 h or 4-5 h for the LES-pretreatment case and for the control case,
respectively, see Figure 5-1).
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LFS-Treated Pigs P (x106 cm/h) a
1 54.5
2 80.2
3 101
4 171
Mean±SD 102±50
Control Pigs
1 4.42
2 2.52
3 6.91
4 0.72
Mean±SD 3.6±2.6
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Figure 5-2: Time variation of the normalized skin electrical resistance of in vivo pig skin
in the presence of ultrasound.
Each number (0) indicates mean± SD (error bars) of 4 experiments. The line is drawn to
guide the eye. Ultrasound parameters utilized were 20 kHz, 6.5 W/cm 2, 5 sec ON, 5 sec
OFF, probe at a distance of 1 cm from the skin surface, total application time of 5 min.
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Table 5.1 shows that a 5 min LFS pretreatment enhanced the mean permeation
rate of mannitol across the in vivo pig skin by about 102/3.6~~28-fold. Figure 5-2 shows
the measured variation of the skin electrical resistance of the in vivo pig skin (normalized
by the initial skin electrical resistance, mean±SD of four repeats) with time during the 5
min ultrasound treatment phase. Figure 5-2 shows that as a result of a 5 min ultrasound
pretreatment, the electrical resistance of the in vivo pig skin dropped to ~5 % of its initial
value, indicating that significant skin structural alteration has occurred (recall that the
skin electrical resistance is a very sensitive indicator of the skin microscopic structure
55).
To examine whether there are any adverse effects of the LFS protocol utilized
(protocol A) on the structure of the in vivo pig skin, we conducted histological studies of
the skin site treated by ultrasound. A skin biopsy was taken at the end of the 4.5 h in vivo
LFS studies. Our histological results indicate no damage in the skin exposed to
ultrasound, as well as in the underlying tissue (see Figures 5-3A and 5-3B). The regions
of pig skin exposed to ultrasound showed no sign of abnormality during the 5 min
ultrasound exposure (protocol A). Furthermore, to assess whether there is any delayed
skin lesion due to the LFS treatment, a skin biopsy was also obtained 2 days after the
ultrasound treatment, and no skin abnormality was found (data not shown).
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Figure 5-3: Histological results for the pig skin in vivo. Figure 3A corresponds to the control (skin not exposed to
ultrasound), and Figures 3B corresponds to skin exposed to low-frequency ultrasound (20 kHz, 6.5 W/cm 2, pulsed wave,
5 min) using a skin biopsy taken 5 h after ultrasound was turned OFF.
5.3.2 In Vivo/In Vitro Correlation of the Effects of LFS on the
Skin Barrier Properties
5.3.2.1 In Vitro/In vivo Correlation of LFS under a Constant Ultrasound
Energy Dose Protocol
Based on the in vivo LFS studies reported above, we have identified ultrasound protocol
A as an efficacious and safe protocol for enhancing the skin penetration rate of mannitol
across the in vivo pig skin. We then conducted in vitro LFS permeation experiments
utilizing the same ultrasound protocol for the three in vitro skin models considered
(including full-thickness and split-thickness pig skin, and heat-stripped human cadaver
skin, referred to as FTS, STS, and HSS, respectively, in the remainder of the Chapter).
We compared the effects of LFS on the skin macroscopic barrier functions (as reflected
in the skin permeability of mannitol and in the skin electrical resistance) of the three in
vitro skin models to those observed with the in vivo pig skin under the same ultrasound
pretreatment protocol (protocol A) to establish if there is a correlation between the in
vivo skin and the three in vitro skin models for the LFS studies conducted.
Figure 5-4 shows the measured enhancement ratio of skin permeability of
mannitol (Ep) across the three in vitro skin models examined due to LFS (protocol A),
along with the result observed with the in vivo pig skin (obtained from Table 5.1). The
enhancement ratio (Ep) was calculated by taking the ratio of the permeability of the
ultrasound-treated skin to that of the control skin. Figure 5-4 shows that upon exposure to
the same ultrasound energy dose (protocol A), the enhancement ratios of the skin
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Figure 5-4: Comparison of the sonophoretic enhancement ratios of the transdermal
transport rates of mannitol, Ep, under the constant ultrasound energy dose protocol
(protocol A) for FTS, STS, HSS, and in vivo pig skin.
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Figure 5-5: Comparison of the time variation of the normalized electrical resistances of in
vivo pig skin and the three in vitro skin models examined during the LFS treatment.
Key: (0) in vivo pig skin, (O) FTS, (0) STS, and (A) HSS. Each point represents the
mean of 4-6 experiments. A typical error bar (SD) is shown for HSS and for the in vivo
pig skin at 5 min to illustrate the magnitude of the variation in the skin electrical
resistance values during the LFS treatment. The various lines are drawn to guide the eye.
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penetration rate of mannitol measured for the three in vitro skin models examined are all
comparable (less than 2.3-fold), and are significantly lower than that observed in vivo
(28-fold). Because the skin electrical resistance is a good indicator of the skin
microscopic structure, 5 1 , 55 in Figure 5-5, we plotted the variation of the skin electrical
resistance with time during the ultrasound pretreatment phase (5 min) for the three in
vitro skin models examined, as well as for the in vivo pig skin (taken from Figure 5-2).
Taken together, Figures 5-4 and 5-5 reveal that the structure of the excised skin in
vitro (for all the three in vitro skin models examined) appears less sensitive to the
ultrasound treatment than the structure of the living pig skin. Note that the electrical
resistance values of the three in vitro skin models exhibit slightly different response rates
to the LFS treatment. However, as shown in Figure 5-5, within experimental error, after 5
min of LFS treatment, these differences are not significant.
In addition to comparing the enhancement effects produced by LFS on the skin
permeation rates of mannitol across the three in vitro skin models examined and the in
vivo pig skin (see Figure 5-4), we also compared the absolute values of the skin
permeabilities of mannitol across the three in vitro skin models and the in vivo pig skin in
the presence and in the absence of LFS under the constant ultrasound energy dose
protocol (protocol A), see Table 5.2. Also listed in Table 5.2 are the values of the skin
electrical resistance, R, of the three in vitro skin models and the in vivo pig skin
determined during the skin permeability measurement phase. Table 5.2 shows that the
passive (control) permeabilities of mannitol across the three in vitro skin models are all
comparable, and are also siguificantly higher than the mannitol permeability measured
with the in vivo pig skin (p O.O5). Table 5.2 also shows that the in vivo pig skin exhibits
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a significantly higher electrical resistance than those of the three in vitro skin models
during the time periods over which the skin passive permeabilities of mannitol were
measured. Because the skin electrical resistance represents a very sensitive indicator of
the skin barrier function (or hydration level 114), this last finding indicates that during
the time period over which the passive permeabilities of mannitol across the in vivo pig
skin and the three in vitro skin models were measured, the in vivo pig skin was in a less
hydrated (or less permeable) state than the excised in vitro skin models, as indicated by
its higher average skin electrical resistance value relative to those of the in vitro skin
models, which had all been subjected to long-term skin hydration (24 h) in the diffusion
cells. This result is consistent with what has been found previously by other researchers.
For example, Yamashita et al. 115 reported that the mannitol permeability across the
excised rat skin in vitro was about 10-fold higher than that measured with the in vivo rat
skin under the same passive diffusion conditions. These authors attributed the observed
difference to the different skin hydration states of the in vivo and the in vitro skin
membranes.
In spite of the fact that the passive permeability of mannitol across the in vivo pig
skin is significantly lower than that measured with the in vitro skin models, upon 5 min
LFS treatment, the permeability of mannitol measured with the in vivo pig skin exceeds
those measured with the FTS, STS, and HSS model membranes by factors of about 3.0,
2.4, and 1.8, respectively (see Table 5.2, where the difference between the skin
permeabilities of mannitol corresponding to the in vivo pig skin and to the FTS and STS
model membranes is statistically significant, p O.O5). These findings suggest that the in
vivo skin is more sensitive to the ultrasound pretreatment than the three in vitro skin
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models examined. Indeed, the three in vitro skin models (FTS, STS, and HSS) all tend to
underestimate the efficacy of LFS, in terms of both the absolute value of the skin
permeability to mannitol, as well as the enhancement ratio of skin permeability of
mannitol due to LFS (see the EP values in Table 5.2). Table 5.2 and Figure 5-4 also show
that there is no significant difference among the three in vitro skin models examined
under the ultrasound conditions examined (protocol A), in terms of both the passive skin
permeability of mannitol, as well as the enhancement of skin permeability of mannitol
due to LFS.8
Table 5.2: Permeability coefficients (P) of mannitol and the corresponding skin specific
electrical resistances (R) of the three in vitro skin models (FTS, STS, and HSS), and of
the in vivo pig skin, in the presence and in the absence of LFS under a constant
ultrasound energy dose protocol (protocol A).
Control LFS 5 min, Protocol A
Skin Type P(xO 5cm/h) R (kQ cm2) P(x105cm/h) R (kQ cm2) Epa
FTS 2.38±0.82 46±7 3.35±1.56 37±7 1.4
STS 2.33±1.23 50±23 4.16±1.01 34±10 1.8
HSS 2.50±1.56 80±43 5.65±2.67 34±26 2.3
In Vivo Pig Skin 0.36±0.26 186±47 10.2±5.0 13±3.4 28
" The enhancement ratio of skin permeability (Ep) was calculated by taking the ratio of the permeability of
the ultrasound-treated skin to that of the control skin.
8 Although the mannitol skin permeability across HSS after 5-ruin LFS is somewhat higher than those
across FTS and STS under the same ultrasound protocol (protocol A), the observed differences are not
statistically significant.
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5.3.2.2 In Vitro/In Vivo Correlation of LFS under a Constant Skin
Electrical Resistance Protocol
From the in vitro/in vivo skin comparative studies under ultrasound protocol A presented
above, we saw that upon skin exposure to the same ultrasound energy dose, the transport
properties of the in vivo skin and of the three in vitro skin models responded to LFS, a
physical skin penetration enhancer, to different extents. As shown in Figure 5-5, the
electrical resistance of the in vivo pig skin decreased more than 10-fold after 5 min
ultrasound treatment, while those of the three in vitro skin samples remained relatively
high (decreased by less than 2-fold). This finding implies that for different types of skin
membranes, different ultrasound energy doses are needed to permeabilize the skin barrier
to a similar extent. To bridge the difference observed between the in vivo pig skin and the
in vitro skin models, we utilized a second ultrasound protocol (protocol B), during which
we varied the amount of ultrasound treatment time for the three in vitro skin models
examined until the skin electrical resistances of the three skin models reached the same
preset value. We selected the average skin electrical resistance value observed with the in
vivo pig skin during protocol A to be the preset skin electrical resistance value under
ultrasound protocol B (as shown in Table 5.2, during the in vivo LFS studies under
ultrasound protocol A, the average skin electrical resistance observed with the in vivo pig
skin was in the range of 13 3 k cm2, mean±SD, n=4). In so doing, our goal was to
investigate whether by matching the skin electrical resistance values of the three in vitro
skin models examined to that of the in vivo pig skin, one may be able to observe some
correlation between the in vivo and the in vitro LFS results. If this turned out to be the
187
case, one could then use this criterion to allow extrapolation of LFS results obtained in
vitro to the actual in vivo situation.
Table 5.3: Ultrasound application times for the three in vitro skin models (FTS, STS, and
HSS) during protocol B, and the resulting measured skin sonophoretic permeabilities of
mannitol (P) and the corresponding skin specific electrical resistances (R), as well as the
skin P and R values of the in vivo pig skin during protocol A.
LFS (Protocol B)
Skin Type
Average LFS
Application Time P(x105 cm/h) R (kQ cm2)
during Protocol B
FTS 43 8.66±1.71 12.6±3.1
STS 37 8.81±2.13 13.5±1.3
HSS 12 9.85±4.82 15.0±3.1
In Vivo Pig Skin 5 (Protocol A) 10.2±5.0 13.0±3.4
Table 5.3 shows the ultrasound application time required for the three in vitro skin
models to reach the preset skin electrical resistance value (13 ± 3 kQ cm 2) at the end of
the ultrasound pretreatment phase. Table 5.3 reveals that under the same ultrasound
conditions (including frequency, intensity, duty cycle, and probe distance), the ultrasound
energy doses (or ultrasound application times) required for the three in vitro skin models
to reach approximately the same values of skin electrical resistance are ranked in the
order: HSS<STS<FTS, with the three in vitro skin models requiring much higher
ultrasound energy doses (longer ultrasound application times) than the living pig skin
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(5min). Figure 5-6 compares the skin LFS permeabilities of mannitol, P, measured using
the three in vitro skin models under the constant skin electrical resistance protocol
(protocol B) with that of the in vivo pig skin reported in Section 5.3.1. Figure 5-6 shows
that the skin permeabilities of mannitol measured with the three in vitro skin models are
all very similar (see also Table 5.3), and that they compare favorably with that measured
using the in vivo pig skin within experimental error. This significant finding
demonstrates that, at the skin electrical resistance level examined in protocol B (13 ± 3
kQ cm2), the three in vitro skin models examined (FTS, STS, and HSS) exhibit similar
transport properties to mannnitol (the model hydrophilic permeant), and that the mannitol
skin permeabilities measured with any of these three in vitro skin models are good
quantitative predictors of the mannitol skin permeability of the living pig skin measured
at approximately the same skin electrical resistance level during LFS.
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Figure 5-6: Comparison of the skin permeabilities of mannitol across the three in vitro
skin models (FTS, STS, and HSS) with that of the in vivo pig skin under a constant skin
electrical resistance protocol (ultrasound protocol B).
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5.3.3 In Vivo/In Vitro Correlation of the Skin Concentration of
Mannitol in the Presence and in the Absence of LFS
In addition to measuring the rate of skin penetration of mannitol across the in vivo pig
skin and the three in vitro skin models examined, we also measured the amount of
residual mannitol in the skin at the end of the skin penetration studies in vivo and in vitro
under ultrasound protocol B, as well as for the passive control condition. The objective
was to quantify the effects of LFS on the skin partitioning of mannitol, as well as to
examine whether the amount of residual mannitol found in the skin tissue in vitro
correlates with that measured with the in vivo skin tissue.
Table 5.4 shows the normalized skin mannitol concentrations after the 24 h
penetration experiments in vitro, and the 4.5 or 5 h penetration experiments in vivo. Note
that the in vivo pig skin and the three in vitro skin models were all pretreated with LFS
(protocol B) or received no ultrasound treatment (controls) prior to the skin penetration
experiments (mean SD; n=4-6). To compare the amounts of residual mannitol
measured in the skin tissue in vivo and in vitro, the skin concentrations of mannitol
(gmol per cm 2 of surface) shown in Table 5.4 were all normalized by the mannitol
concentrations in the donor compartments (gmol/ml) in each skin penetration experiment
(this was required because during the in vivo and the in vitro skin penetration studies,
different concentrations of mannitol solution were utilized in the donor compartments,
see Section 5.2.2). Table 5.4 reveals that the amount of mannitol retained in the skin
tissue measured with the three in vitro skin models, during both passive diffusion and the
LFS-treatment (protocol B), compare favorably with that measured using the in vivo pig
skin (p>O.O5).
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Table 5.4: Normalized skin mannitol concentrations measured with the three in vitro skin
models examined and with the in vivo pig skin at the end of the control experiments and
of the LFS experiments (protocol B).
Skin Type * Control LFS (Protocol B) Ratio
(cm) b (cm) b
FTS c 5.69±2.15 8.34±2.66 1.47
STS c 5.44±0.97 7.41±2.48 1.36
HSS c 5.57±1.55 7.99±2.76 1.43
In Vivo Pig Skin C 4.73±0.58 7.48±2.08 1.58
a The normalized skin concentrations ((gmol per cm2 of surface)/(gmol/ml)) of mannitol were measured at
the end of the skin penetration experiments in vivo (4.5 or 5 h in the ultrasound and in the control cases,
respectively) and in vitro (24 h). Each value indicates the mean ± SD of 4-6 experiments.
b The skin concentrations of mannitol ((kmol per cm 2 of surface)) were normalized by the concentrations of
mannitol in the donor cells utilized in the skin penetration experiments.
Statistically not different from the controls (p>0.05; two-tailed t test for unpaired data).
Table 5.4 also shows that the LFS-treatment (protocol B) leads to slight increases
in the skin concentration of mannitol both in vivo and in vitro. However, a student t-test
reveals that within experimental error, the increase in the skin concentration of mannitol
(<1.6-fold) is not statistically significant (p>0.05) for both the in vivo pig skin and the
three in vitro skin models. Recall that the LFS protocol B significantly increased the skin
penetration rate of mannitol across both the in vivo and the in vitro skin membranes (the
observed enhancement ratios range from 3.6 to 28-fold, see Table 5.3). Therefore, one
may conclude that under the LFS conditions examined, the observed increase in the skin
penetration rate of mannitol outweighs the observed increase in the mannitol skin
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concentration. This result suggests that in the case of hydrophilic drugs, like mannitol,
low-frequency sonophoresis represents a good method for enhancing the skin penetration
rate (systemic absorption) of the hydrophilic drugs, 8, 26, 83 while its usefulness as a
method for the topical delivery of hydrophilic drugs, where an increase in the skin
concentration of the drug and the minimization of the systemic absorption of the drug are
the desired goals, needs to be carefully examined. Our preliminary results obtained with
mannitol as the model hydrophilic permeant tend to suggest that LFS, under the
conditions examined, may not be an ideal method for enhancing the concentration of
hydrophilic drugs in the skin.
5.4 Discussion
5.4.1 LFS Pretreatment (Protocol B) Does not Result in a
Significant Modification of the Skin Effective Pore Radius
for the Three In Vitro Skin Models Examined
With heat-stripped human skin (HSS) and full-thickness pig skin (FTS) as the model
membranes, we 83 and others 46, 48, 49 have reported that there is a quantitative
correlation between the skin permeability (P) to highly hydrophilic permeants, such as
urea, mannitol, and sucrose, and the corresponding skin electrical resistance (R) during
skin passive transport (in the absence of skin penetration enhancers). In particular, we
have recently developed a skin porous-pathway theory to rationalize the observed
relationship between the skin P and R in the case of highly hydrophilic permeants. 8 3 The
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theory predicts 83 that if the hydrophilic permeant diffuses through the skin via the same
type of "aqueous" pathway as the current-carrying ions contained in the electrolyte
solution surrounding the skin, then: (i) the skin P in vitro is linearly correlated with the
corresponding skin R on a log-log plot with a slope of -1, and (ii) the intercept of the
correlation line is a function of the skin average pore radius (r). Using this theory, one
can estimate the skin average pore radius under various skin penetration conditions, as
well as distinguish two possible types of skin diffusion enhancement mechanisms for
hydrophilic permeants induced by the skin penetration enhancers: (i) enlargement of the
skin average pore radius, and/or (ii) creation of new pores or reduction of the tortuosity of
the existing pores within the skin.9
In a recent study, 83 using FTS and HSS as the two in vitro skin models, we
investigated the skin transport rate of mannitol under a long-term LFS protocol to
elucidate the effects of LFS on the characteristics of the skin porous pathway. We
showed that during the long-term LFS protocol utilized (20kHz ultrasound at 1.6 W/cm2
was applied in a pulsed mode, 0.1 sec ON, 0.9 sec OFF, for 10 or 20 h on HSS and FTS,
respectively), the transdermal transport of mannitol across the in vitro FTS and HSS can
be adequately described by the skin porous-pathway theory. Specifically, the skin P and
R exhibit a linear correlation on a log-log plot with a slope close to -1. Utilizing the
porous-pathway theory, we estimated the effective skin pore radii of the two in vitro skin
models in the presence and in the absence of a long-term LFS treatment. Specifically, we
found that: (i) the passive skin effective pore radius of FTS and HSS are not significantly
9 Because the theory predicts that the y-intercept value of the logP-logR correlation line is a function of the
skin average pore radius (r), but not a function of the skin porosity or tortuosity, one can quantitatively
detect whether there is a significant pore enlargement effect due to the enhancer action by comparing the
intercept value of the enhancer-mediated skin penneation data with that of the control case. The two
possible mechanisms of skin diffusion enhancement can thus be distinguished. 8 3
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different (26± 19 A), and (ii) under the long-term LFS protocol utilized, the skin effective
pore radius of FTS remains unchanged, while that of HSS is significantly enlarged by the
LFS conditions utilized.83
In this Chapter, we have utilized a short-duration ultrasound pretreatment protocol
(LFS protocol B) to treat both the in vivo pig skin and the three in vitro skin models
examined to ascertain if there is a correlation between in vivo skin and the in vitro skin
models during the LFS studies. The advantage of using a short-term, higher-intensity
ultrasound pretreatment protocol versus using a long-term low-intensity LFS protocol (as
the one utilized in Ref.83) to enhance the skin permeation rate, is that the short-term
method offers higher in vivo compliance, as well as represents an ideal ultrasound
application method for future clinical applications of LFS.5 1 To gain insight into the
mechanisms of skin transport enhancement of mannitol by the short-application, high-
intensity LFS pretreatment protocol utilized in this Chapter (protocol B), we applied the
previously developed skin porous-pathway theory to quantify the effects of the LFS
pretreatment on the transport characteristics of the skin porous pathway across the three
in vitro skin models examined (FTS, STS, and HSS). Specifically, two questions were
addressed: (i) does LFS pretreatment protocol (protocol B) lead to any significant
modification of the skin effective pore radii of the three in vitro skin models examined,
and (ii) do the skin effective pore radii of the three in vitro skin models examined remain
similar under the LFS condition (protocol B) utilized in this Chapter. In a separate set of
experiments (data not shown), we measured the skin effective pore radius within STS
under the passive diffusion condition using mannitol as the model permeant, and found
195
that the passive skin effective pore radius of STS is comparable to those of FTS and HSS
(26± 19 A).83
To examine whether the LFS condition utilized in this Chapter (protocol B) leads
to any significant modification of the skin effective pore radii of the three in vitro skin
models examined, we compared the skin P and R data measured during LFS (protocol B)
with those obtained under passive control conditions (data taken from Ref 83) (see
Figure 5-7). For each of the three in vitro skin models, a single average experimental data
point is shown in Figure 5-7, corresponding to the LFS case under protocol B (each point
is the mean±SD of 4-6 experiments). Also shown in Figure 5-7 is the previously obtained
correlation trend line (dashed line) for the skin passive diffusion case with FTS, STS, and
HSS as the model membranes. Note that the intercept of this previously obtained log P-
log R correlation line corresponds to an average skin passive effective pore radius of 26
A (because FTS, STS, and HSS exhibit an identical skin average pore radius during the
passive diffusion of mannitol, these three in vitro skin models share the same correlation
line on the logP-logR plot).8 3 The objective here was to compare the y-intercept values
of the skin logP-logR data obtained with the three in vitro skin models during LFS
studies (protocol B) with that of the correlation trend line for the skin passive control case
(the dashed line in Figure 5-7). By examining whether the skin P and R data obtained
with the three in vitro skin models during LFS studies fall along the same correlation
trend line of the passive diffusion case, one can deduce whether significant pore size
modification effects have occurred in the skin membrane due to the LFS pretreatment
(protocol B). If it is found that the LFS data fall along the same trend line of the passive
diffusion data, then one may conclude that the skin effective pore radii during LFS are
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not significantly different from those found in the passive case. If, on the other hand, it is
found that the skin P and R values measured during LFS deviate significantly from the
passive correlation trend line, then one may conclude that significant modification of the
skin effective pore radii has occurred due to the LFS protocol (protocol B) utilized.
As can be seen from Figure 5-7, the LFS data corresponding to the three in vitro
skin models examined under protocol B all fall along the passive correlation trend line
(within experimental error, the y-intercept of the LFS data is not significantly different
from that of the passive correlation trend line). Therefore, Figure 5-7 shows that the LFS
pretreatment protocol (protocol B) does not lead to a significant modification of the skin
effective pore radius of the three in vitro skin models examined. In other words, the skin
effective pore radii of the three in vitro skin models after the LFS pretreatment under the
conditions utilized in this Chapter (protocol B) are all comparable to that in the passive
case.
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Figure 5-7: Comparison of the previously determined log P-log R correlation curve 83
(dashed line) for the passive in vitro skin models (FTS, STS, and HSS) with mannitol as
the model permeant, with the measured skin P and R values of the three in vitro skin
models during LFS under ultrasound protocol B.
Key: (0) FTS during LFS, (5) STS during LFS, and (A) HSS during LFS. Each point
represents mean±SD (error bars) of 4-6 experiments. The y-intercept of the dashed line
(correlation curve for the passive in vitro skin) corresponds to an average skin effective
pore radius of 26 k.83
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5.4.2 In Vitro Skin Models Characterized by Different Mechanical
Supports Exhibit Different Response to LFS under Long-
Term LFS Protocols
In a recent study,8 3 utilizing a long-term sonophoresis protocol, we demonstrated that
different enhancement mechanisms existed during LFS when different in vitro skin
preparations were utilized as the skin models (heat-stripped skin vs. full-thickness skin).
Specifically, we showed that under the same ultrasound frequency, intensity, duty cycle,
and application distance, the enhancement of the mannitol permeability across HSS was
significantly higher than that observed with FTS. Furthermore, these two in vitro skin
models also exhibited significantly different skin effective pore radii during LFS (r of
FTS after 20 h LFS remained comparable to that under passive diffusion conditions (~26
A), while r of HSS after 10 h LFS was significantly enlarged to > 125 A). These
previous findings appear inconsistent with the findings from the in vivo/in vitro
comparative studies of LFS presented in this Chapter, where the three in vitro skin
models examined were found to be essentially identical in terms of their response to LFS.
We can explain the observed differences in the results of the two studies as
follows. In the previous studies of LFS,83 although the same ultrasound parameters,
including intensity, frequency, duty cycle, and application distance, were utilized to treat
both ItS and FTS, these two in vitro skin models responded to the ultrasound treatment
to different extents over time. Specifically, in Ref. 83, the electrical resistance of HSS
reached an average value of around 0.6 kQ cm2 after 10 h of ultrasound treatment, while
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that of FTS only reached a value of around 7 kQ cm 2 after 20 h of ultrasound treatment.
As a result, our comparison of the mannitol permeability of the two in vitro skin models
during LFS in Ref. 83 was made at two very different levels of skin electrical resistance.
Due to the very different extents of skin structural perturbation experienced by these two
in vitro skin models during LFS (as indicated by the very different skin electrical
resistances of these two skin models), the skin permeability of mannitol across HSS after
10 h LFS was about 16-fold higher than that across LFS after 20 h LFS (data reported in
Ref. 83). In addition, the enhancement mechanisms of these two skin models during LFS
also exhibited significant differences. When the skin structural perturbation is less severe
(R ~7 kQ cm2), skin permeabilization occurs through the mechanism of new pore
induction and/or reduction of the tortuosity of existing pores, as observed in the case of
FTS. On the other hand, when the skin structural perturbation occurs to a greater extent
(R ~ 0.6 kM cm2 ), a new mechanism - enlargement of the skin effective pore radius -
was observed, as in the case of HSS. The different responses exhibited by HSS and FTS
to the long-term LFS protocol can be attributed to the different mechanical properties of
these two in vitro skin models. Specifically, in the case of HSS, the skin membrane is
lacking the mechanical support from the epidermis-dermis junction that is present in the
FTS. As a result, the skin barrier function of HSS is perturbed by the ultrasound
treatment (a mechanical wave) to a greater extent than that of FTS during the long-term
LFS studies. 8 3
Due to the safety constraints associated with the in vivo LFS studies, in this
Chapter, we did not adopt the same long-term LFS protocol to address the in vivo/in vitro
correlation of LFS as that utilized in the previous LFS studies in vitro 83 (a preliminary
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safety study using the in vivo pig as the animal model indicated that the long-term
ultrasound protocol adopted in Ref 83 is not suitable for in vivo studies, data not shown).
Comparing the results of the previous in vitro long-term LFS studies with those of the in
vivo/in vitro comparative studies presented in this Chapter utilizing short-term LFS
protocols (protocols A and B), we found that within the range of ultrasound conditions
examined in this Chapter (short-term LFS), the three in vitro skin models examined
appear essentially equivalent in terms of studying the efficacy and underlying
mechanisms of LFS. On the other hand, when stronger ultrasound conditions were
utilized in the in vitro LFS experiments, 8 3 HSS and FTS behaved as two very different in
vitro skin models in terms of their responses to the ultrasound treatment (the efficacy and
the underlying mechanisms of LFS associated with these two skin models differed
significantly). Based on these results, one can conclude that there are different domains
of ultrasound conditions (resulting in very different degrees of skin perturbation), for
which the different in vitro skin models may behave very differently in terms of their
responses to the LFS treatment. Therefore, it is important to compare the various in vitro
skin models with the in vivo skin case within the same domain of ultrasound conditions
(that is, at a similar degree of skin structural perturbation, as reflected in similar values of
the skin electrical resistance).
201
5.4.3 Relationship between Skin Permeation Rate of Mannitol and
Skin Electrical Resistance During LFS In Vivo
Using FTS and HSS as the in vitro skin models, we have recently shown that there is a
quantitative relationship between the skin permeability (P) to hydrophilic permeants
(such as mannitol and sucrose) and the skin specific electrical resistance (R) during LFS.
51, 83, 84 Based on this relationship, we have utilized skin electrical resistance (R)
measurements as quantitative indicators of the effect of LFS on the skin transport
properties during the studies of LFS to simplify the experimental procedures involved
(the skin electrical resistance can be measured nearly instantaneously and with less effort
than the skin permeability).5 1 , 84 To investigate whether a similar correlation exists for
the in vivo skin case, in Figure 5-8, we plotted the permeability of mannitol (P) across the
in vivo pig skin as a function of the corresponding skin electrical resistance (R) of the in
vivo pig skin. Two groups of in vivo data are shown in Figure 5-8. The open circles (0)
correspond to the passive experiments (n=4), while the filled circles (0) correspond to
the LFS experiments (n=4). A linear regression (solid line) of the eight data points
obtained from the in vivo pig experiments shows that the correlation between the in vivo
skin P and R values is reasonably good (R2 =0.9 1), with the slope of the linear regression
curve in the range of -1.33±0.42 (95% confidence interval). Figure 5-8 shows that the
passive and the LFS skin permeation data of mannitol measured with the in vivo pig skin
exhibit a general trend that is consistent with what was observed with the in vitro skin
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Figure 5-8: Relationship between the mannitol skin permeability, P (cm/h), and the skin
specific electrical resistance, R (kQ cm2), of the in vivo pig skin measured during the
LFS and the control experiments.
Key: (0) in vivo control experiments (n=4), and (0) in vivo LFS experiments (n=4; 20
kHz, 6.5 W/cm2, 5 sec ON, 5 sec OFF, probe at a distance of 1 cm from the skin surface,
total application time of 5 min). The solid line corresponds to the linear regression of the
in vivo data, including both the control and the LFS cases. The slope of the best-fit line is
-1.33±0.42 with R2=0.91.
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previously.4 6 ' 48, 49, 83 The slope value of the correlation line for the in vivo data (LFS
and passive control) is not significantly different from -l within the 95% confidence
interval. The slight deviation of the mean value of the measured slope from -1 may be
attributed to the limited number of in vivo pig experiments that were utilized to obtain the
correlation trend line.
Figure 5-8 indicates that in future LFS studies in vivo, one can potentially utilize
the skin electrical resistance measurement as an indicator of the skin permeability of
hydrophilic permeants to simplify the experimental procedures associated with the in
vivo studies for product development purposes (because of the unique nature of this skin
property-the electrical resistance of the skin can be measured nearly instantaneously
during the application of the skin penetration enhancers). To quantitatively estimate the
skin effective pore radius of the in vivo pig skin (following the method described recently
in Ref.8 3 ), and then compare that with the values determined in the in vitro skin cases
examined, a more extensive in vivo skin permeation study needs to be conducted. Indeed,
due to the experimental error associated with the skin permeation experiments, in order to
obtain reliable measurements of the correlation trend line of the skin P and R values for a
given skin permeation condition, a relatively large number of skin permeation studies
needs to be conducted. Nevertheless, based on the limited number of in vivo data
currently available, we felt that it would be instructive to carry out an initial estimation of
the skin effective pore radius for the in vivo pig skin. Based on the data shown in Figure
5-8, we estimated the average skin effective pore radius of the living pig skin to be about
15 A (since the two sets of the in vivo skin permeation data, passive vs. LFS-
pretreatment, fall along a trend line with a slope not significantly different from -1, we
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did not distinguish the skin effective pore radii in the two cases). One may then conclude,
based on the limited set of available in vivo data, that our initial estimation of the skin
effective pore radius for the in vivo pig skin is reasonable, being comparable to the value
that was estimated for the in vitro pig skin (26±19A).83
5.5 Conclusions
Under a constant ultrasound energy dose protocol (protocol A, 5 min LFS), no good
correlation was observed between the in vivo pig skin and the three in vitro skin models
examined - the effects of LFS on the barrier functions of the in vivo pig skin (as
measured by the enhancement ratio of the skin permeation rate of mannitol and by the
reduction of the skin electrical resistance) were found to be much more pronounced than
those observed with the excised skin models in vitro. In addition, upon exposure to the
same ultrasound energy dose, pig skin in vivo exhibited higher absolute values of skin
permeability to mannitol and lower skin electrical resistance than those corresponding to
the three in vitro skin models examined.
During the second set of in vivo/in vitro skin comparative studies, a modified
ultrasound protocol was utilized (protocol B), during which the three in vitro skin models
were treated with different ultrasound energy doses until the skin electrical resistance
values of the three in vitro skin models reached approximately the same value as that of
the in vivo pig skin measured during protocol A (5 min LFS). Under this constant skin
electrical resistance protocol, a good correlation was observed between the skin
permeability to mannitol measured using the three in vitro skin models and that of the in
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vivo pig skin. Taken together, the results from the two sets of in vivo/in vitro skin
comparative studies indicate that: (i) living skin in vivo is more sensitive to the
ultrasound treatment than the excised in vitro skin models, and consequently, that in
order to mimic the in vivo LFS situation, longer application times of the same ultrasound
protocol are needed during the in vitro LFS studies to be able to observe the same level of
skin permeabilization effects that are observed with the in vivo skin, (ii) when utilizing
the skin electrical resistance as a quick indicator of the skin permeabilization state of the
in vitro skin, the constant skin electrical resistance protocol leads to a good in vivo/in
vitro correlation, (iii) within the range of LFS conditions examined as part of protocol B,
the three in vitro skin models exhibited similar transport properties to mannitol and
similar skin effective pore radius values under both passive and LFS conditions.
However, when a long-term LFS protocol (higher energy dose protocol) was utilized 83
during the in vitro skin permeation experiments, the skin membrane without the dermis
support, that is, the heat-stripped skin, exhibited a different enhancement mechanism
from that of the full-thickness skin, and (iv) during the LFS studies in vivo, a semi-
quantitative P-R relationship was observed for the in vivo pig skin, similar to that
observed in the in vitro skin case. This result suggests that the electrical resistance of the
in vivo skin may be utilized as an instantaneous indicator of the permeation properties of
the living skin to hydrophilic permeants to simplify the experimental procedures and/or to
achieve real-time control of the enhancer action in vivo.
In the next Chapter (Chapter 6), I will present a general experimental protocol and
data analysis method based on Fick's Laws for predicting the skin steady-state
permeability from the measurements of the transient skin diffusion rate. The applicability
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of the prediction method will be tested using direct experimental measurements. The
Fickian diffusion model was also utilized to shed light on the skin permeation
mechanisms of different classes of model permeants (hydrophilic vs. hydrophobic).
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Chapter 6
Prediction of Steady-State Skin Permeability
of Polar and Nonpolar Permeants across
Excised Pig Skin Based on Measurements of
Transient Diffusion
6.1 Introduction
The skin of mammals provides the barrier to water loss and to the intrusion of exogenous
molecules. Skin permeability is a key parameter for characterizing the transdermal
transport of solutes, and as such, it is essential for designing and evaluating the efficacy
of transdermal drug delivery systems.5 2 Traditionally, the experimental determination of
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skin permeability requires observation of the steady-state rate, or the pseudo-steady-state
rate, of drug transport across the skin.5 2 , 116 Due to the significant barrier function of
the skin, the lag time for establishing steady-state of drug transport may be several hours
or even days. 1 17 , 118 Therefore, there is a clear need to develop new experimental
approaches to reduce the measuring time required for the determination of skin
permeabilities both in vivo and in vitro. Tojo et al. 118 and Pirot et al. 119 developed two
different approaches for predicting the steady-state skin permeability in vivo based on
measurements of the drug uptake in the skin using the tape-stripping technique. While
both methods were shown to be effective for predicting the steady-state skin permeability
in vivo, neither method is readily applicable to the in vitro case. The limitation results
from the experimental procedure involved, in that both methods make use of the tape-
stripping technique to measure drug uptake in the skin. Because tape-stripping fails to
generate uniform layers of the skin tissue (SC) removed in vitro (the skin in vitro lacks
sufficient mechanical strength), 12 0 the methods developed by Pirot et al. and Tojo et al.
cannot be readily implemented to accurately predict the skin permeability in vitro. There
are two main shortcomings associated with the current skin permeability measurement
method in vitro: (1) the process is very time-consuming (typically, 1-2 days), 1 1 8 and (2)
the skin samples are subjected to long-term hydration, a condition which is not
commonly encountered in actual clinical situations. 12 1 As a result, the skin permeability
determined under such conditions may not reflect the properties of the actual biologically
relevant skin membrane. Clearly, it is desirable to develop a shorter duration permeability
measurement protocol that would allow one to evaluate the permeability of excised skin
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samples within a clinically meaningful time frame to minimize the possible
effects/interferences associated with skin hydration.
With this in mind, we propose a noninvasive in vitro experimental protocol and a
simple data analysis method based on Fick's diffusion laws for estimating the steady-
state skin permeability in vitro based on measurements of the transient-phase skin
permeation. In this method, we use the cumulative amount of drugs transported across the
skin (Qt), which is the primary experimental quantity measured in any in vitro skin
permeation studies, to predict the skin permeability. As will be shown in the Theory
Section, by analyzing the transient Qt vs. t data of a given skin sample using a two-
parameter Fickian diffusion model developed from Fick's Second Law, the actual values
of the two model parameters (D/L 2 and KL, where D is the skin diffusion coefficient of
the permeant, L is the skin pathlength, and K is the skin/vehicle partition coefficient of
the permeant) can be determined, which then enables estimation of the steady-state skin
permeability (P= (KL)(D/L2 ) =KD/L).
In this Chapter, using split-thickness pig skin and full-thickness pig skin as the
two model membranes, the transdermal diffusion of three hydrophobic permeants
(estradiol, testosterone, and dolichol) and of two hydrophilic permeants (mannitol and
sucrose) possessing different molecular weights were studied. The two-parameter Fickian
diffusion model was utilized to predict both the steady-state skin permeability and the
entire time-course of the cumulative amount of permeant transported across the skin
based on the transient Qt vs. t data. The model predictions for each skin sample were then
compared with experimental measurements (steady-state skin permeability and the entire
time-course of permeant transport across the skin) obtained with the same piece of in
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vitro skin to test the usefulness of the method, as well as to provide insight into the skin
permeation mechanisms for the two classes of permeants examined. Specifically, as will
be shown later in this Chapter, utilizing the two-parameter Fickian diffusion model as a
tool, we demonstrated that the skin porous pathway within the excised pig skin is
significantly altered due to skin hydration during a time-course of 48 h, while the skin
lipid pathway remains largely unaffected. We then utilized a recently developed skin
porous-pathway theory, 83 along with the two-parameter Fickian diffusion model to
estimate the skin effective pore radii within the excised pig skin at different hydration
states during the diffusion cell studies. The objective here was to characterize the
hydration behavior of excised pig skin for the transport of various permeants, and to gain
insight into the mechanisms of hydration-induced skin permeabilization using excised pig
skin as the skin model.
6.2 Theory
6.2.1 Assumptions Underlying the Application of Fick's Diffusion
Laws
Fick's diffusion laws (First Law and Second Law) have been utilized extensively in the
past three decades to analyze skin permeation data.1 16, 122 In particular, Scheuplein and
Blank reported 5 2 thirty years ago that Fick's First Law (expressing the proportionality
between the solute steady-state flux, Jss, and the applied solute concentration difference,
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AC, that is, J, = (KD / L)AC = PAC)1O is satisfied quite well in describing the
transdermal diffusion of various permeants (whether the permeant is a gas, an ion, or a
nonelectrolyte, except in cases when the permeant damages the skin). The applicability of
Fick's First Law implies that the skin permeability (P) is constant, or equivalently, that
the skin can be treated as an inert homogeneous membrane whose barrier function does
not vary as the applied permeant concentration, AC, changes. In addition to Fick's First
Law, which defines the steady-state permeability of the skin (P=KD/L), Fick's Second
Law (-= D 2 , assuming that C varies only in the direction perpendicular to the
at 4r2
membrane surface, denoted by x) describes the time-dependent variation of permeant
concentration in the membrane. Taken together, D, K, L, and P are the four parameters
that are commonly utilized to describe the skin intrinsic permeation/barrier properties
(note that only three of these parameters are independent, since P=KD/L). In the
transdermal drug delivery literature, Fick's laws have been used to: (1) estimate the
transport properties (D and K) of the skin tissue for a given permeant to shed light on the
skin permeation mechanisms of various classes of permeants in the presence or in the
absence of skin penetration enhancers, 1 15, 123-134 and (2) predict the steady-state skin
permeability in vivo based on short-term skin permeation measurements to minimize the
experimental work associated with the in vivo skin permeation studies. 1 1 8, 119
10 The equation shown here is the steady-state global form of Fick's First Law, under the assumption that D
is constant everywhere in the skin (a homogeneous membrane). A more general local expression of Fick's
First Law is given by, J, = -D, (dCl / dx), where J,, is the local permeant flux at position x in the
membrane, and Dx and C, are the local permeant diffusion coefficient and concentration at position x in the
membrane, respectively.
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In spite of the differences in the boundary conditions utilized in the previous
applications of Fick's Second Law (skin absorption/desorption 1 2 4 , 127, 128 vs. skin
permeation 118, 119, 129-135), it is frequently assumed that: (1) the skin behaves as an
inert homogeneous membrane with constant D and K values (the skin barrier has been
modeled either as a single-layer barrier, 118, 119, 125, 126, 132, 135, 136 or as a two-
layer barrier with one 129-131 or two types of transdermal pathways 115, 133, 134), (2)
permeants traverse the skin via pure diffusion, and (3) no binding or enzymatic reaction
of permeants occurs inside the skin (that is, every permeant molecule that enters the skin
remains intact and can participate freely in the diffusion process). 1 18, 119 More
sophisticated mathematical modeling of transdermal transport has also been carried out
by relaxing the three assumptions above. For example, Liron et al. 12 7 studied the
desorption of water vapor from the skin using a water-concentration dependent function
to describe the water diffusivity in the SC. Simultaneous diffusion and bioconversion
models have also been developed to account for the effects of enzyme activity in the
viable skin to predict the plasma concentration of topically applied drugs in vivo, as well
as to determine the diffusion and metabolism-related parameters of the different skin
layers (SC and viable skin tissue). 13 7 -14 4
6.2.2 Selection of Theoretical Model and Model Implementation
The goal of the current studies was to propose a simple solution for improving the
traditional skin permeability measurement procedure to shorten the time of duration skin
permeation studies in vitro. With this in mind, in this Chapter, we focused on
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investigating the usefulness of the transient-phase skin permeation data for predicting the
steady-state skin permeability. To model the skin transient diffusion, we adopted the
simplest possible mathematical model- the non-steady-state solution to Fick's Second
Law for a single-layer skin membrane-, and tested whether this two-parameter model
can be utilized as a tool for determining the steady-state skin permeation rate of various
permeants in vitro based on the transient diffusion data.
Under the three assumptions stated in Section 6.2.1 (for an additional discussion
of the model assumptions, see the Appendix 6A), the well-known solution to Fick's
Second Law for a single-layer, inert skin membrane is given by:112
- Q = F(KL) 1 2 (1) exp(- (D/ L2)n27r2t) (6-1)
ACd L6 irn 
_
where Qt is the experimentally measured cumulative amount of permeant transported
across the skin, A is the skin diffusion area, Cd is the permeant concentration in the donor
cell, Q, (=Qt/(ACd)) is the normalized cumulative amount of permeant transported across
the skin expressed in units of length, and K, D, and L were defined earlier. By fitting the
experimental transient-phase Q, vs. t data to Eq. (6-1), the two model parameters (D/L 2
and KL) in Eq. (6-1) can be determined, which then enables the estimation of the steady-
state skin permeability (P=(KL)(D/L 2 )=KD/L). The two fitted model parameters (DIL 2
and KL) can then also be utilized to predict the entire time-course of the skin permeation
using Eq. (6-1).
It should be pointed out that, in the past, the same mathematical model (Fick's
Second Law with the boundary conditions of the skin permeation experiments) has been
utilized in the transdermal drug delivery literature for various purposes. Okamoto et al.
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used this mathematical model to analyze the skin permeation data of 6-mercaptopurine
(6-MP) across excised guinea pig skin to assess the effects of different chemical
enhancers on the diffusion and partitioning of 6-MP in the skin.13 2 Knutson et al. applied
Fick's Second Law to analyze the skin permeation of steroids across the hairless mouse
skin (whole skin and stripped skin) to determine the D and K values associated with the
different layers of the skin tissue (the SC and the viable epidermis/dermis). 13 1 Li et al.
applied a similar mathematical model 1 13 to accurately determine the lag time associated
with the transdermal diffusion of urea across human epidermal membrane, and to
evaluate the errors resulting from the extrapolation of the observed "linear" flux region to
the abscissa to determine lag times. 14 5 The common feature underlying previous
applications of Fick's Second Law is that it was utilized to analyze the Qt vs. t data
collected primarily during the steady-state phase of the skin permeation experiments,'1
and as a result, the model parameters, K and D, were determined based on the long-term
steady-state behavior of the skin membrane. Instead, in this Chapter, we analyze the
transient-phase skin diffusion data separately from the later-time (steady-state phase)
skin diffusion data to evaluate the applicability of the transient-phase skin permeation
data for estimating the skin permeation properties. To this end, we designed our diffusion
cell experiments such that the skin diffusion data in the transient-phase was monitored as
closely as that in the steady-state phase (higher concentrations of the test solutions of the
radiolabeled permeants were utilized in the diffusion cell studies to facilitate accurate
detection of the transient-phase skin permeation). The mathematical model (Eq. (6-1))
"' The early-stage skin permeation data were not followed closely in these previous studies partially
because the low concentrations of radiolabeled permeants utilized in the donor compartment of the
diffusion cell made the accurate collection of transient diffusion data difficult.
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was then utilized to analyze the short-term skin permeation data, from which a prediction
of the steady-state skin permeability could be made as explained above. The predicted
steady-state skin permeability was then compared with the experimental value deduced
during the observed steady-state/pseudo-steady-state phase of permeant transport to test
the validity and usefulness of the model.
6.3 Experimental Section
6.3.1 Materials
The five model permeants, D-[3H]mannitol, [14C]sucrose, [3H]estradiol, [3H]testosterone,
and [3Hi]dolichol, examined in this Chapter were obtained from American Radiolabeled
Chemicals (ARC, St. Louis, MO) with a purity 99%. The physicochemical properties of
these five model permeants are listed in Table 6.1.
Table 6.1: Physicochemical properties of the five model permeants examined.
Permeants MW log (K0 /2)
Estradiol 272 3.86a
Testosterone 288 3.31
Dolichol 1544 31.5k
Mannitol 182 -3.1
Sucrose 342 -2.34
The K/,~ values were taken from Hansch and Leo53 unless otherwise noted. a Reference . b Yu, B.,
unpublished data.
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Both mannitol and sucrose were received in solid form, and were dissolved in
PBS (phosphate-buffered saline; phosphate concentration, 0.01 M; NaCl concentration,
0.137 M; Sigma Chemical Company, St. Louis, MO) to prepare donor solutions at a
concentration of around 100 gCi/ml. Solutions of estradiol, testosterone, and dolichol,
received at a concentration of around 1mCi/ml in pure ethanol, were diluted with PBS to
obtain test solutions at concentrations of 100, 50, and 50 gCi/ml, respectively. The donor
solutions of estradiol, testosterone, and dolichol contained 10%, 5% and 5% ethanol
(v/v), respectively. Female Yorkshire pigs (40-45kg) were purchased from local farms,
and the skin (back) was harvested within one hour after sacrificing the animal. The
subcutaneous fat was trimmed off using a razor blade, and the full-thickness pig skin was
cut into small pieces and stored in a -80 'C freezer for up to 2 months. The split-
thickness pig skin (500 jm) was prepared from the full-thickness pig skin using a Padgett
dermatome (St. Louis, MO) before each experiment. Split-thickness and full-thickness
pig skin were chosen as skin models for the permeation studies of hydrophobic and
hydrophilic permeants, respectively. This was done because thinly dermatomed skin
sections ( 500 pm) were considered as good skin models for percutaneous absorption
studies of hydrophobic permeants (the thick dermal tissue contained in full-thickness skin
can present an artificial barrier for hydrophobic compounds), 10 7 , 109 while in the case of
hydrophilic permeants, for which the dermal barrier is negligible, full-thickness skin is
considered as a good in vitro skin model due to its simplicity of preparation.
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6.3.2 Methods
6.3.2.1 In Vitro Measurements of the Time-Course of Skin Permeation
and of the Steady-State Skin Permeability
Passive skin permeation studies were conducted with vertical diffusion cells (Permegear
Inc., Riegelsville, PA) following the methods described in Section 2.3.2.1, and are briefly
described here. 8 3 The donor and the receiver compartments of the diffusion cells were
filled with PBS to equilibrate the skin for an hour, and the skin electrical resistance was
measured before each experiment to check the skin quality using the previously published
methods. 5 1, 83 Skin samples with a specific electrical resistance of less than 35 kOhm-
cm2 were considered damaged and not used in the diffusion cell studies.47 The donor
compartment was then emptied, and was subsequently filled with a 2.5 ml solution of the
radiolabeled permeants. Samples were taken from the receiver and from the donor
compartments periodically during the duration of the permeation experiments (48 h). The
radioactivity in the collected samples was counted using a liquid scintillation counter
(Packard 2000 CA). The cumulative amount of permeant penetrating through the skin
(Qt) was determined as a function of time based on the measured permeant concentration
in the receiver compartment over time, and the steady-state skin permeability was
calculated based on the observed linear portion of the skin permeation profile using
Fick's First Law, P = ' 'dQ (AC~ Cd, see the Appendix 6A). The skin
AAC dt dt
electrical resistance was measured during the in vitro skin permeability experiments
according to methods described in Section 2.3.2.2. 51, 83
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6.4 Results
6.4.1 Transdermal Diffusion of the Hydrophobic Permeants:
Estradiol, Testosterone, and Dolichol
The early-stage transient-phase skin permeation data (Q, vs. t: 0-12 h) of the three model
hydrophobic permeants, estradiol, testosterone, and dolichol, across split-thickness pig
skin are plotted as a function of time in Figures 6-1(a), (b), and (c). The y-axis is the
normalized cumulative amount of permeant transported across the skin in units of cm
(recall that Q, = Qt /(ACd)). The experimental points shown in each Figure correspond to
averages of three skin samples (mean + SD). The solid lines shown in each Figure
correspond to the best-fit curves of the experimental data according to Eq. (6-1).
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Figure 6-1: Transient transdermal diffusion of the three hydrophobic permeants examined
(Q, vs. t: 0-12 h) across pig skin in vitro. (a) estradiol, (b) testosterone, and (c) dolichol.
Key: (0) experimental measurements (each point represents the mean±SD of three
diffusion experiments). The solid lines represent the best-fit curves of the experimental
data using Eq. (6-1).
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The deduced (D/L 2) and (KL) values (including the deduced values of the skin transport
lag time, tiag=L 2/6D) based on Figures 6-1(a), (b), and (c), as well as the predicted steady-
state skin pemeabilities (Pss, pred) of the three hydrophobic permeants examined, are listed
in Table 6.2. Also listed in Table 6.2 are the experimentally determined steady-state skin
permeabilities (P,,, exp) of the three model hydrophobic permeants examined. The Ps, exp
values of the three model hydrophobic permeants were determined over day 1 and day 2
of the diffusion cell studies over two arbitrarily chosen time windows (22-25 h and 41-48
h) corresponding to the observed straight-line portions of the measured Q, vs. t profiles
(see Figures 6-2(a), (b), and (c)), and are compared with the predicted steady-state skin
permeabilities (Pss, ped) based on the two-parameter Fickian diffusion model in Table 6.2.
Table 6.2: Model parameters (D/L 2 and KL) of the Fickian diffusion model estimated
based on the 0-12 h transient skin permeation data of the hydrophobic permeants,
estradiol, testosterone, and dolichol, including a comparison of the predicted steady-state
skin permeabilities (P s, pred) with the experimentally observed values (Pss, exp).
Estradiol Testosterone Dolichol
0.0134±0.0033 0.0267±0.010 0.0471±0.0079
D/L 2 (h')
0.128±0.010 0.0748±0.0164 0.00850±0.00088
KL (cm)
13.1±3.7 7.0±3.0 3.6±0.6
tiag (h)
Pss, pred 1.69±0.34 1.90±0.42 0.40±0.02
(0-12h)
(x 10-3 cm/h)
Pss, exp 1.71i0.41 1.82±0.42 0.42±0.17
(22-25h)
(x103 cm/h)
Pss, exp 1.73±0.31 1.74±0.34 0.59±0.22
(41-48h)
(x10 3_cmlh) ______________________________
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The time courses of skin penetration (Q, vs. t), corresponding to the three
hydrophobic permeants examined, measured over the entire time duration of 48 h during
the in vitro diffusion studies, are plotted in Figure 6-2, along with the skin permeation
profiles predicted by the two-parameter Fickian diffusion model. The Q, profiles were
predicted using Eq. (6-1) with the values of (D/0) and (KL) deduced from Figures 6-
1(a), (b), and (c) (see Table 6.2). In Figure 6-2, the various dashed lines represent the
predicted time-course (12-48h) of the skin permeation profiles, while the short-term skin
permeation data (0-12 h) are fitted by the two-parameter Fickian diffusion model
(denoted by the various solid lines in Figure 6-2). The experimental points shown in
Figure 6-2 correspond to averages ± SD of three skin permeation experiments. Table 6.2
and Figure 6-2 clearly show that Eq. (6-1) (a two-parameter Fickian diffusion model with
constant parameter values) not only predicts well the steady-state skin permeability, but
also captures the entire time-course of the in vitro skin permeation profiles for the three
hydrophobic permeants examined. Therefore, one may conclude that the two-parameter
Fickian diffusion model (with constant parameter values) represents a useful tool for
predicting the steady-state skin permeability of hydrophobic permeants based solely on
short-term skin diffusion data.
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Figure 6-2: Comparison of the experimentally measured time-course of the skin
penetration of the three hydrophobic permeants examined (Q, vs. t: 0-48 h) through pig
skin in vitro with the predictions of the two-parameter Fickian diffusion model.
(a) estradiol, (b) testosterone, and (c) dolichol. Key: (0) experimental measurements
(mean±SD of three diffusion experiments). The dashed lines represent the predicted skin
permeation profiles (12-48 h) using the D/L2 and KL values listed in Table 6.2, and the
solid lines represent the fitted portions of the skin permeation data (0-12 h) using Eq. (6-
1).
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We then compared the experimental skin permeability values of the model hydrophobic
permeants across the split-thickness pig skin reported in this Chapter with the literature
values. The measured skin permeabilities of estradiol and testosterone from a
PBS/ethanol solution (with 10% and 5 % ethanol v/v concentration, respectively) across
the pig skin were about 1.7x10-3 cm/h and 1.8x10-3 cm/h, respectively (see Table 6.2).
These values are of the same order as those reported previously in the literature.
Specifically, the permeabilities of estradiol and testosterone in PBS across human
cadaver heat-stripped skin were reported to be about 3.0 x10-3 cm/h and 2.0 x10-3 cm/h,
respectively, 7 and across full-thickness hairless mouse skin as the skin membrane, the
permeability of estradiol in PBS was reported to be about 7.9x10 3 cm/h.13 1 Regarding
dolichol, no literature value was found to compare against the measured permeability
(0.42 x1o-3 cm/h) reported in Table 6.2. A discussion of the lag time values observed for
the model hydrophobic permeants in this study is presented in Appendix 6B.
6.4.2 Transdermal Diffusion of Hydrophilic Permeants: Mannitol
and Sucrose
To test the feasibility of utilizing the two-parameter Fickian diffusion model with
constant parameter values (Eq. (6-1)) to predict the skin permeability of hydrophilic
permeants based on the short-term measurements of the transient skin permeation in
vitro, we conducted in vitro diffusion cell studies using two model hydrophilic
permeants, mannitol and sucrose. The transient-phase skin permeation data of the two
permeants (Q, vs. t: 0-12 h) across full-thickness pig skin are presented in Figures 6-3(a)
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Figure 6-3: Transient transdermal diffusion of the two hydrophilic permeants examined
(Q, vs. t: 0-12 h) across pig skin in vitro. (a) mannitol and (b) sucrose.
Key: (0) experimental measurements (each point represents the mean±SD of three
diffusion experiments). The solid lines represent the best-fit curves of the experimental
data using Eq. (6-1).
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and 6-3(b). The various experimental points shown in each Figure correspond to averages
of three skin samples (mean±SD). The solid lines shown in each Figure correspond to the
best-fit curves of the experimental data according to Eq. (6-1). The deduced (D/L2) and
(KL) values (including the deduced values of the skin transport lag time, tiag=L 2/6D),
based on Figures 6-3(a) and 6-3(b), as well as the predicted steady-state skin
permeabilities (PS, pred) of mannitol and sucrose, are listed in Table 6.3.
Table 6.3: Model parameters (D/L 2 and KL) of the Fickian diffusion model estimated
based on the 0-12 h transient skin permeation data of the hydrophilic permeants, mannitol
and sucrose, including a comparison of the steady-state skin permeabilities predicted by
the model (Pss, pred) with the experimentally observed values (Ps, exp).
Mannitol Sucrose
0.0529±0.0138 0.0455±0.0125
D/L 2 (h-')
2.29±1.14 1.80±0.71
KL (x 10-4cm)
3.3±0.9 3.9±1.1
tiag(h)
Pss, pred 1.11±0.26 0.839±0.397
(0-12h)
(x 10-5%cm/h)
Pss, exp 3.94±3.48 a 1.45±0.74 a
(20-24h)
(x10- 5 cm/h)
Pss, exp 5.13±3.54 b 3.17±1.16"b
(28-40h)
(x10-1 cm/h)
Pssexp 7.54±4.07" 7.41±4.29"A
(44-48h)
(x10-5_cm/h)_____________ 
________ _____
aStatistically not different from the Pss, pwed (0-12 h) values (pz>O.O5; two-tailed t test for unpaired data).
b StatistiCally different from the Pss, pred (0-12 h) values (p<O.O 5; two-tailed t test for unpaired data).
231
We then directly measured the steady-state skin permeabilities of mannitol and
sucrose (PSS, exp) based on the experimental Q, vs. t profiles, and compared these
experimental values with the corresponding model-predictions (Pss, pred). Specifically, we
measured the P, exp values for mannitol and sucrose over three different time windows
beyond the transient-phase (t >> tag) during the in vitro diffusion cell studies (20-24h, 28-
40h, and 44-48h, see Table 6.3). In addition, the deduced (D/L 2 ) and (KL) values based
on the transient-phase data were also utilized to predict the entire time-course (48 h) of
skin permeation of the two hydrophilic permeants. The resulting predicted Q, vs. t
profiles (dashed lines) are compared with the experimental values in Figures 6-4(a) and
6-4(b). The solid lines in Figures 6-4(a) and 6-4(b) correspond to the model-fitted curves
for the transient-phase skin permeation data (0-12h).
Table 6.3 shows that there are apparent discrepancies between the steady-state
skin permeabilities (Ps, pred) predicted by the model and the experimentally determined
values (Ps,, exp) for both mannitol and sucrose; the difference between Pss, prea and Pss, exp
(28-40h and 44-48h) is statistically significant (p<0.05). Moreover, Figures 6-4(a) and 6-
4(b) clearly show that the predicted time-course of skin permeation of both mannitol and
sucrose (dashed lines) show significant negative deviations from the experimentally
measured skin permeation profiles after around 20 h. Therefore, it appears that the two-
parameter Fickian diffusion model (with constant parameter values) fails to predict the
steady-state behavior of skin permeation of hydrophilic permeants across the excised pig
skin based on the measurements of short-term skin diffusion data.
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Figure 6-4: Comparison of the experimentally measured time-course of the skin
permeation of the two hydrophilic permeants examined (Q, vs. t: 0-48 h) through pig skin
in vitro with the predictions of the two-parameter Fickian diffusion model.
(a) mannitol and (b) sucrose. Key: (0) experimental measurements (mean±SD of three
diffusion experiments). The dashed lines represent the predicted skin permeation profiles
(12-48 h) using the D/L 2 and KL values listed in Table 6.3, and the solid lines represent
the fitted portions of the skin permeation data (0-12 h) using Eq. (6-1).
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It is noteworthy that the ranges of the skin permeability values of mannitol and
sucrose measured during our in vitro diffusion cell studies using excised pig full-
thickness skin as the model membrane (see the Pss, exp values measured over the three
different time windows shown in Table 6.3) compare favorably with the literature values
obtained with human epidermal membrane as the model membrane (0.79-44x10-5 cm/h
and 0.65-21 x10-5 cm/h for mannitol and sucrose, respectively 44). This result is
consistent with the previously established notion that pig skin in vitro exhibits similar
barrier functions as those of the in vitro human skin, and therefore, serves as a good skin
model of human skin for in vitro percutaneous absorption studies.5 4 , 110
6.5 Discussion
6.5.1 Implications of the Modeling Results for the Hydrophobic
and the Hydrophilic Permeants Using a Two-Parameter
Fickian Diffusion Model
Although the time course of skin permeation of both hydrophobic and hydrophilic
permeants across in vitro skin is generally described as consisting of two-phases-the
lag-time phase (transient phase) and the steady-state or pseudo-steady-state phase 116_
our attempt to utilize a two-parameter Fickian diffusion model with constant parameter
values to describe the time-dependent diffusion of both classes of permeants has revealed
dramatically different behaviors. Indeed, the observed time-dependent transdermal
diffusion of the three hydrophobic permeants examined across split-thickness pig skin
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compared favorably with that predicted by a two-parameter Fickian diffusion model with
constant parameter values (that is, the entire skin permeation time course, including both
the transient and the steady-state phases, can be described adequately by the two-
parameter Fickian diffusion model). On the other hand, for the two hydrophilic permeants
examined, the model parameters (D/L and KL, which reflect the skin intrinsic
properties) estimated from the short-term transient-phase skin permeation data did not
predict the trend of the later-time skin penetration rate. These findings indicate that
changes in the skin properties have occurred during the time course of the in vitro
diffusion cell studies, which affect the diffusion of the hydrophilic permeants, but do not
significantly affect the diffusion of the hydrophobic permeants. Therefore, the two
patterns of skin permeation profiles of polar and nonpolar permeants, as revealed by the
two-parameter Fickian diffusion model (Figures 6-2 and 6-4), provide direct support for
two important conclusions: (i) hydrophilic permeants and hydrophobic permeants follow
different types of pathways as they traverse the skin,4 8 , 122, 146 and (ii) skin hydration
alters mainly the skin porous pathway (the dominant pathway of the hydrophilic
permeants), while it does not alter significantly the barrier function of the dominant
pathway of the hydrophobic permeants (the lipoidal pathway) for up to 48 h when
excised pig skin is utilized as the skin model.
The effects of hydration on the transdermal diffusion of various classes of
permeants across hairless mouse skin have been studied previously. Our findings with
excised pig skin are consistent with what other researchers have found using hairless
mouse skin as the model membrane. 147, 148 In particular, Behl et al. conducted 147
multiple sequential measurements of the skin permeabilities of various alcohols across
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hairless mouse skin over a time course of 5 days, and found that skin hydration has
different effects on the skin permeabilities of the different alcohols, depending upon the
different hydrophilicities of the model permeants examined. Lambert et al. studied 148
the effects of skin hydration on the skin permeabilities of various hydrophobic and
hydrophilic permeants across hairless mouse skin, and reported that skin hydration leads
to enhancement of the skin porous pathway within the hairless mouse skin, but does not
significantly alter the skin lipid pathway of the excised hairless mouse skin. Previously,
the transport properties of hairless mouse skin have been studied extensively, and its
hydration tendency has been well documented. 147, 149, 150 Although excised pig skin
has been recognized as a better skin model of human skin than hairless mouse skin for in
vitro percutaneous absorption studies based on its morphological and functional
characteristics, 5 4 , 110 the effects of skin hydration on its transport properties have not
been investigated systematically in the past. Our findings indicate that caution should be
exercised when utilizing excised pig skin as the skin model for human skin during in
vitro drug permeation studies, especially in the case of hydrophilic drugs. Whereas in
vitro human epidermal membrane is less likely to be affected by long-term hydration
(that is, its permeability to hydrophilic permeants should remain stable over a time course
of several days), 14 5 , 151 excised pig skin may undergo significant hydration-induced
barrier degradation over the duration of typical in vitro diffusion cell studies (as clearly
revealed in Figures 6-4(a) and 6-4(b)). Accordingly, minimization of the exposure time of
pig skin to water during the in vitro diffusion cell studies is desirable.
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6.5.2 Two-Parameter Fickian Diffusion Model as a Useful Tool
for Studying the Mechanisms of Skin Permeation and for
Predicting Skin Permeability
The attractiveness of the method presented in this Chapter is that it provides a direct tool
for distinguishing the real lag-time effect from the skin barrier-degradation effect by
examining the measured skin permeation profile (Q, vs. t) of a given permeant. Indeed,
the model used here is capable of quantitatively detecting two types of curvatures in the
Q, vs. t curve - the lag-time-associated curvature and the curvature resulting from skin
barrier alteration. If the two-parameter Fickian diffusion model with constant parameter
values can describe the entire time course of skin permeation of a given permeant
reasonably well, then that indicates that the curved portion of the Q, vs. t curve originates
solely from the lag-time effect, and that the skin permeation pathway of that particular
permeant is not altered significantly over the time frame examined. On the other hand, if
a deviation of the model Q, vs. t prediction from the experimental values is observed
beyond a certain time point, then that indicates that significant skin barrier alteration has
occurred beyond that time point. In addition, the method presented here can be used as a
simple tool to determine the type of skin transport pathway for different types of
permeants (porous pathway vs. lipoidal pathway), since these two types of transdermal
transport pathways respond very differently to skin hydration over time.
Based on the results obtained above for the hydrophilic and for the hydrophobic
permeants examined, use of the two-parameter Fickian diffusion model with constant
parameter values provides a useful tool to predict the steady-state skin permeabilities of
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hydrophobic permeants in vitro. On the other hand, at first sight, use of the model appears
"inappropriate" in the case of hydrophilic permeants, since it underestimates the steady-
state rate of skin permeation of these permeants. Nevertheless, after considering the
implications of the model deviations from the experimental measurements in the case of
the hydrophilic permeants (see Figures 6-4(a) and 6-4(b), and recalling that the observed
deviation indicates that significant alteration of the skin barrier function has occurred
during the in vitro diffusion cell studies), we conclude that the two-parameter Fickian
diffusion model may, in fact, provide a valuable tool to estimate the permeability of a
skin membrane to hydrophilic permeants at the early stages of the diffusion cell studies
(when skin hydration is less severe). While the skin permeability values determined using
the traditional steady-state method normally correspond to a highly hydrated skin
membrane, use of the two-parameter Fickian diffusion model discussed in this Chapter
enables estimation of the permeability of a less-hydrated skin membrane (a condition
which is more typical of that encountered in the in vivo and the clinical situations).
6.5.3 Utilization of Hindered-Transport Theory to Quantify the
Effects of Hydration on the Skin Porous Pathway within
the Excised Pig Skin
The effects of water exposure on the skin structure and its baffler function have been
studied from various perspectives in the past. It has been reported that skin hydration is
capable of increasing skin permeabilities, 1 52, 153 as well as of altering the skin
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morphology and its mechanical properties.123, 154, 155 Warner et al. utilized 156
electron microscopy to visualize the effects of prolonged skin exposure to water on the
lipid ultrastructure of in vitro pig skin and in vivo human skin, and demonstrated that
water acts very similarly to a surfactant solution to disrupt the SC lamellar lipid
ultrastructure, both in in vitro pig skin and in in vivo human skin, and can produce
corneocyte separations. Biophysical characterizations of hydrated skin samples have also
been conducted with other techniques such as DSC and FTIR, with the majority of these
studies reaching similar conclusions. 1 5 7-15 9 Recently, our group has developed a theory
to quantify the effect of skin penetration enhancers on the skin transport properties of
hydrophilic permeants (which traverse the skin via a porous pathway). 8 3 Using this
theory, one can estimate the skin effective pore radii under various skin penetration
conditions, as well as distinguish two possible types of skin diffusion enhancement
mechanisms for hydrophilic permeants: (i) enlargement of the skin effective pore size,
and/or (ii) creation of new pores or reduction of the tortuosity of the existing pores within
the skin.12 Because we have shown earlier that skin hydration acts primarily on the skin
porous pathway within the excised pig skin, below, we utilize the recently developed skin
porous-pathway theory to analyze the observed skin permeation data of mannitol and
sucrose across the in vitro pig skin, in an attempt to gain insight into the mechanisms of
skin penetration enhancement by skin hydration (viewed as a skin penetration enhancer).
12 The theory predicts that if a hydrophilic permeant diffuses through the skin via the same type of
"aqueous" pathway as the current-carrying ions in the electrolyte solution contacting the skin, the measured
steady-state skin penneability (P) to the hydrophilic penneant is linearly correlated with the corresponding
skin electrical resistance (R) on a log-log plot. The slope of the log P-log R correlation line is equal to -1,
and the intercept value is a function of the skin average pore radius, but is not a function of the skin
porosity or tortuosity. Therefore, using this theory, one can quantitatively detect whether there is a
significant pore enlargement effect due to the enhancer action by comparing the intercept value of the
enhancer-mediated skin permeation data with that of the control case. As a result, the two possible modes
of skin penetration enhancement can be distinguished.
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In a recent publication, 8 3 we have demonstrated that both mannitol and sucrose
satisfy the skin porous-pathway hypothesis during passive diffusion across the excised
full-thickness pig skin. Based on the experimentally determined intercept values of the
log P-log R correlation in the case of these two permeants,3 the passive average pore
radius within excised pig skin was estimated to be 26±19 A and 28±15 A, respectively. It
is noteworthy that the skin permeability values (P) of mannitol and sucrose utilized to
estimate the skin effective pore radii of the excised pig skin reported in Ref. 11 were
obtained utilizing the traditional skin permeability measurement protocol (that is, skin
permeation studies were carried out for 24 h, and the skin permeabilities were determined
from the slopes of the measured Q, vs. t profiles, typically ranging from 20-24 h). The
skin electrical resistances were measured during the same time window, and the resulting
logP-logR correlation curve was utilized to estimate the skin average pore radius within
the excised pig skin. The skin average pore radii reported (26±19 A and 28±15 A, with
mannitol and sucrose as two permeant molecules, respectively), therefore, reflect the state
of excised pig skin at the end of the first day of the in vitro diffusion cell studies. In other
words, it corresponds to a particular hydration state of the in vitro pig skin (24 h of
hydration).
To assess the effects of skin hydration on the skin porous pathway of hydrophilic
permeants, that is, to ascertain whether skin hydration leads to significant pore
enlargement effects for the excised pig skin during the in vitro diffusion cell studies, we
evaluated the skin effective pore radii of the in vitro pig skin at various hydration states
during the 48 h diffusion cell studies utilizing the previously developed skin porous-
pathway theory, 83 and compared them with the previously reported skin effective pore
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radii of the pig skin under a 24 h hydration condition (26±19 A and 28±15 A, with
mannitol and sucrose as two permeant molecules, respectively 8 3 ). Specifically, we
divided the 48 h skin permeation measurements of each skin sample into four consecutive
time windows (0-12 h, 20-24h, 28-40 h, and 44-48 h) to represent four different hydration
states of the in vitro pig skin. We then determined the steady-state skin permeability (P)
and the corresponding skin electrical resistance (R) over each of these four time windows
separately. The permeabilities of excised pig skin to mannitol and sucrose determined
over the four time windows of the diffusion cell studies are listed in Table 6.3. During the
last three time windows (t >> tiag), the steady-state skin permeabilities were measured
using the traditional skin permeability measurement protocol (that is, the P values were
calculated directly from the slopes of the measured Q, vs. t profiles). On the other hand,
for the first time window (0-12 h), over which the majority of the skin penetration data
was in the transient phase, the "steady-state"13 skin permeability (s, pred: 0-12h) was
estimated using the method described above based upon the two-parameter Fickian
diffusion model. The two-parameter Fickian diffusion model is particularly useful here
for determining the "steady-state" permeability of a skin sample at the early stages of the
diffusion cell studies (0-12 h), that is, the model "predicts" the "steady-state"
permeability of a skin sample at its less-hydrated state without having to actually observe
the steady-state transport in the experimental Q, vs. t profile.
13 The word "steady-state" is used here to emphasize that the skin permeability is a material property of the
skin membrane (depending on the skin structure only). Even when the actual steady state of transport is not
observed over a certain time window during the in vitro diffusion cell studies, this property of the skin
membrane can still be probed.
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We then plotted the skin permeabilities (P) to mannitol and to sucrose at the four
different hydration states as a function of the corresponding skin electrical resistances (R)
measured over the same time windows (see Figures 6-5(a) and 6-5(b), respectively). Each
Figure shows four data points, corresponding to the four different skin hydration states
(0: 0-12h, A: 20-24h, 0: 28-40h, and E: 44-48h). Each data point corresponds to the
average of three different skin samples (mean+SD). Figures 6-5(a) and 6-5(b) show that
during the in vitro diffusion cell studies, as skin hydration develops (04 A-+0 40),
the skin R decreases, while the corresponding skin P increases, clearly indicating that the
skin barrier becomes increasingly permeable due to skin hydration.
Also shown in Figures 6-5(a) and 6-5(b) are the correlation trend lines for
mannitol and sucrose, which were obtained in a recent study by our group (the range
(mean±SD) of the y-intercept values of the correlation trend lines for mannitol and
sucrose was determined based on 17 and 24 skin repeats, respectively). 8 3 Specifically,
for each hydrophilic permeant examined, two trend lines are plotted in Figures 6-5(a) and
6-5(b). The y-intercept values of the two correlation trend lines plotted for each model
permeant correspond to the upperbound and to the lowerbound of the estimated skin
effective pore radii values obtained with that model permeant (26±19 A and 28±15 A for
mannitol and sucrose, respectively. Recall that the y-intercept value of the logP-logR
correlation trend line is a function of the skin effective pore radii). As discussed earlier,
these previously reported ranges of skin average pore radii estimations correspond to a
particular skin hydration state of excised pig skin during the in vitro diffusion cell studies
(that is, 20-24h of hydration). The wide range of the skin average pore radii estimated for
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Figure 6-5: Correlation of skin permeabilities (P) of the two hydrophilic permeants
examined (mannitol and sucrose), measured at different states of skin hydration during
the in vitro diffusion cell studies, and the corresponding skin specific electrical
resistances (R).
Key: (a) mannitol (n=3), and (b) sucrose (n=3). Each data point corresponds to the
average ± SD of three diffusion experiments measured over one time window during the
diffusion cell studies (0: 0-12h, A: 20-24h, 0: 28-40h, and E: 44-48h). The two
dashed lines in each Figure depict the upperbound and the lowerbound of the correlation
trend lines for the passive diffusion of mannitol and sucrose, reported recently.8 3 The
correlation windows depicted by these dashed lines correspond to a range of skin
effective pore radii of 26±19 A for mannitol, and of 28±15 A for sucrose.
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one skin permeation condition reflects the variability in different skin samples (note that,
in addition, part of the observed variation is due to the experimental error associated with
the determination of the skin P and R values). Any change that is smaller than this range
can be considered not to be statistically significant. In other words, we could not
distinguish changes in the skin average pore radius within the two ranges, 26± 19 A and
28+15 A using mannitol and sucrose as the model hydrophilic permeants, respectively.
Figures 6-5(a) and 6-5(b) show that with mannitol and sucrose as the two model
hydrophilic permeants, respectively, the four data points in each Figure (representing the
four different skin hydration states) all fall within the same correlation windows on the
logP-logR plots. Figures 6-5(a) and 6-5(b) indicate that no significant alteration of the
skin effective pore radius of the excised pig skin has occurred during the 48 h in vitro
diffusion cell studies. Therefore, one may conclude that skin hydration, as an effective
skin penetration enhancer, 147, 148, 156 does not affect significantly the skin effective
pore radii within the excised pig skin during the time-course of a 48 h skin permeation
study. In view of the above, hydration modifies the skin porous pathway (and as a result,
enhances the transport of hydrophilic permeants) mainly through inducing new pores in
the pig skin and/or making the existing skin porous pathway less tortuous (as reflected by
the decrease in the skin R values). 83 The above result indicates that the transport of
hydrophilic permeants across the hydrated excised pig skin remains hindered. 4 3
Recently, we studied the effects of low-frequency ultrasound (20 kHz) on the skin
porous pathway of hydrophilic permeants, 83 and found that the ultrasound treatment
under the conditions examined (1.6 W/cm2, 0.1 sec ON 0.9 sec OFF, total application
time of 24 h) does not alter significantly the skin effective pore radii within the full-
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thickness pig skin, and that the enhancement of skin permeation of hydrophilic permeants
by ultrasound results from the induction of new pores and/or the reduction of the
tortuosity of the existing pores. Comparing the effect of low-frequency ultrasound 83
with that of skin hydration discussed in this Chapter, one may conclude that these two
enhancers, one physical (ultrasound) and the other chemical (water), under the
experimental conditions examined, act through a similar mechanism in enhancing the
skin permeation of the hydrophilic permeants. The discussion above demonstrates that
the skin porous-pathway theory developed recently by our group may serve as a useful
tool to assess the effects of skin penetration enhancers (such as hydration) on the skin
microscopic structure, and allows one to probe the mechanisms of skin transport
enhancement in the case of hydrophilic permeants. The theory may also be potentially
applied to other skin penetration enhancers, including chemical enhancers and
iontophoresis.
6.6 Conclusions
I showed that the two-parameter Fickian diffusion model with constant paramter values
represents a simple, yet very useful, tool for studying the skin permeation of both
hydrophobic and hydrophilic permeants. The model can be utilized to quantitatively
distinguish the real lag-time effects from the skin barrier degradation over time in a
measured skin permeation profile (that is, to detect whether and when significant
modification of the skin baffler function has occurred due to the action of skin
penetration enhancers, such as hydration, during the in vitro diffusion cell studies). With
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excised pig skin as the model membrane, we demonstrated that: (i) in the case of
hydrophobic permeants, the two-parameter Fickian diffusion model with constant
parameter values serves as a useful tool for predicting the skin steady-state permeability
across the in vitro pig skin based on the short-term measurements of the transient skin
diffusion, and therefore, can be utilized to shorten the experimental time required for
determining the skin permeabilities of these permeants, (ii) in the case of hydrophilic
permeants, excised pig skin undergoes significant hydration-induced barrier degradation
over the duration of typical in vitro diffusion cell studies (t >20 h). Our results indicate
that caution should be exercised when utilizing excised pig skin as the skin model for
human skin during in vitro drug permeation studies. While the skin permeability values
determined using the traditional steady-state method normally correspond to a highly
hydrated skin sample, the two-parameter Fickian diffusion model with constant
parameter values enables an estimation of the skin permeability of the skin membrane at
its less-hydrated state (a condition which is more representative of the in vivo and the
clinical situations).
Utilizing the two-parameter Fickian diffusion model and a recently developed
skin porous-pathway theory, we also characterized the effects of skin hydration on the
skin porous pathway of hydrophilic permeants within the excised pig skin. We found that
hydration leads to induction of new pores/reduction of the tortuosity of existing pores
within the excised pig skin during the 48 h diffusion cell studies conducted, while the
average skin pore radii remain relatively constant for up to 48 h.
In the next Chapter (Chapter 7), a summary of the thesis as well as a discussion of
possible future research directions will be presented.
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Appendix 6A-Model Assumptions
In addition to the three main assumptions presented in Section 6.2.1, the applicability of
Eq. (6-1) also assumes that the concentration of the permeant in the donor compartment
(Cd) is maintained constant, while that in the receiver compartment (Cr) is zero
throughout the 48 h experiments. The appropriateness of utilizing Eq. (6-1) to predict the
48 h skin permeation data (Q, vs. t) under the experimental conditions examined was
evaluated using a mass balance method. Specifically, we calculated the amount of
permeant that had left the donor compartment and entered either the skin tissue or the
receiver compartment during the 48 h diffusion cell studies to evaluate the variations in
the values of Cd and Cr. We assessed the maximum changes in the values of (Cd-Cr) for
the five model permeants examined. For estradiol and testosterone, the two most
permeable permeants among the five model compounds tested, the relative changes in the
values of (Cd-Cr) were found to be less than 6% and 7%, respectively, during the 48 h
diffusion cell studies. For dolichol, mannitol, and sucrose, the relative changes in the
values of (Cd-Cr) during the 48 h experiments were found to be less than 1%. Therefore,
the assumption underlying Eq. (6-1) regarding a constant concentration difference across
the skin is satisfied reasonably well. Accordingly, the observed deviation of the
experimentally measured (Q, vs. t) curves from the model predictions, in the case of the
hydrophilic permeants (see Figures 6-4(a) and 6-4(b)), cannot be attributed to changes in
the permeant concentration difference across the skin during the in vitro diffusion cell
studies.
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Appendix 6B-Comparison of Experimental Lag Time
Associated with Transdermal Transport of Estradiol
with Literature Values
The lag time of estradiol transport across the split-thickness pig skin observed in our
studies (~13h, see Table 6.2) is significantly larger than that reported for human heat-
stripped skin (~40 min).34 We hypothesize that this difference is mainly due to the
different thicknesses of the viable skin tissues present in these two types of skin
membranes-the split-thickness pig skin examined here contains a layer of viable
epidermis and dermis with a thickness of about 475 pm (if we assume that the thickness
of the pig SC is 25 pm 160), while the human heat-stripped skin has only about 50-100 pm
thickness of viable epidermis. 52 Because of the lack of literature data on the transport lag
time of estradiol across split-thickness pig skin, in order to corroborate our proposed
explanation, we compared the pig skin lag time data with previously reported lag time
values of excised hairless mouse skin, a skin membrane that also displays a significant
thickness of viable tissue. Based on the data reported by Tojo et al. 129 and by Knutson et
al. 13 1, the lag time of estradiol transport across hairless mouse skin ranges from 2.5-4 h.
Since the thickness of the SC and the viable epidermis/dermis in the hairless mouse skin
is thinner (10 and 370gm, respectively) than that in the split-thickness pig skin case
(25gm and 475gm, respectively), we used a previously reported method 129, 130 to
extrapolate the lag time data obtained by Tojo et al.129 for hairless mouse skin to predict
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the lag time of estradiol transport across the split-thickness pig skin, assuming that the
transport properties (D and K values) of the two types of in vitro skin are similar, except
that the thicknesses of the two types of skin membranes are different. The resulting
estimated lag time of estradiol transport across the split-thickness pig skin ranges from 7-
12 h, which is in very good agreement with the result that we obtained during our in vitro
pig skin experiments (tiag of estradiol ~13h).
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Chapter 7
Thesis Summary and Future Research
Directions
7.1 Thesis Summary
Over the last four decades, ultrasound has been used extensively for medical diagnostics
(imaging of babies) and physical therapy. Previous work by our group has shown that
ultrasound at a frequency of 20 kHz significantly enhances transdermal transport of
drugs, a phenomenon referred to as Low-Frequency Sonophoresis (LFS). Low-frequency
ultrasound was also found to increase the permeability of human skin to high-molecular
weight proteins, thus making transdermal administration of these molecules potentially
feasible.
The enhancement of transdermal drug transport by low-frequency sonophoresis
(LFS, 20kHz) may result from enhanced diffusion due to ultrasound-induced skin
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alteration and/or from forced convection. To understand the relative roles played by these
two mechanisms in LFS, a combined theoretical and experimental investigation was
conducted (see Chapter 2). A theory describing the transdermal transport of hydrophilic
permeants in both the absence and the presence of ultrasound was developed using
fundamental equations of membrane transport, hindered-transport theory, and
electrochemistry principles. With mannitol as the model permeant, the role of convection
in LFS was evaluated experimentally with two commonly used in vitro skin models-
human cadaver heat-stripped skin (HSS) and pig full-thickness skin (FTS). My results
suggest that convection plays an important role during LFS of HSS, while its effect is
negligible when FTS is utilized under a long-term LFS protocol (9-20 h). The theory
developed was utilized to characterize the transport pathways of hydrophilic permeants
during both passive diffusion and LFS with mannitol and sucrose as two probe
molecules. Results show that the porous pathway theory can adequately describe the
transdermal transport of hydrophilic permeants in both the presence and the absence of
ultrasound. Ultrasound alters the skin porous pathways by two mechanisms: (1) enlarging
the skin effective pore radii, or (2) creating more pores and/or making the pores less
tortuous. During passive diffusion, both HSS and FTS exhibit the same skin effective
pore radii (r = 28±13 A). In contrast, during LFS, r within HSS is greatly enlarged (r >
125 A), while r within FTS does not change significantly (23±10 A). The observed
different roles of convection during LFS across USS and FTS can be attributed to the
different degrees of structural alteration that these two types of skin undergo during the
long-term LFS protocols utilized (9-20 h). The theory developed not only can be utilized
to characterize the effects of LFS (a physical skin penetration enhancer) on the skin
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microscopic transport properties (r, skin effective pore radius, and Ei, the ratio of skin
porosity to tortuosity) of hydrophilic permeants, but can also be used to predict the skin
permeation rates of these compounds in the presence of LFS. In addition, the theoretical
framework developed can potentially be used to study the transport enhancement
mechanisms of other skin penetration enhancers, such as chemical enhancers (for
example, water, see Chapter 6) and iontophoresis.
Two-Photon Microscopy (TPM) was utilized to examine the cellular distribution
of the skin transport pathway of hydrophilic permeants in the presence and in the absence
of LFS (see Chapter 3). Based on the TPM imaging of the 3D-distribution of a
hydrophilic probe (Sulfurhodemine B) in the skin, the relevance of the intercellular and
intracellular domains for the transport of hydrophilic permeants was inferred. My results
revealed that the distribution of the skin pathway of hydrophilic permeants in the absence
of LFS is primarily intercellular (between the cornified cells). Application of LFS causes
the formation of localized transport regions on the skin, and within each localized
transport region, the distribution of the skin pathway of hydrophilic permeants is a
function of the skin depth. Specifically, in the superficial region of the skin, the pathway
is both intercellular and intracellular, while in the deeper regions of the skin barrier
(Stratum Corneum, SC), the pathway is primarily intercellular. This inhomogeneous 3D-
distribution of the hydrophilic probe in the SC suggests heterogeneity in the nature of the
skin permeabilization mechanisms by LFS, which may be attributed to the cavitation
mechanism.
In Chapter 4, the role of ultrasound-induced cavitation during LFS was
investigated systematically using a series of physical and chemical cavitation detection
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techniques. First, a high-pressure LFS cell was constructed to selectively suppress
cavitation in the LFS system, while not affecting the non-cavitational effects of
ultrasound, to test the importance of cavitation during LFS, and an acoustic method was
utilized to directly monitor cavitation activity in the LFS system. The results from the
high-pressure LFS cell studies provide direct experimental evidence that ultrasound-
induced cavitation indeed plays the key role during LFS. By selectively suppressing
cavitation outside the skin using a high-viscosity coupling medium, I further
demonstrated that cavitation occurring outside the skin is responsible for the skin
permeabilization effect, while internal cavitation (cavitation inside the skin) was not
detected using the acoustic measurement method under the ultrasound conditions
examined. Acoustic measurements of two possible types of cavitation activity (transient
vs. stable) indicate that transient cavitation plays the dominant role in inducing skin
permeabilization. Finally, through quantification of the transient cavitation activities at
two specific sites of the LFS system using chemical and physical dosimetry techniques,
including comparing the dependence of the measured cavitation activities on ultrasound
intensity with that of the skin permeabilization effect, I demonstrated that transient
cavitation occurring on, or in the vicinity of, the skin membrane (asymmetric bubble
collapse) is the central mechanism that is responsible for the enhancement of skin
permeability by LFS. This finding suggests that LFS-induced skin permeabilization
results primarily from the direct impact of gas bubbles collapsing on the skin surface
(resulting in microjets and shock waves). Histological studies with in vivo pig skin
showed that under the LFS conditions examined, no skin damage is detected.
Accordingly, future investigations directed at the optimization of the LFS conditions
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should aim at localizing the transient cavitation activity in the vicinity of the skin
membrane, for example, by utilizing focused ultrasound.
To investigate the in vivo/in vitro correlation during LFS, as well as to identify
the relevant in vitro skin models for in vitro LFS studies to predict the effects of LFS in
vivo, a comparative study of LFS with in vivo and in vitro skin was conducted using pig
as the animal model (see Chapter 5). Three types of well-accepted in vitro skin models in
the passive transdermal transport literature, heat-stripped skin (HSS), split-thickness skin
(STS), and full-thickness skin (FTS), were examined. My results showed that upon
exposure to the same ultrasound energy dose, no good correlation is observed between
the in vivo skin and the three in vitro skin models studied, including HSS, STS, and FTS.
When using the skin electrical resistance as a quick indicator of the skin permeabilization
state during LFS, the difference between the in vivo and the various in vitro skin models
can be diminished. Specifically, under a constant skin electrical resistance protocol
(during which the in vivo and the in vitro skin samples were treated with different
ultrasound energy doses to reach the same preset electrical resistance value determined
by the in vivo value), a good correlation was observed between the LFS permeability of
mannitol measured using the three in vitro skin models and that of the in vivo pig skin.
Histological studies conducted with the in vivo pig skin showed that the LFS protocol (5
min pretreatment with LFS) that was shown to be efficacious in enhancing the skin
penetration rate of mannitol across the in vivo pig skin, and was also utilized for the in
vivo/in vitro skin comparative studies, is safe for the living skin.
Since in an earlier set of mechanistic studies of LFS in vitro (see Chapter 2), using
a long-term LFS protocol (9-20 h), I demonstrated that HSS and FTS undergo different
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degrees of structural alteration during LFS, comparison of these previously obtained
results with those obtained from the in vivo/in vitro correlation studies clearly indicate
that there are different domains of ultrasound conditions (resulting in very different
degrees of skin perturbation), for which the different in vitro skin models may behave
very differently in terms of their responses to the LFS treatment. Under the short-term
LFS conditions examined in the in vivo/in vitro correlation study, the three types of in
vitro skin models are essentially equivalent in terms of studying the efficacy and
mechanisms of LFS. However, when stronger ultrasound conditions were utilized in the
in vitro skin permeation experiments (like the long-term LFS protocols examined in
Chapter 2), HSS and FTS behaved as two very different in vitro skin models in terms of
their responses to the LFS treatment (the efficacy and the underlying mechanisms of LFS
associated with these two skin models differed significantly). Therefore, one may
conclude that it is important to choose appropriate ultrasound conditions during the in
vitro LFS studies in order to extrapolate the in vitro results to the in vivo skin case. With
this in mind, the in vivo/in vitro LFS correlation studies conducted as part of this thesis
provide valuable guidelines for this extrapolation.
The in vivo/in vitro LFS correlation studies (see Chapter 5) also revealed that
there is a good correlation between the skin concentration of mannitol (the model
hydrophilic permeant examined) in the in vivo skin and those in the three in vitro skin
models. In addition, the LFS-induced flux enhancement is found to be significantly
higher than the enhancement of the skin concentration of mannitol both in vivo and in
vitro. This result suggests that LFS represents a good method for enhancing the systemic
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absorption of hydrophilic permeants, while it may not be an ideal method for enhancing
topical drug delivery for the same class of permeants.
In an attempt to develop a general experimental protocol to shorten the skin
permeability measurement procedure, I evaluated the usefulness of a two-parameter
Fickian diffusion model (with constant parameter values) for predicting the skin steady-
state permeation rates of both hydrophobic and hydrophilic permeants from short-term
measurements of skin diffusion (see Chapter 6). My results demonstrated that this
Fickian diffusion model represents a useful tool for predicting the skin steady-state
permeability of hydrophobic permeants, as well as the entire time-course of the skin
permeation profile of this class of permeants. On the other hand, in the case of
hydrophilic permeants, the same model can be used to estimate the permeability of a skin
membrane at its less-hydrated state, although it does not predict the entire time-course of
the skin permeation profile of this class of permeants due to the skin barrier degradation
over time. By modeling the transdermal diffusion of both hydrophilic and hydrophobic
permeants using the same Fickian diffusion model, important mechanistic insight was
obtained regarding the transport mechanisms of these two classes of permeants, as well as
regarding the effects of skin hydration on the barrier functions of excised pig skin in
vitro: (i) hydrophilic permeants and hydrophobic permeants follow different types of
penetration pathways as they traverse the skin, (ii) skin hydration alters mainly the skin
porous pathway (the dominant pathway of the hydrophilic permeants), while it does not
alter significantly the baffler function of the dominant pathway of the hydrophobic
permeants (the lipoidal pathway) for up to 48 h when excised pig skin is utilized as the
skin model, and (iii) utilizing the previously developed skin porous-pathway theory (see
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Chapter 2), I found that skin hydration (water viewed as a skin permeation enhancer)
affects the skin porous pathway through a mechanism of induction of new pores/making
the existing pores less tortuous (a mechanism similar to that of LFS). In other words, the
transport of hydrophilic permeants across the hydrated excised pig skin remains hindered.
7.2 Future Research Directions
Future tesearch can be conducted along the following five directions to address both
fundamental aspects (7.2.1-7.2.3) and practical aspects (7.2.4-7.2.5) concerning the LFS
technique.
7.2.1 Understanding the Origin of the Localized Transport Region
during LFS and Achieving Control over Its Formation
In Chapter 3, it was found that 20 kHz LFS induces the formation of a single localized
transport region (LTR) on the skin membrane. TPM imaging of the probe distribution in
the skin indicated that significant skin permeabilization occurred in the localized
transport region (LTR), while the structure of the rest of the skin area remained
approximately unchanged during LFS (see Chapter 3). Therefore, one may conclude that
in order to maximize the efficacy of the LFS technique, there is a need to understand and
subsequently control the formation of the LTR on the skin during LFS. With this mind,
the first objective is to understand the origin of the LTR formed during LFS (20 kllz).
A plausible explanation for the formation of the LTR during LFS (20kHz) is as
follows. The heterogeneity in the lateral distribution of the model hydrophilic probe
(SRB, see Chapter 3) in the skin (that is, the observed formation of the LTR) may be
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attributed to the heterogeneity in the cavitation zone in the coupling medium on top of the
skin during LFS. It is known that when a cavitation bubble collapses in a liquid, more
cavitation events may take place in its vicinity during the subsequent acoustic cycles,
because the small bubbles originating from this collapsing bubble can act as additional
cavitation nuclii. 19 It is also known that unevenness on a solid surface acts as an ideal
nucleation site for cavitation. 19 Therefore, we hypothesize that initial cavitation events
that take place on the skin surface due to exposure to 20 kHz ultrasound result in the
formation of a localized cavitation zone on top of that particular skin site during the
subsequent acoustic cycles (that is, the irregularities/unevenness of the skin surface
caused by the initial cavitation events lead to nucleation of more cavitation bubbles on
that same site on top of the skin membrane during the subsequent acoustic cycles).
Because the cavitation zone is "locked" on top of one specific skin area, the cumulative
effects of cavitation-induced mechanical stresses lead to the formation of a single LTR
during LFS (20kHz). On the other hand, the rest of the skin area is not exposed
effectively to significant amounts of cavitation energy, and therefore, remains similar to
the control skin.
To confirm the above hypothesis, the following experiments may be conducted:
(i) purposely introducing cavitation nucleation site(s) on the skin surface (for example, by
introducing artificial skin defects) prior to exposure to 20 kHz ultrasound to test whether
the location of the LTR is determined by that of the pre-introduced cavitation site(s) on
the skin. If the pre-introduced cavitation site(s) indeed determine the formation of the
LTR during LFS (20 kHz), one can then perform additional studies to optimize the
ultrasound application conditions (such as frequency, intensity, coupling medium, and
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patterning of the skin surface with nucleation sites) in order to maximize the efficacy of
LFS. Some initial thoughts along this line would involve manipulating the cavitation field
on top of the skin to make full use of the entire skin transport area, so that a higher
transport enhancement ratio can be achieved subject to the skin safety constraints (see
Section 7.2.5).
7.2.2 Biophysical Characterization of Ultrasound Effects on the
Skin Structure at the Molecular Level
In this thesis, utilizing hindered-transport theory and macroscopic measurements of skin
transport rates and skin electrical resistance, I demonstrated (see Chapter 2) that
hydrophilic permeants traverse the skin via a porous (aqueous) pathway, and that LFS
alters the skin porous pathway of hydrophilic permeants through two mechanisms
(increasing the skin effective pore radius, or increasing the ratio of skin porosity to skin
tortuosity). The effects of LFS on the skin structure can also be probed at the molecular
level using various biophysical techniques to gain insight into the structural basis of these
ultrasound-induced changes in the skin transport properties during LFS. Specifically, in
the transdermal transport literature, the effects of various chemical enhancers on the skin
components (lipids and protein-filled corneocytes) have been probed using Fourier
Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC),
Nuclear Magnetic Resonance Spectroscopy (NMR), and x-ray diffraction 30, 85 to
provide insight into the molecular mechanisms of penetration enhancement induced by
these chemical enhancers. 16 1 162 163 It will be infonnative to conduct similar
biophysical studies of LFS to characterize the LFS-induced skin structural changes at the
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molecular level, which will then enable a comparison of the molecular mechanisms
responsible for the action of LFS with those responsible for chemical enhancer action.
Specifically, these biophysical techniques can be combined with the Two-Photon
Microscopy (TPM) technique to gain insight into the effects of ultrasound on some
particular structure of the stratum corneum (SC), such as the lipid-protein envelope
surrounding the corneocytes, which has important implications for the barrier properties
of the SC. 7 0 , 135 Preliminary TPM imaging studies of in vitro human skin exposed to 20
kHz ultrasound (see Chapter 3) revealed that LFS causes some degree of probe
penetration into the corneocytes (particularly at the superficial layers of the SC). In other
words, the imaging results suggest that some of the covalently-bound lipid-protein
envelopes of the corneocytes have become permeabilized by LFS, particularly at the
superficial layers of the SC, which could contribute to the observed enhancement of skin
permeability during LFS (the skin tortuosity is decreased due to the formation of
intracellular pathways). To confirm this mechanistic finding, a thermal analysis technique
(DSC) can be utilized to investigate whether the covalently-bound structures of the cell
envelopes of the corneocytes have been disturbed by LFS. A thermal transition near 80
'C is believed to be associated with this cell envelope (covalently-bound lipids with the
proteins). A recent publication has shown7 0 that when the lipid-protein cell envelope is
missing from the SC, the 80 *C thermal transition peak disappears completely from the
DSC profile. Therefore, DSC may be utilized as a useful tool to study the effects of LFS
on the conformation of the various forms of skin lipids (lipid lamellae and the cell
envelope), which are responsible for maintaining the baffler function of the skin.6 8 -7 0
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7.2.3 Quantification of the Effects of LFS on the Skin Transport
Properties Using Two-Photon Microscopy
Two-Photon Microscopy (TPM) is a technique that permits the 3D visualization in
unfixed skin samples of the cellular distribution of fluorescent probes after topical
applications. In a recent publication by Yu et al., 164 a theoretical framework and
experimental method have been developed based on the TPM technique for quantifying
the chemical enhancer (oleic acid)-induced changes in the skin transport properties, such
as the skin diffusion coefficient (D), the vehicle to skin surface partition coefficient (K),
and the skin barrier thickness (h). This method can also be utilized in the LFS case to
quantify the effects of LFS (a physical enhancer) on the skin transport properties (D, K,
and h) to shed light on the mechanisms of LFS action. Subsequently, the mechanisms of
LFS can be compared with those of chemical enhancers (such as oleic acid 164 ) to
elucidate whether there is any difference in the enhancement mechanisms of these two
different classes of skin penetration enhancers (physical vs. chemical) for the transport of
both hydrophilic and hydrophobic permeants.
7.2.4 Understanding the Dependence of the Effects of LFS on
Ultrasound Frequency
In a recent study by our group,5 1 in an attempt to optimize ultrasound parameters for the
application of LFS, studies have been conducted to address the dependence of 20 kHz
LFS on the various ultrasound parameters, including intensity, duty cycle, and pulse
length. Results showed that the enhancement of skin permeability varies linearly with the
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ultrasound intensity and the ultrasound ON-time (in the case of pulsed ultrasound, the
ultrasound ON-time equals the product of the total ultrasound application time and the
duty cycle), while it is independent of the ultrasound duty cycle and pulse length.
However, the dependence of the effect of LFS on ultrasound frequency remains
unclear. Ultrasound frequency is an important parameter that can be tuned to control the
biological applications of ultrasound, particularly in the case of LFS, where cavitation
was found to play a key role for skin permeabilization by LFS (the cavitation field is a
strong function of the ultrasound frequency 165). Additional studies should be conducted
to elucidate the relationship between the effect of LFS and the ultrasound frequency.
Subsequently, one can utilize this understanding to optimize the ultrasound application
conditions (frequency, intensity, and treatment time) for the design of clinical LFS
devices.
7.2.5 LFS Safety
Preliminary LFS (20 kHz) safety studies have been conducted as part of this thesis, as
well as in Ref.8. However, the ultrasound conditions utilized in these studies are
limited--only one ultrasound frequency (20 kHz) and a single ultrasound treatment were
examined. Future safety assessments of the effect of a single, as well as of multiple, LFS
exposures under different ultrasound conditions (frequency, intensity, and treatment time)
should be undertaken. The latter is of special importance for the delivery of chronic
drugs, such as insulin, where the skin of patients will be treated with ultrasound
repeatedly. Histological studies and skin electrical resistance measurements should be
conducted with in vivo animal models (rat or pig) to address two issues regarding skin
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safety: (a) acute and delayed effects of ultrasound on living skin tissue (histology), and
(b) reversibility of the skin barrier properties after LFS, as measured by the skin electrical
resistance (a good indicator of the skin barrier function).
The in vivo skin safety study is important for the practical applications of LFS. It
can also provide important guidelines for the selection of ultrasound conditions for the in
vitro LFS studies, in that the degree of skin perturbation observed with the in vitro skin
should be within the safety limits (as indicated by the skin electrical resistance value)
dictated by the in vivo skin safety study to ensure that the in vitro LFS results have
meaningful implications for the in vivo case.
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